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1 Summary	Correct	 gene	 expression	 patterns	 are	 central	 for	 cellular	 function	 and	 the	development	 of	 organisms.	 This	 is	 controlled	 by	 regulatory	 elements	 such	 as	enhancers	and	promoters.	In	this	thesis,	I	present	work	from	two	projects	with	the	 goal	 to	 identify	 design	 principles	 of	 promoter	 and	 enhancer	 activity	 in	mammalian	genomes.	In	the	first	part	of	the	thesis,	I	focused	on	CpG	island	promoters.	This	promoter	type	represents	the	majority	of	mammalian	promoters	and	is	characterised	by	a	high	 density	 of	 the	 CpG	 dinucleotide.	 However,	 to	 what	 extent	 and	 how	 this	characteristic	dinucleotide	contributes	to	promoter	activity	is	still	unclear	and	is	one	 central	 question	 of	 this	 project.	 By	 monitoring	 binding	 of	 transcription	factors	 (TFs)	 assumed	 to	play	a	 role	 in	CpG	 island	activity	 and	quantifying	 the	activity	of	promoter	mutants	and	artificial	promoters,	we	gained	insight	into	the	role	 of	 CpGs	 in	 transcriptional	 activity.	 The	 generated	 data	 suggests	 that	 high	CpG	 density	 is	 not	 sufficient	 for	 transcriptional	 activity,	 yet	 necessary	 when	combined	 with	 more	 complex	 TF	 binding	 motifs.	 We	 could	 further	 show	 that	DNA	methylation	decreases	activity	of	promoter	mutants	with	low	CpG	density.	Our	 experiments	 led	 us	 to	 hypothesise	 that	 high	 CpG	 density	 is	 required	 to	generate	a	chromatin	environment	permissive	for	transcriptional	activity.	In	 the	 second	 part	 of	 the	 thesis,	 I	 focused	 on	 cell	 type	 and	 tissue	 specific	regulatory	elements.	To	illustrate	an	experimental	workflow	to	identify	and	test	regulatory	elements	for	transcriptional	activity	in	specific	cell	types,	we	used	the	mouse	retina,	a	very	specialised	tissue	comprised	of	~50	cell	 types.	To	 identify	regulatory	 elements,	 we	 combined	 transcriptome	 and	 epigenome	 profiling	 to	map	 the	 regulatory	 landscape	 of	 four	 distinct	 cell	 types	 isolated	 from	 mouse	retinas	 (rods,	 cones,	 horizontal	 and	 starburst	 amacrine	 cells).	 This	 data	 also	revealed	 sequence	 determinants	 and	 candidate	 TFs	 that	 control	 cellular	specialisation.	 We	 tested	 previously	 identified	 regulatory	 regions	 using	 a	parallelised	 reporter	 assay	 for	 their	 ability	 to	 autonomously	 control	transcriptional	 activity	 in	 the	 four	 cell	 types.	 We	 were	 able	 to	 generate	 a	catalogue	 of	 cis-regulatory	 regions	 active	 in	 retinal	 cell	 types	 and	 further	
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demonstrate	 their	 utility	 as	 a	 potential	 resource	 for	 cellular	 tagging	 and	manipulation.		Taken	 together,	 the	 work	 presented	 here	 advances	 our	 knowledge	 about	location	 and	 regulation	 of	 regulatory	 regions	 that	 function	 in	 specialised	 cell	types	and	also	provides	insight	into	the	regulation	of	CpG	island	promoters	that	tend	to	be	ubiquitously	expressed.		 	
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2 Introduction		
2.1 Transcriptional	regulation	The	blueprint	of	organisms	is	encoded	within	long	deoxyribonucleic	acid	(DNA)	molecules	 comprised	 of	 only	 four	 different	 subunits.	 These	 subunits,	 termed	nucleotides,	each	consist	of	deoxyribose,	a	phosphate	group,	and	one	of	the	four	bases;	 cytosine	 (C),	 guanine	 (G),	 adenine	 (A),	 and	 thymine	 (T).	 The	 shape	 and	function	 of	 all	 cells	 in	 an	 organism	 are	 encoded	 in	 stretches	 of	 these	 four	nucleotides	termed	regulatory	regions	and	genes.		The	 human	 haploid	 genome	 is	 estimated	 to	 be	more	 than	 3	 gigabases	 in	 size	(Venter	et	al,	2001)	while	the	genome	of	the	bacterium	Escherichia	coli	is	around	4.6	megabases	(Blattner,	1997),	a	difference	of	nearly	700-fold.	Despite	this	large	difference	 in	genome	size,	humans	only	have	about	seven	 times	 the	number	of	genes	of	Escherichia	coli	(Venter	et	al,	2001;	Blattner,	1997).	This	 indicates	that	the	complexity	of	an	organism	is	not	simply	determined	by	the	number	of	genes.	Additionally,	 gene	 size	does	not	 increase	by	more	 than	100-fold	 from	E.	coli	 to	human,	 suggesting	 that	 the	 human	 genome	 contains	more	 non-protein	 coding	bases	 (Venter	 et	 al,	 2001;	 Blattner,	 1997).	 Indeed,	 while	 ~88%	 of	 the	 E.	 coli	genome	is	coding	for	proteins	(Blattner,	1997)	only	~3%	of	the	human	genome	codes	 for	 proteins	 (ENCODE,	 2012).	 The	 vast	 majority	 of	 the	 human	 genome	represents	 non-protein	 coding	 regulatory	 regions	 and	 relicts	 of	 evolution	(Palazzo	 &	 Gregory,	 2014;	 ENCODE,	 2012).	 Such	 a	 genome	 composition	 in	multicellular	 eukaryotes,	 like	 human	 or	 mouse,	 requires	 additional	 layers	 of	regulation	 compared	 to	 unicellular	 eukaryotes	 or	 prokaryotes.	 The	 different	shapes	and	functions	of	cells	in	complex	organisms	require	correct	expression	of	genes	 and	 tuning	of	 gene	expression	 levels	 according	 to	 specific	 requirements.	This	 is	 controlled	 by	 transcriptional	 regulatory	 regions	 in	 the	 DNA	 sequence.	These	regions	can	be	located	at	the	start	of	a	gene	or	more	distally	(Maston	et	al,	2006).	The	sequence	of	these	regulatory	regions	is	 interpreted	by	DNA	binding	proteins	and	the	temporal	integration	of	regulatory	events	can	be	performed	by	chromatin	structure.		
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2.2 Cis-regulatory	elements	Gene	expression	has	to	be	controlled	on	several	levels	with	the	primary	layer	of	regulation	 being	 the	DNA	 sequence	 itself,	 due	 to	 the	 fact	 that	 it	 does	 not	 only	encode	gene	products	but	also	determines	their	expression	patterns	in	the	whole	organism.	Cis-regulatory	elements	are	sequence	stretches	in	the	genome	with	the	ability	 to	 control	 spatiotemporal	 gene	 expression	 levels	 (Maston	 et	al,	 2006).	These	 elements	 can	 be	 broadly	 divided	 into	 those	 that	 lie	 proximal	 to	 the	transcriptional	 start	 sites	 (TSS)	 of	 genes,	 called	 promoters	 (Grosschedl	 &	Birnstiel,	1980a,	1980b),	or	more	distal	from	the	TSS,	called	enhancers	(Banerji	
et	al,	1981,	1983;	Müller	&	Schaffner,	1990).		
2.2.1 Promoters		Promoters	 are	 cis-regulatory	 elements	 located	 directly	 at	 and	 around	 the	 TSS.	Besides	enabling	the	initiation	of	transcription	by	RNA	polymerase	II,	promoters	also	regulate	gene	expression	patterns.	The	first	discovered	eukaryotic	promoter	was	the	one	controlling	the	histone	H2A	gene	in	Xenopus	oocytes	nearly	40	years	ago	(Grosschedl	&	Birnstiel,	1980a,	1980b).	Since	then,	most	of	the	work	focused	on	identifying	sequence	elements	within	the	region	surrounding	the	TSS,	called	the	core	promoter.	This	region	allows	RNA	polymerase	II	to	initiate	transcription	and	extends	about	40	base	pairs	(bp)	upstream	of	the	TSS.	It	consists	of	different	core	 promoter	 elements	 that	 are	 bound	 by	 TFs	 that	 establish	 a	 pre-initiation	complex	 (Haberle	&	Lenhard,	 2016).	The	pre-initiation	 complex	positions	RNA	polymerase	 II	 and	denatures	DNA	 in	order	 for	 transcription	 to	 start.	The	most	frequently	occurring	core	promoter	elements	are	the	TATA-box	and	the	Initiator	element.	 The	 TATA-box	 lies	 approximately	 30	 bp	 upstream	 of	 the	 TSS	 and	 is	bound	by	TFIID,	which	recruits	the	pre-initiation	complex.	The	Initiator	element	overlaps	with	the	TSS	and	directs	transcriptional	initiation	(Figure	1).	However,	there	 are	 no	 universal	 promoter	 elements	 and	 although	many	 promoters	 lack	these	 elements,	 RNA	 polymerase	 II	 is	 still	 able	 to	 productively	 initiate	transcription	(Haberle	&	Lenhard,	2016).	Besides	 the	 core	 promoter,	 other	 sequence	 features	 control	 promoter	 activity.	These	are	sequences	that	can	be	bound	by	DNA	binding	proteins	such	as	TFs	that	
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interpret	 the	 regulatory	 sequence	and	are	able	 to	directly	or	 indirectly	 control	activity	 of	 the	 promoter.	 DNA	 binding	 proteins	 recruit	 co-activators	 and	 co-repressors,	 the	 sum	 of	 these	 regulatory	 inputs	 then	 results	 in	 a	 controlled	transcriptional	output	that	forms	the	basis	of	cellular	function	(Figure	1).	The	 first	 attempts	 to	 understand	 the	 logic	 of	 sequence	 elements	 controlling	transcriptional	 activity	 in	 mammals	 started	 already	 more	 than	 30	 years	 ago	(Myers	 et	al,	 1986).	 Despite	 this,	 we	 are	 still	 unable	 to	 predict	 transcriptional	activity	 just	 based	 on	 the	 DNA	 sequence.	 But	 there	 are	 a	 number	 of	 sequence	features	that	are	predictive	of	regulatory	function.	One	 feature	 that	 aids	 in	 the	 prediction	 of	 the	 regulatory	 activity	 of	 a	 DNA	sequence	 in	 vertebrates	 is	 the	 density	 of	 the	 dinucleotide	 CpG	 (Ioshikhes	 &	Zhang,	2000).	CpG	rich	sequences	tend	to	overlap	with	promoters	predominantly	controlling	 genes	 broadly	 expressed	 across	 different	 cell	 types	 and	 tissues,	 so	called	housekeeping	genes.	However,	not	all	promoters	are	CpG	rich.	The	density	of	CpGs	within	all	promoters	is	distributed	in	a	bimodal	fashion,	separating	them	in	CpG	poor	and	CpG	rich	promoters	(Mohn	&	Schübeler,	2009)	(also	see	chapter	2.5	CpG	islands).	Part	of	this	thesis	will	focus	on	CpG	rich	promoters	and	the	role	of	the	dinucleotide	CpG	in	transcriptional	activity	of	this	promoter	type	(see	3.1	Design	principles	of	CpG	island	promoter	activity).		
2.2.2 Enhancers	Enhancers	 are	 distal	 regulatory	 elements	 that	 can	 enhance	 promoter	 activity	independent	 of	 their	 distance	 (Müller	 &	 Schaffner,	 1990).	 Together	 with	promoters,	 they	 control	 transcriptional	 activity.	 Reports	 suggested	 that	 some	transcription	 also	 takes	 place	 at	 enhancers	 (enhancer	 RNA).	 However,	 these	transcripts	are	only	 lowly	abundant	and	unstable	 (Kim	et	al,	 2010;	Wang	et	al,	2011;	Hah	et	al,	2013).	The	first	identified	enhancer	was	a	72	bp	long	sequence	that	originated	from	the	SV40	 virus	 genome.	 Placing	 this	 enhancer	 in	 front	 of	 a	 rabbit	 hemoglobin	 b1	gene	 on	 a	 plasmid	 resulted	 in	 200	 times	 higher	 activity	 in	 HeLa	 cells	 than	without	 this	 sequence	 (Banerji	 et	al,	 1981).	 Two	 years	 later	 the	 same	 lab	 also	identified	the	first	animal	enhancer	(Banerji	et	al,	1983).	
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Similar	to	promoters,	enhancers	are	bound	by	DNA	binding	proteins	such	as	TFs.	These	 proteins	 can	 recruit	 additional	 factors	 with	 activating	 or	 repressive	function	and	together,	 the	complex	of	enhancer	and	proteins	 interacts	with	the	promoter	to	control	gene	expression	levels	(Figure	1).	The	combined	regulatory	inputs	 of	 the	 promoter	 and	 enhancer(s)	 tune	 gene	 expression	 depending	 on	cellular	 function	(Shlyueva	et	al,	2014).	Looping	allows	for	 interaction	between	enhancers	and	promoters	even	when	they	are	several	kilo-	 to	megabases	away	from	each	other	(Amano	et	al,	2009).	Enhancer	 function	 is	 especially	 central	 for	 the	 control	 of	 cell-type	 specific	expression,	but	also	for	genes	active	across	several	cell-types.	The	modularity	of	enhancers	allows	the	cell	 to	utilise	different	enhancers	 in	distinct	cell	 types	 for	the	same	promoter	or	several	enhancers	can	act	in	concert	to	establish	required	expression	 levels	 of	 a	 gene	 in	 a	 specific	 cell	 type	 (Xu	&	 Smale,	 2012;	 Smith	&	Shilatifard,	 2014;	 Smallwood	 &	 Ren,	 2013;	 Calo	 &	 Wysocka,	 2013;	 Arnone	 &	Davidson,	1997).	Part	of	this	thesis	will	focus	on	identification	of	active	enhancers	in	different	cell	types	and	functional	testing	of	their	autonomous	activity	(See	3.2	Cis	regulatory	landscape	of	the	retina).		
	
Figure	1:	Promoters	and	enhancers	control	gene	expression	
Enhancers	and	promoters	are	bound	by	TFs	 that	 together	 regulate	gene	activity.	
The	 promoter	 contains	 the	 core	 promoter	 including	 TATA-box	 (TATA)	 and	 the	
initiator	element	(Inr).	TFIID	binds	to	the	TATA-box	and	enables	recruitment	of	the	
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pre-initiation	 complex	 (PIC)	 that	 positions	 RNA	 polymerase	 II	 (RNAPII)	 and	
denatures	DNA	 in	order	 for	 transcription	 to	 start.	Transcription	 factors	 (TF)	 can	
recruit	co-activators	or	co-repressors.		
2.3 DNA	binding	proteins	DNA	 sequence	 is	 interpreted	 by	 proteins	 in	 order	 to	 establish	 correct	transcriptional	 levels.	 The	 first	 protein	 interacting	 with	 DNA	 and	 controlling	gene	expression	was	 identified	 in	prokaryotes.	The	authors	named	this	protein	'regulator',	 while	 now	 they	 are	 generally	 called	 transcription	 factors	 (Jacob	 &	Monod,	 1961).	 Extensive	 research	 on	 these	 types	 of	 proteins	 uncovered	many	more	TFs.	TFs	can	directly	lead	to	increased	transcriptional	activity	by	interaction	with	the	transcriptional	machinery	by	promoting	initiation,	elongation	or	re-initiation	of	transcription	 (Maston	 et	 al,	 2006).	 For	 example,	 the	 TF	 Sp1	 has	 two	transactivation	domains	(Courey	&	Tjian,	1988;	Oka	et	al,	2004)	that	can	directly	interact	with	TBP	(TATA-Binding	Protein)	(Emili	et	al,	1994)	and	TAF4	(TATA-Box	 Binding	 Protein	 Associated	 Factor	 4)	 of	 the	 transcriptional	 initiation	machinery	 (Gill	 et	 al,	 1994)	 and	 thereby	 promote	 initiation.	 Alternatively,	transcription	 can	 be	 indirectly	 influenced	 by	 the	 recruitment	 of	 cofactors	 that,	for	example,	allow	binding	of	other	TFs	(de	la	Serna	et	al,	2005)	(See	also	chapter	2.6	Transcription	factors	and	chromatin).	TFs	typically	recognize	6-8bp	long	stretches	of	DNA	called	TF	motifs	(Kadonaga,	2004).	 Such	 motifs	 occur	 every	 4,000-70,000bp	 in	 the	 genome	 by	 chance.	However,	 only	 a	 small	 proportion	 of	 occurrences	 of	 a	 motif	 sequence	 in	 the	genome	 are	 bound	 with	 the	 majority	 remaining	 unbound.	 This	 opens	 the	interesting	question	on	what	determines	TF	binding	besides	motif	sequence.	One	possible	 explanation	 is	 that	 TF	 binding	 requires	 direct	 or	 indirect	 interactions	between	TFs.	This	 suggests	 that	 if	motifs	of	a	number	of	 factors	 co-occur,	 they	are	more	efficiently	bound.	Often	this	requires	that	the	TF	motifs	are	placed	at	a	certain	 distance	 from	 each	 other	 to	 sterically	 allow	 interaction	 of	 the	 factors	(Reiter	et	al,	2017).	In	line	with	this,	many	TFs	form	homo-	or	heterodimers,	and	
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therefore,	 their	motifs	are	often	comprised	of	TF	motif	pairs	(Jolma	et	al,	2013,	2015)	(See	also	chapter	2.6	Transcription	factors	and	chromatin).		
2.4 Chromatin	and	transcriptional	regulation	In	 eukaryotic	 cells,	 DNA	 is	 associated	with	 proteins,	 forming	 a	 complex	 called	chromatin.	The	most	abundant	proteins	in	the	nucleus	are	histones	that	together	with	DNA	form	the	nucleosome.	A	stretch	of	147bp	of	DNA	 is	wrapped	around	the	histone	octamer	consisting	of	two	copies	each	of	histones	H2A,	H2B,	H3	and	H4	 (Kornberg	 &	 Thomas,	 1974;	 Richmond	 &	 Davey,	 2003).	 Initially,	 it	 was	thought	 that	 nucleosomes	 only	 play	 a	 role	 in	 chromosome	 compaction	 to	 fit	eukaryotic	 genomes	 into	 the	 nucleus.	 Now	 we	 know	 that	 different	 chromatin	states	also	serve	a	regulatory	function	with	active	regulatory	regions	residing	in	open	 chromatin	 (euchromatin)	 and	 inactive	 regions	 located	 within	 tighter	packed	closed	chromatin	(heterochromatin)	(Voss	&	Hager,	2013).	It	was	shown	that	active	promoters	are	located	within	euchromatin	and	have	low	nucleosome	occupancy	and	a	nucleosome	free	region	at	 the	TSS	(Schones	et	al,	2008).	Such	differences	in	chromatin	structure	can	affect	TF	binding	to	DNA,	this	is	discussed	in	chapter	2.6.		
2.4.1 Histone	modifications	In	addition	to	differences	in	the	positioning	and	occupancy	of	nucleosome	across	the	genome,	their	histone	components	can	be	posttranslationally	modified.	Such	histone	modifications	occur	mainly	on	the	N-terminal	tails	of	histone	H3	and	H4,	and	 correlate	with	 active	 or	 inactive	 regulatory	 states	 (Kouzarides,	 2007).	 For	example,	 inactive	heterochromatin	 is	marked	by	 the	methylation	of	 lysine	9	or	lysine	 27	 on	 histone	 H3	 (H3K9me3	 and	 H3K27me3)	 and	 H2AK119	ubiquitylation.	By	contrast,	 active	euchromatin	 is	marked	by	acetylated	 lysines	on	histones	H3	and	H4	(Kouzarides,	2007).	Within	 euchromatin,	 different	 cis-regulatory	 elements	 contain	 characteristic	histone	modifications.	Active	promoters	 are	marked	by	H3K4me3	and	H3K9ac	around	 the	 TSS	 and	 H3K36me3	 in	 the	 gene	 body,	 while	 active	 enhancers	 are	modified	by	H3K4me1	and	H3K27ac	(Barth	&	Imhof,	2010;	Shlyueva	et	al,	2014).	
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Posttranslational	 histone	 modifications	 probably	 do	 not	 affect	 transcription	directly	but	via	 intermediate	steps	since	 they	can	be	bound	and	 interpreted	by	proteins.	 For	 example,	 H3K9me3	 has	 been	 shown	 to	 be	 bound	 by	heterochromatin	 protein	 1	 (HP1),	 which	 mediates	 transcriptional	 repression	(Loyola	et	al,	 2001).	Many	other	proteins	have	been	 identified	 that	 are	 able	 to	recognise	 different	 histone	 modifications	 and	 thereby	 potentially	 influence	transcriptional	regulation	(Yun	et	al,	2011).	However,	 for	histone	modifications	in	 both	 eu-	 and	 heterochromatin	 it	 is	 still	 unclear	 how	 gene	 activation	 or	silencing	 is	 established	 and	 if	 histone	 marks	 are	 a	 cause	 or	 consequence	 of	changes	in	TF	binding	and	transcription.		
	
Figure	 2:	 Histone	 modifications	 at	 active	 enhancers	 and	 promoters	 and	
outside	 of	 regulatory	 regions.	 Inactive	 chromatin	 has	 high	 nucleosome	
occupancy	and	is	marked	by	H3K9me3.	Active	enhancers	are	marked	by	H3K4me1	
and	H3K27ac.	TSS	of	promoters	is	marked	by	H3K4me3	while	gene	bodies	display	
H3K36me2/3.	
	
2.4.2 DNA	Methylation	In	 addition	 to	 nucleosome	 occupancy	 and	 posttranslational	 histone	modifications,	DNA	 itself	 can	be	modified	and	 thereby	 contribute	 to	 chromatin	structure	and	regulation.	Most	of	the	Cs	in	the	dinucleotide	CpG	are	methylated	
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at	 the	 fifth	 position	 of	 the	 pyrimidine	 ring	 in	 vertebrate	 genomes	 (Lister	 et	al,	2009).	In	vertebrates,	this	CpG	methylation	is	catalysed	by	Dnmt3a	and	Dnmt3b,	and	maintained	through	cell	division	by	Dnmt1	(Hermann	et	al,	2004).	Removal	of	DNA	methylation	can	be	brought	about	either	passively	by	cell	division	(Chen	
et	 al,	 2003)	 or	 enzymatically	 by	 members	 of	 the	 TET	 family	 (Tahiliani	 et	 al,	2009).	DNA	 methylation	 is	 linked	 to	 gene	 repression	 (Cedar,	 1988).	 Two	 possible	mechanisms	have	been	suggested	how	DNA	methylation	can	lead	to	repression:	(1)	 by	 preventing	 the	 binding	 of	 TFs	 that	 require	 CpGs	 in	 their	 motif	 to	 be	unmethylated	(Watt	&	Molloy,	1988;	Iguchiariga	&	Schaffner,	1989;	Prendergast	&	 Ziff,	 1991;	 Campanero	 et	 al,	 2000;	 Domcke	 et	 al,	 2015),	 or	 (2)	 through	attracting	proteins	 that	bind	methylated	CpGs	 specifically	 (Meehan	et	al,	 1989;	Hendrich	 &	 Bird,	 1998)	 and	 consequently	 block	 binding	 of	 other	 factors	 or	recruit	repressors.	A	group	of	proteins	that	specifically	bind	methylated	CpGs	are	the	MBD	(Methyl-CpG-binding	 domain)	 proteins	 (Ohki	 et	al,	 2001;	 Ho	 et	al,	 2008;	 Baubec	 et	al,	2013;	Hendrich	&	Bird,	1998).	These	proteins	are	able	to	recruit	cofactors	that	mediate	 chromatin	 repression	 (Meehan	 et	 al,	 1989;	 Hendrich	 &	 Bird,	 1998;	Hendrich	&	Tweedie,	2003).	For	example,	Mbd2	is	part	of	the	Mi2/NuRD	histone	deacetylase	repressor	complex	(Zhang	et	al,	1999)	or	MeCp2	that	also	associates	with	histone	deacetylase	complexes	(Nan	et	al,	1997).	Although	the	majority	of	CpGs	within	vertebrate	genomes	are	methylated,	there	are	 specific	 regions	 that	 have	 decreased	 or	 no	DNA	methylation.	 For	 example,	active	enhancers	and	promoters	tend	to	have	low	methylation	levels	(Stadler	et	
al,	 2011).	By	 contrast,	 the	methylation	 state	of	 inactive	promoters	depends	on	sequence	composition	(Schübeler,	2015).	Promoters	with	a	high	density	of	CpGs	are	 unmethylated	 even	 if	 they	 are	 inactive,	 these	 promoters	 are	 called	 CpG	islands	(CGIs)	(Bird	et	al,	1985)	(Figure	3).		
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Figure	3:	Distribution	of	DNA	methylation	in	vertebrate	genomes.	
The	 majority	 of	 CpGs	 in	 vertebrate	 genomes	 are	 methylated,	 while	 active	
regulatory	 regions	 and	 inactive	 CpG	 rich	 promoters	 are	 only	 lowly	 or	
unmethylated.	(adapted	from	(Schübeler,	2015))		
2.5 CpG	islands	While	 the	 majority	 of	 CpGs	 in	 mammalian	 genomes	 are	 methylated,	unmethylated	CpGs	are	 concentrated	 in	 specific	 regions	 called	CGIs	 (Bird	et	al,	1985).	CGIs	overlap	with	~60%	of	human	and	mouse	promoters,	resulting	 in	a	bimodal	distribution	of	CpG	density	in	promoters	(Mohn	&	Schübeler,	2009).	Within	vertebrates,	CGIs	have	been	defined	as	at	least	200bp	long	regions	with	a	G+C	content	of	at	 least	50%	and	an	observed-to-expected	ratio	 (OE)	of	at	 least	0.6	where	OE	is	the	number	of	CpGs	/	(number	of	Cs	x	number	of	Gs)	x	length	of	the	region	in	nucleotides	(Gardiner-Garden	&	Frommer,	1987).	However,	 if	and	how	 the	 higher	 CpG	 density	 at	 CGIs	 compared	 to	 the	 rest	 of	 the	 genome	contributes	 to	 transcriptional	 activity	 of	 CGI	 promoters	 has	 not	 yet	 been	comprehensively	assessed	and	is	a	central	question	of	this	thesis.		
2.5.1 CpG	islands	are	specific	to	vertebrates	CGIs	 have	 been	mainly	 studied	 in	mammals	 but	 are	 present	 in	 all	 vertebrates	that	 have	 extensive	 CpG	 methylation	 (Han	 et	 al,	 2008).	 The	 branching	 of	invertebrates	 and	 vertebrates	 coincides	 with	 the	 appearance	 of	 DNA	methylation.	 Ciona	 intestinalis,	 an	 organism	 that	 is	 close	 to	 the	 invertebrate-vertebrate	 boundary,	 exhibits	 a	mosaically	methylated	 genome.	Genes	 that	 are	
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located	within	methylated	domains	of	the	Ciona	genome	have	been	shown	to	be	sometimes	 associated	 with	 short	 CGI-like,	 unmethylated	 regions	 at	 the	 TSS	(Suzuki	et	al,	2007).		
2.5.2 Theories	why	CGIs	have	a	higher	CpG	density	than	the	rest	of	the	
genome	Genomes	 of	 organisms	 with	 DNA	 methylation	 in	 the	 germ	 line	 are	 generally	depleted	 in	CpGs	 (Bird,	1980;	 Jones,	 2012).	This	phenomenon	 is	 thought	 to	be	caused	by	different	mutation	rates	of	methylated	versus	unmethylated	CpGs.	C	to	T	conversion	accounts	for	most	of	the	spontaneous	mutations	within	DNA	(Shen	
et	al,	1994).	Unmethylated	Cs	can	deaminate	to	Uracil,	which	is	an	improper	base	in	DNA,	 it	 is	efficiently	recognized	by	 the	DNA	mismatch	repair	machinery	and	replaced	by	a	C	(Barnes	&	Lindahl,	2004).	By	contrast,	methylated	Cs	within	the	CpGs	are	deaminated	to	Ts,	which	is	a	proper	base	that	is	incorrectly	paired	with	G	after	the	mutation	event.	Although	this	mismatch	is	thought	to	be	repaired	by	glycosylases	capable	of	replacing	the	T,	such	as	MBD4	and	TDG,	this	is	still	 less	efficient	than	repair	of	Uracils	(Millar,	2002;	Hendrich	et	al,	1999;	Neddermann	&	 Jiricny,	 1993).	 Therefore,	 following	 a	 round	of	 replication,	 a	methylated	C	 is	more	 likely	 to	 mutate	 to	 a	 T	 than	 an	 unmethylated	 C	 and	 this	 results	 in	 the	depletion	 of	 CpGs	 throughout	 the	 genome.	 CpG	 islands	 are	 regions	 that	 are	unmethylated	in	the	germ	line,	which	accounts	for	their	decreased	loss	of	CpGs	during	evolution	(Bird,	1980;	Cohen	et	al,	2011).	This	theory	suggests	that	CpGs	can	 be	 seen	 as	 a	 footprint	 of	 evolution	 due	 to	 different	 mutation	 rates	 of	chemically	 distinct	 forms	 of	 CpGs	 without	 precluding	 any	 functional	 role.	Alternatively,	 CpG	 density	 could	 play	 a	 functional	 role,	 leading	 to	 selective	pressure	that	could	contribute	to	CpG	maintenance	throughout	evolution	(Bird,	2011;	Deaton	&	Bird,	2011).	 In	 fact,	CpG	density	 is	 so	 far	 the	best	predictor	of	promoter	 activity	 from	 the	 DNA	 sequence	 alone	 (Ioshikhes	 &	 Zhang,	 2000).	 A	functional	role	of	CpGs	for	transcriptional	activity	is	not	mutually	exclusive	with	a	model	where	CpGs	are	a	 footprint	of	 evolution.	There	would	be	no	purifying	selection	on	CpG	density	if	the	density	of	CpGs	for	functionality	is	lower	than	the	equilibrium	of	deamination	rates	versus	CpG	gain	by	spontaneous	mutations.	
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Taken	 together	 CpG	 islands	 are	 likely	 a	 product	 of	 different	mutation	 rates	 of	methylated	and	unmethylated	CpGs,	however	this	does	not	preclude	a	functional	role	for	CpGs.		
2.5.3 CpG	islands	overlap	with	promoters	About	 60%	 of	 mouse	 and	 human	 promoters	 in	 the	 genome	 are	 CpG	 islands,	leading	to	a	bimodal	distribution	of	promoter	CpG	densities	in	the	genome,	those	that	 are	 CpG	 rich	 and	 those	 that	 are	 CpG	 poor	 (Figure	 4)	 (Mohn	&	 Schübeler,	2009).	 While	 CpG-poor	 promoters	 are	 generally	 associated	 with	 narrow	expression	 patterns,	 CGI	 promoters	 are	 thought	 to	 be	 active	 across	many	 cell	types	 controlling	 ubiquitously	 expressed	 housekeeping	 genes	 (Larsen	 et	 al,	1992;	Butler	&	Kadonaga,	2002).	However,	~30%	of	CGI	genes	are	tissue	specific	and	include	important	developmental	regulators	such	as	the	hox	genes	(Mohn	&	Schübeler,	2009).	Several	 lines	 of	 evidence	 suggest	 that	 CGI	 promoters	 are	 regulated	 differently	from	CpG	poor	 promoters:	 (1)	At	 the	DNA	 level,	 the	 skewed	 representation	 of	CpGs,	 Gs	 and	 Cs	 in	 CGIs	 implies	 that	 a	 different	 set	 of	 factors	 is	 involved	 in	interpreting	these	sequences.	(2)	CGI	promoters	can	initiate	transcription	across	a	 rather	 broad	 region,	 while	 CpG	 poor	 promoters	 typically	 have	 very	 precise	TSSs,	as	evident	from	CAGE	(cap	analysis	by	gene	expression)	datasets	(Carninci	
et	 al,	 2006).	 This	 is	 thought	 to	 be,	 in	 part,	 attributed	 to	 the	 fact	 that	 CGIs	generally	lack	a	TATA-box	that	enables	focused	initiation	(Sandelin	et	al,	2007).	To	date,	most	of	 the	biochemical	work	on	transcriptional	 initiation	has	 focused	on	 CpG	 poor	 promoters,	 simply	 because	 of	 experimental	 convenience	 and	 the	fact	that	the	first	model	promoters	were	of	viral	origin	and	CpG	poor	(Zhu	et	al,	2008;	 Saxonov	 et	al,	 2006;	 Antequera	&	 Bird,	 1993;	 Ioshikhes	&	 Zhang,	 2000;	Bajic	et	al,	2006;	Shen	et	al,	2012;	Butler	&	Kadonaga,	2002;	Benoist	&	Chambon,	1981).	 As	 a	 consequence,	 we	 lack	 knowledge	 about	 functional	 promoter	elements	controlling	transcriptional	activity	within	CGI	promoters.		
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Figure	 4:	 The	 CpG	 density	 of	 vertebrate	 promoters	 has	 a	 bimodal	
distribution.	
Histogram	 of	 CpG	 densities	 of	 all	 promoters	 in	 the	 Drosophila	 (a)	 and	 mouse	
genome	(b).		
(a)	 CpG	 densities	 of	 promoters	 in	 the	 invertebrate	 genome	 of	 Drosophila	
melanogaster	is	unimodally	distributed.	
(b)	 CpG	 densities	 of	 promoters	 in	 the	 vertebrate	 genome	 of	 Mus	 musculus	 is	
bimodally	distributed.	Barplots	below	show	expression	 levels	 for	three	genes	with	
different	CpG	densities	across	19	different	tissues	in	mouse.	
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2.5.4 CpG	islands	and	chromatin	Besides	 their	 unique	 sequence	 composition,	 CpG	 islands	 also	 have	 a	characteristic	chromatin	structure,	with	the	distinctive	hallmark	being	that	they	are	mostly	unmethylated	in	normal	cell	types.	It	has	been	shown	that	high	CpG	density	alone	is	sufficient	for	a	sequence	to	remain	unmethylated	(Lienert	et	al,	2011;	Krebs	et	al,	2014).	Additionally	binding	of	specific	TFs	has	an	even	higher	potential	 to	 prevent	 DNA	 sequence	 from	 getting	 methylated	 especially	 in	combination	with	high	CpG	density	(Lienert	et	al,	2011;	Krebs	et	al,	2014).	This	is	 in	 agreement	 with	 a	 putative	 role	 of	 the	 CGI	 binder	 Sp1	 in	 keeping	 CGIs	unmethylated	(Brandeis	et	al,	1994;	Macleod	et	al,	1994).	CpG	 islands	 are	marked	 by	 the	 histone	modification	H3K4me3	 independent	 of	transcriptional	activity	(Weber	et	al,	2007;	Guenther	et	al,	2007;	Mikkelsen	et	al,	2007).	 H3K4me3	 can	 interact	 with	 the	 NuRF	 chromatin	 remodeling	 complex	suggesting	a	role	in	keeping	the	promoter	accessible	(Li	et	al,	2006;	Wysocka	et	
al,	 2006).	 In	 agreement	 with	 that,	 CGIs	 have	 been	 shown	 to	 be	 depleted	 of	nucleosomes	independent	of	transcriptional	activity	(Fenouil	et	al,	2012)	(Figure	5).	CpG	island	promoters	show	reduced	levels	of	H3K36me2	compared	to	CpG	poor	promoters.	Removal	of	this	modification	is	mediated	by	the	histone	demethylase	activity	of	the	ZF-CxxC	domain	containing	protein	KDM2A	(Tsukada	et	al,	2006).	Inactive	 CpG-island	 promoters	 are	marked	 by	 H3K27me3	 (Mohn	&	 Schübeler,	2009)	(Figure	5).		
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Figure	5:	Chromatin	at	CGI	promoters	versus	CpG	poor	promoters	
Chromatin	at	(a)	active	promoters	and	(b)	inactive	promoters.	In	contrast	to	CpG	
poor	promoters,	CGI	promoters	stay	open	and	DNA	methylation	free	independent	of	
transcriptional	activity.	
	
2.5.5 ZF-CxxC	 domain	 containing	 proteins	 bind	 unmethylated	 CpGs	
specifically	In	 addition	 to	 classical	TFs	 that	bind	6bp	or	 longer	motifs,	 there	 are	 also	DNA	binding	proteins	 that	only	bind	very	short	motifs	such	as	MBD	proteins,	which	bind	 methylated	 CpGs	 (discussed	 in	 2.4.2),	 or	 ZF-CxxC	 domain	 containing	proteins	 that	 specifically	 bind	 unmethylated	 CpGs	 (Voo	 et	al,	 2000;	 Long	 et	al,	2013).	The	bipartite	modification	and	distribution	pattern	of	CpGs	 leads	 to	a	~50-fold	higher	concentration	of	unmethylated	CpGs	at	CpG	islands	than	elsewhere	(Bird,	2011).	 The	 shortness	 of	 the	motif	 and	 the	 strong	 asymmetry	 in	 the	 density	 of	unmethylated	CpGs	suggest	that	ZF-CxxC	domain	containing	proteins	function	in	a	 concentration	 dependent	 manner	 allowing	 them	 to	 have	 high	 specificity	 for	CpG	 islands	 despite	 the	 simplicity	 of	 the	motif	 compared	 to	 classic	 TFs	 (Bird,	2011).	
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ZF-CxxC	 domain	 containing	 proteins	 have	 been	 shown	 to	 alter	 the	 chromatin	environment	at	 their	binding	site.	For	example,	KDM2A	and	KDM2B	have	been	described	 as	 H3K36	 demethylases	 with	 preference	 for	 H3K36me2.	 They	 are	thought	 to	 prevent	 H3K36me2	 spreading	 into	 the	 promoter,	 which	 would	interfere	 with	 transcriptional	 initiation	 (Tsukada	 et	al,	 2006;	 Blackledge	 et	al,	2010).	Another	ZF-CxxC	domain	containing	protein	linked	to	an	active	chromatin	state	is	the	H3K4	methylase	Cfp1.	H3K4me3	occurs	around	the	TSS	of	promoters	and	 can	 be	 bound	 by	 the	 chromatin	 remodeler	 Chd1	 (Clouaire	 et	 al,	 2012;	Flanagan	 et	al,	 2005).	 Additionally,	 ZF-CxxC	 domain	 containing	 proteins	 were	suggested	 to	 play	 a	 role	 in	 protecting	 CGIs	 from	methylation	 (Thomson	 et	al,	2010;	Long	et	al,	2013;	Boulard	et	al,	2015).	Not	all	proteins	containing	ZF-CxxC	domains	are	linked	to	active	chromatin.	The	DNA	 methylation	 maintenance	 enzyme,	 Dnmt1,	 also	 has	 a	 ZF-CxxC	 domain.	Structural	 studies	 showed	 that	 in	 this	 case	 the	 ZF-CxxC	 domain	 ensures	 that	unmethylated	CpGs	stay	unmethylated	through	the	cell	cycle.	If	Dnmt1	binds	to	unmethylated	 CpGs,	 this	 domain	 blocks	 access	 of	 the	 catalytic	 site	 to	 the	 CpG	dinucleotide	(Song	et	al,	2012).	Taken	together,	ZF-CxxC	domain	containing	proteins	could	interpret	CpG	density	to	directly	or	indirectly	influence	chromatin	environment.		
2.6 Transcription	factors	and	chromatin	TFs	 bind	 only	 a	 subset	 of	 their	 potential	 binding	 sites	 in	 higher	 eukaryotic	genomes	(Biggin,	2011).	One	possible	explanation	why	not	all	motifs	are	bound	is	 that	 not	 all	 regions	 in	 the	 genome	 are	 equally	 accessible	 for	 TFs	 due	 to	differences	 is	 chromatin	 structure.	 High	 nucleosome	 occupancy	 could,	 for	example,	prevent	TF	binding	(John	et	al,	2011;	Svaren	&	Hörz,	1997).	Indeed,	 it	has	 been	 shown	 that	 accessibility	 does	 correlate	 with	 occupancy	 of	 many	 TF	classes	(Biggin,	2011).	The	difference	in	accessibility	of	TF	binding	sites	offers	the	opportunity	for	more	sophisticated	regulatory	mechanisms.	For	example,	TFs	might	have	to	cooperate	in	order	to	penetrate	closed	chromatin,	with	only	the	combined	DNA	affinity	of	two	or	more	TFs	being	high	enough	 to	bind	 low	accessible	 regions	 (Figure	6a)	
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(Miller	&	Widom,	2003).	In	another	mechanism,	one	TF	can	be	required	to	bind	and	modify	the	chromatin	environment	so	that	another	TF	can	bind.	It	is	thought	that	 TFs	 that	 are	 able	 to	 bind	 regardless	 of	 chromatin	 accessibility	 recruit	chromatin	 remodelling	 complexes	 to	 establish	 accessible	 chromatin	 allowing	binding	of	other	TFs	(Figure	6b)	(Voss	et	al,	2011).	Additionally,	binding	of	TFs	to	DNA	can	be	prohibited	by	DNA	methylation	(Watt	&	Molloy,	1988;	Iguchiariga	&	Schaffner,	1989;	Prendergast	&	Ziff,	1991;	Campanero	et	al,	2000;	Domcke	et	
al,	2015).	For	example,	Nrf1	cannot	bind	its	motif	 if	 it	 is	methylated.	 If	another	factor	 such	 as	 CTCF	 binds	 a	 methylated	 region	 containing	 an	 Nrf1	 motif,	 this	leads	to	demethylation	of	the	surrounding	region	and	allows	Nrf1	to	bind	(Figure	6c)	 (Domcke	 et	al,	 2015).	 Such	 mechanisms	 do	 not	 necessarily	 require	 direct	interaction	 between	 TFs	 and,	 therefore,	 could	 be	 utilised	 by	 the	 cell	 to	temporally	integrate	regulatory	events.	Rather	than	interacting	with	other	TFs	and	their	motifs,	the	DNA	context	itself	in	which	the	motif	is	placed	could	serve	as	means	to	control	binding.	For	example,	one	 could	 imagine	 that	 high	 CpG	 density	 excludes	 DNA	 methylation	 allowing	DNA	methylation	 sensitive	TFs	 to	bind	 (Lienert	et	al,	 2011;	Krebs	et	al,	 2014).	This	 would	 make	 sense	 especially	 for	 genes	 that	 are	 active	 across	 many	 cell	types	and,	therefore,	accessibility	has	to	be	ensured	for	TFs	to	bind.	Part	of	this	thesis	 focuses	 on	 the	 impact	 of	 CpG	 density	 on	 transcriptional	 activity,	 TF	binding,	and	the	link	to	DNA	methylation.		
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Figure	6:	Models	for	cooperative	access	to	TF	motifs	on	chromatin.	
(a)	Cooperative	binding	of	two	TFs	without	chromatin	remodeling.	
(b)	TF1	can	bind	regardless	of	chromatin	state	and	recruits	chromatin	remodeling	
complexes	making	the	DNA	accessible	for	binding	of	TF2.	
(c)	CTCF	binding	leads	to	localised	demethylation	of	DNA	allowing	binding	of	DNA	
methylation	sensitive	TFs,	like	Nrf1.		
2.7 Identification	of	cis-regulatory	elements	In	order	to	understand	the	principles	of	transcriptional	regulation,	it	is	essential	to	 identify	 cis-regulatory	 elements.	 Several	 methods	 have	 been	 developed	 to	identify	these	elements.	Promoters	can	be	detected	by	mapping	the	TSS	of	genes	across	the	genome.	However,	this	only	informs	on	where	the	transcript	starts	but	not	 about	 where	 a	 promoter	 region	 starts	 and	 ends.	 Another,	 more	 general	method	to	identify	cis-regulatory	regions	is	to	map	chromatin	accessibility.	One	
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genome-wide	 method	 that	 takes	 advantage	 of	 the	 difference	 in	 chromatin	accessibility	 at	 open	 and	 closed	 regions	 is	 DNase	 I	 hypersensitivity	 site	sequencing	 (DHS-seq).	 DHS-seq	 is	 based	 on	 the	 fact	 that	 increased	 chromatin	accessibility	correlates	with	 the	 increased	probability	 that	DNA	will	be	cleaved	by	the	endonuclease	DNaseI.	These	cut	sites	are	then	located	by	high	throughput	sequencing	 and,	 therefore,	 provide	 a	 genome	 wide	 map	 of	 chromatin	accessibility	(Crawford	et	al,	2006).	A	more	 recently	 developed	method	 to	 identify	 accessible	 chromatin	 regions	 is	ATAC-seq	(Assay	for	transposase-accessible	chromatin).	ATAC-seq	is	based	on	a	transposase	that	 integrates	preferentially	at	accessible	regions.	The	transposon	contains	 PCR	 amplification	 primers	 that	 are	 used	 to	 amplify	 genome	 wide	integration	sites.	These	sites	are	again	detected	by	sequencing,	giving	a	genome	wide	profile	of	chromatin	accessibility	(Buenrostro	et	al,	2015).	
Cis-regulatory	 regions	 are	marked	by	 characteristic	 histone	modifications	 such	as	acetylation	of	lysines	at	histones	H3	and	H4	or	H3K4me3	at	promoters.	These	histone	marks	can	be	utilised	to	 identify	cis-regulatory	elements	(Heintzman	et	
al,	2007,	2009;	Calo	&	Wysocka,	2013).	Another	 chromatin	 feature	 marking	 cis-regulatory	 elements	 is	 reduced	 DNA	methylation	at	CpGs	compared	to	inactive	regions	of	the	genome.	As	for	histone	marks,	 this	 characteristic	 footprint	 can	 be	 used	 to	 identify	 cis-regulatory	elements	(Stadler	et	al,	2011;	Hodges	et	al,	2011;	Ziller	et	al,	2013).	Furthermore,	DNA	methylation	is	detected	by	bisulfite	sequencing,	which	gives	a	quantitative	measurement	of	DNA	methylation.	Another	 advantage	of	 this	 technique	 is	 that	only	 naked	 DNA	 is	 required	 as	 starting	material	 while	 all	 the	 other	 described	approaches	 require	 intact	 nuclei	 or	 chromatin,	 making	 it	 suitable	 also	 for	samples	that	are	difficult	to	handle.		
2.8 Quantification	of	cis-regulatory	element	activity	Prediction	of	cis-regulatory	elements	by	the	above-mentioned	methods	does	not	inform	 on	 functional	 relevance	 or	 the	 ability	 of	 identified	 regions	 to	autonomously	 drive	 transcription.	 Therefore,	 in	 order	 to	 elucidate	 regulatory	principles,	 transcriptional	 activity	 of	 cis-regulatory	 elements	 outside	 of	 their	
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genomic	sequence	context	has	to	be	functionally	tested.	To	test	the	ability	for	cis-regulatory	 elements	 to	 autonomously	 activate	 transcription	 they	 are	 placed	adjacent	to	a	reporter	gene	whose	gene	product	can	be	quantified,	such	as	GFP.	Promoter	activity	can	be	directly	tested	for	their	ability	to	autonomously	initiate	transcription	 while	 enhancers	 have	 to	 be	 placed	 in	 proximity	 to	 a	 minimal	promoter,	allowing	RNA	polymerase	II	to	initiate	transcription.	Quantification	of	the	reporter	gene	product	can	be	done	on	the	RNA	level	using	quantitative	polymerase	chain	reaction	(qPCR)	or	 in	situ	hybridization	followed	by	 imaging.	 Such	 assays	 can	 be	 parallelised	 using	 next-generation	 sequencing	techniques.	 To	 link	 the	 transcripts	 to	 the	 cis-regulatory	 element	 they	originate	from,	 unique	 sequences	 ('Barcodes')	 are	 included	 in	 the	 transcribed	 sequence	(Patwardhan	et	al,	2009,	2012;	Shen	et	al,	2015;	Mogno	et	al,	2013;	Melnikov	et	
al,	2012;	Kwasnieski	et	al,	2012;	White	et	al,	2013).	Alternatively,	enhancers	can	be	placed	downstream	of	a	minimal	promoter	to	directly	transcribe	the	assayed	sequence	(Arnold	et	al,	2014).	Expression	of	reporter	genes	can	also	be	quantified	by	its	enzymatic	activity	(e.g.	luciferase	or	β-galactosidase	as	reporter	genes),	 fluorescence	(e.g.	GFP)	or	with	specific	antibodies.	Many	of	 these	approaches	are	compatible	with	determining	activity	in	whole	organisms	using	imaging	based	assays	that	visualise	abundance	and	 location	 of	 reporter	 gene	 products	 (Shlyueva	 et	 al,	 2014).	 The	 use	 of	fluorescent	 proteins	 under	 the	 transcriptional	 control	 of	 the	 cis-regulatory	element	can	be	used	for	parallelisation.	Cells	can	be	sorted	based	on	intensity	of	the	 fluorescent	 protein	 and	 DNA	 from	 the	 sorted	 populations	 sequenced	 to	identify	 the	 cis-regulatory	 elements	 in	 each	bin	 of	 activity.	 This	method	 is	 less	quantitative	 compared	 to	 barcodes	 integrated	 in	 the	 RNA	 but	 allows	 to	 also	monitor	heterogeneity	of	activity	 in	the	population	(Sharon	et	al,	2012;	Levo	et	
al,	2017).		
2.9 Cell	type	specificity	Cellular	 identity	 is	brought	about	by	activation	and	repression	of	genes	 leading	to	 characteristic	 cell	 type	 specific	 gene	 expression	 patterns.	 This	 is	 thought	 to	rely	 on	 the	 interplay	 between	 TFs	 and	 cis-regulatory	 elements.	 Enhancers	
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display	high	variability	in	activity	across	different	cell	types,	suggesting	that	they	play	a	central	role	in	cell	type	specific	regulation	of	gene	expression	(Xu	&	Smale,	2012;	 Smith	 &	 Shilatifard,	 2014;	 Smallwood	 &	 Ren,	 2013;	 Calo	 &	 Wysocka,	2013).	To	learn	more	about	how	cell	type	specificity	is	brought	about,	enhancers	have	been	systematically	mapped	in	a	plethora	of	tissues	and	cell	lines	based	on	their	chromatin	states.	The	data	from	these	studies	provided	a	large	catalogue	of	putative	regulatory	regions	(Neph	et	al,	2012;	Thurman	et	al,	2012;	Ernst	et	al,	2011).	One	tissue	that	has	an	extraordinary	diversity	of	different	cell	types	is	the	retina,	making	it	an	interesting	model	to	study	cell	type	specificity.		
2.10 The	 retina,	 an	 example	 for	 high	 cell	 type	 specificity	 within	
one	tissue	The	eye	 is	 an	elaborate	 sensory	organ	 that	 allows	vision.	Perception	of	 light	 is	enabled	by	 the	 retina,	 a	 complex	neuronal	 tissue.	 It	 is	 comprised	of	more	 than	fifty	 functionally	 specialised	 cell	 types,	 each	 of	 them	 contributing	 to	 the	generation	of	an	image.		
2.10.1 The	anatomy	of	the	retina	and	cell	type	specificity	The	cells	in	the	retina	are	organised	in	layers.	The	photoreceptor	layer	and	outer	nuclear	 layer	consists	of	 light	sensitive	cells	called	photoreceptors	 that	capture	light.	There	are	two	types	of	photoreceptors;	rods,	which	grant	black	and	white	vision	 in	 low	 light	 condition,	 and	 cones,	which	 allow	 color	 vision	under	 bright	light	 conditions.	 Their	 outer	 segments	 are	 embedded	 in	 the	 retinal	 pigment	epithelium.	 Photoreceptors	 are	 connected	 to	 interneurons	 like	 horizontal	 cells	(HCs)	 and	amacrine	 cells	 in	 the	outer	plexiform	 layer	 to	 integrate	 and	process	their	 signals	 in	 the	 inner	 nuclear	 layer	 (Swaroop	 et	al,	 2010).	 Horizontal	 cells	(HCs)	are	a	low	abundant	cell	type.	These	cells	are	thought	to	adjust	the	systems’	response	 to	 overall	 illumination	 level	 and	 enhance	 contrast	 between	 adjacent	light	and	dark	regions	(Masland,	2001).	Within	the	inner	plexiform	layer,	connections	are	made	to	ganglion	and	amacrine	cells	that	reside	in	the	ganglion	cell	layer	(Swaroop	et	al,	2010).	Part	of	the	signal	is	 processed	 in	 this	 layer.	 For	 example,	 a	 special	 type	 of	 amacrine	 cells,	 the	
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starburst	 amacrine	 cells	 (SACs),	 are	 able	 to	 discriminate	 directionality	 of	 a	stimuluses’	 movement	 making	 them	 essential	 for	 image	 motion	 stabilisation	(Yoshida	 et	al,	 2001).	 Ganglion	 cells	 relay	 the	 signal	 via	 the	 optic	 nerve	 in	 the	optic	 nerve	 fiber	 layer	 to	 visual	 brain	 centers	 (Figure	 7)	 (Masland,	 2001;	Swaroop	et	al,	2010).		
	
Figure	7:	Anatomy	of	the	Retina.	
The	cells	within	the	retina	are	organised	in	layers.		The	 development	 and	 maintenance	 of	 different	 cell	 types	 with	 very	 specific	functions	 within	 the	 retina	 is	 based	 on	 correct	 spatiotemporal	 expression	 of	genes.	This	has	 to	be	 tightly	controlled	by	regulatory	elements.	While	 the	gene	expression	patterns	of	many	retinal	 cell	 types	have	been	studied	 in	health	and	
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disease	(Siegert	et	al,	2009,	2012),	what	regulatory	elements	bring	about	 these	expression	 patterns	 is	 still	 unclear.	 Information	 on	 important	 regulatory	elements	is	crucial	to	identify	the	molecular	players	interpreting	the	instructive	code	to	better	understand	cell	type	formation	and	maintenance.		The	identification	of	autonomously	active	regulatory	regions	and	key	TFs	is	not	only	 important	 to	 understand	 cell	 type	 specificity	 in	 healthy	 cells,	 it	 is	 also	 a	crucial	step	on	the	way	to	design	gene	therapies	for	retinal	diseases.	Part	of	the	work	 in	 this	 thesis	 focuses	 on	 the	 identification	 and	 functional	 validation	 of	regulatory	regions	in	retinal	cell	types.			
2.10.1 Gene	therapy	Incorrect	gene	expression	or	faulty	gene	products	in	retinal	cell	types	can	lead	to	retinopathies	 that	can	result	 in	visual	 impairment	and	even	blindness	 (Sahel	&	Roska,	 2013).	 One	 approach	 that	 could	 aid	 in	 improving	 or	 curing	 visual	impairment	 or	 blindness	 is	 gene	 therapy.	 The	 unique	 morphological	characteristics	 of	 the	 eye	 and	 the	 fact	 that	 it	 is	 immune	 privileged,	 makes	 it	especially	 suited	 for	 this	 type	of	 therapy	 (Bainbridge	et	al,	 2006;	Roosing	et	al,	2014).	 Gene	 therapy	 relies	 on	 the	 delivery	 of	 a	 transgene	 controlled	 by	 a	promoter-enhancer	 construct	 that	 ensures	 expression	 of	 the	 transgene	 in	 the	right	cell	types.	The	eye	is	especially	suited	for	viral	delivery	of	transgenes	since	it	 is	 a	 small,	 closed	 compartment	 that	 allows	 high	 viral	 concentrations	 with	relatively	 low	 amounts	 of	 virus.	 Additionally,	 viruses	 can	 be	 delivered	 to	different	ocular	structures	due	to	the	eyes	compartmentalisation	(Sahel	&	Roska,	2013).	An	example	for	the	potential	of	gene	therapy	is	RPE65	gene	replacement	in	leber	congenital	amaurosis,	a	retina	dystrophie	leading	to	visual	impairment	(Sahel	&	Roska,	2013).	One	form	of	this	disease	is	caused	by	mutations	of	the	RPE65	gene	that	 is	 specific	 for	 the	 retinal	 pigment	 epithelium.	 Adeno-associated	 virus	mediated	delivery	of	the	functional	RPE65	gene,	controlled	by	a	CMV	promoter,	into	 the	eye	of	dogs	 that	are	affected	by	RPE65	mutations	 led	 to	restoration	of	vision	 (Acland	 et	 al,	 2001).	 Later,	 clinical	 trials	 in	 humans	 showed	 that	 this	therapy	 also	 leads	 to	 improved	 vision	 in	 patients	 (Bainbridge	 et	 al,	 2008;	
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Hauswirth	et	al,	2008;	Maguire	et	al,	2008).	This	encouraging	example	shows	the	potential	of	gene	therapy.	One	risk	of	gene	therapy	can	be	adverse	effects	due	to	expression	of	transgenes	outside	 of	 target	 cells	 or	 wrong	 expression	 levels.	 This	 could	 be	 reduced	 by	specific	expression	of	the	transgene	at	physiological	levels	in	the	target	cell	type.	The	 results	 of	 part	 of	 this	 thesis	 demonstrate	 a	 strategy	 how	 to	 make	 a	 step	towards	 identification	of	autonomously	active	cell	 type	specific	enhancers	with	different	activity	levels.		 	
	 26	
2.11 Scope	of	this	thesis	Even	 though	 fundamental	 to	 biology,	 we	 still	 have	 a	 limited	 understanding	 of	how	DNA	sequence	controls	transcriptional	activity	of	enhancers	and	promoters.	The	majority	of	promoters	 in	our	genome	are	rich	 in	 the	CpG	dinucleotide	and	their	high	CpG	density	has	been	linked	via	correlation	to	transcriptional	activity	(Weber	et	al,	 2007;	Guenther	et	al,	 2007;	Thomson	et	al,	 2010;	Deaton	&	Bird,	2011;	Fenouil	et	al,	2012).	In	 the	 first	part	of	 the	work	presented	here	we	asked	 if	CpGs	contribute	 to	 the	transcriptional	 activity	 of	 CpG	 island	 promoters.	 We	 explored	 if	 CpGs	 play	 a	regulatory	role	only	when	they	are	located	in	TF	motifs	or	if	their	overall	density	in	 regulatory	 regions	 is	more	 important.	We	 further	 asked	 how	 their	 function	relates	to	DNA	methylation.		We	addressed	these	questions	by	monitoring	binding	of	TFs	assumed	to	play	a	role	 in	 CGI	 activity.	 Additionally,	 we	 generated	 a	 large	 number	 of	 promoter	mutants,	 including	 artificial	 promoter	 sequences,	 and	 quantified	 their	transcriptional	 activity	 in	 wild-type	 and	 DNA	 methylation-free	 murine	embryonic	 stem	 cells.	 Together	 these	 experiments	 gave	 insight	 into	 how	 very	short	motifs	such	as	the	CpG	dinucleotide	impact	transcriptional	activity.		To	 gain	 further	 insight	 into	 how	 regulatory	 regions	 contribute	 to	 cell	 type	specific	 gene	 expression	 patterns,	 we	 investigated	 cell	 type	 specific	 control	 of	gene	expression	in	the	mouse	retina	in	the	second	part	of	this	thesis.	Identifying	
cis-regulatory	 elements	 is	 essential	 in	 order	 to	 understand	 the	 transcriptional	regulatory	 principles	 that	 control	 cell-type	 specification.	 Important	 questions	that	remain	include:	Which	regions	in	the	genome	are	involved	in	gene	activity	within	 specific	 cell	 types?	 Are	 the	 identified	 regulatory	 regions	 autonomously	active	and	how	can	this	be	tested	in	high-throughput	in	specific	cell	types?	Which	TFs	play	a	role	in	the	transcriptional	activity	of	identified	regulatory	elements?	Towards	addressing	these	questions,	we	established	an	experimental	framework	that	allows	 identification	of	 regulatory	elements	within	specific,	 and	even	rare,	cell	types	of	the	mouse	retina.	To	test	autonomous	activity	of	these	elements	in	specific	cell	types	we	developed	a	high-throughput	reporter	assay.	Additionally,	we	 used	 the	 generated	 data	 to	 identify	 TFs	 that	 play	 a	 role	 in	 the	 activity	 of	
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regulatory	regions	in	different	cell	types	and	tested	them	by	quantifying	activity	of	regions	with	mutated	motifs.		
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3 Results	
3.1 Design	principles	of	CpG	Island	promoter	activity	
Prepared	manuscript							
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Abstract	CpG	islands	represent	 the	majority	of	promoters	 in	mammalian	genomes.	They	are	CpG	rich	and	mostly	devoid	of	DNA	methylation.	To	which	extend	and	how	these	characterizing	CpGs	contribute	to	promoter	activity	and	regulation	remains	open.	 To	 gain	 insights	 into	 this	matter,	we	monitored	 binding	 of	 transcription	factors	assumed	to	play	a	role	for	CpG	island	activity	and	tested	a	large	number	of	promoter	 mutants	 including	 artificial	 promoter	 sequences	 for	 their	transcriptional	activity	with	and	without	insertion	into	the	genome.	This	revealed	that	CpG	density	and	motif	occurrence	is	a	good	predictor	for	transcription	factor	binding.	Rigorous	functional	testing	of	promoter	mutants	showed	that	high	CpG	density	is	not	sufficient	for	transcriptional	activity,	yet	necessary	when	combined	with	more	 complex	 transcription	 factor	motifs.	 Our	 comprehensive	 study	 also	reveals	 that	 DNA	 methylation	 results	 in	 a	 further	 decrease	 in	 transcriptional	activity	of	promoter	mutants	with	low	CpG	density.	This	leads	to	a	model	where	a	high	CpG	density	is	required	to	generate	a	chromatin	environment	permissive	for	transcriptional	activity.			
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Introduction	Gene	regulation	establishes	correct	spatio-temporal	expression	patterns	essential	for	cellular	function.	Correct	gene	expression	is	controlled	at	multiple	levels,	the	first	 being	 DNA	 sequence.	 Regulatory	 regions	 are	 interpreted	 by	 DNA	 binding	proteins	such	as	transcription	factors	(TFs).	Additionally,	changes	 in	chromatin	structure	 enable	 temporal	 integration	 of	 regulatory	 events	 through	 dynamic	processes	including	cell	division	and	organism	development.	One	essential	chromatin	component	in	mammals	is	DNA	methylation	of	Cytosines	(Cs)	that	reside	in	a	Cytosine-phosphate-Guanine	(CpG)	context	(Lister	et	al,	2009;	Stadler	et	al,	2011).	The	majority	of	CpGs	in	mammalian	genomes	are	methylated	while	unmethylated	CpGs	are	concentrated	in	specific	regions	called	CpG	islands	(CGIs)	(Bird	et	al,	1985).	CGI	criteria	have	been	defined	to	be	at	 least	200bp	in	length	with	a	G+C	content	of	at	least	50%	and	an	observed	to	expected	(OE)	ratio	of	at	 least	0.6,	where	OE	is	number	of	CpGs	/	(number	of	Cs	x	number	of	Gs)	x	length	of	the	region	in	nucleotides	(Gardiner-Garden	&	Frommer,	1987).	In	human	and	mouse,	 CGIs	 overlap	with	~60%	 of	 the	 promoters,	 resulting	 in	 a	 bimodal	distribution	of	promoter	CpG	density	(Figure	1A)	(Mohn	&	Schübeler,	2009).	Since	many	CGI	promoters	are	ubiquitously	active	across	many	cell	types	(Larsen	et	al,	1992),	most	initiation	events	of	RNA	Polymerase	II	occurs	within	CGI	promoters.	There	are	two	mutually	not	exclusive	hypotheses	for	the	enrichment	of	CpGs	at	CGI	promoters	compared	to	the	rest	of	the	genome:	(1)	CpGs	represent	a	footprint	of	 evolution	 since	 the	 mutation	 rate	 differs	 between	 methylated	 and	unmethylated	CpGs	(Bird,	1980).	Unmethylated	Cs	deaminated	to	uracils	(Barnes	&	Lindahl,	2004)	which	are	efficiently	repaired	while	methylated	Cs	deaminate	to	Ts	which	is	a	proper	genomic	base	and	inefficiently	repaired	leading	to	a	higher	mutation	rate.	This	is	supported	by	the	fact	that	most	of	the	CpG	islands	do	indeed	have	a	lower	CpG	frequency	than	expected	by	chance	based	on	G	and	C	content	(OE<1)	and	that	most	divergence	between	close	mammalian	species	is	observed	at	Cs	residing	within	CpGs	methylated	in	the	germline	(Weber	et	al.,	2007).	In	an	alternative	scenario	(2)	CpGs	can	act	as	a	signaling	module:	CpGs	have	been	thought	to	contribute	to	gene	regulation	via	several	mechanisms	(Bird,	2011).	It	has	 been	 shown	 that	 CpG	 density	 can	 protect	 a	 DNA	 sequence	 from	 DNA	methylation	(Lienert	et	al,	2011;	Krebs	et	al,	2014;	Wachter	et	al,	2014;	Long	et	al,	
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2016).	 Possible	 mechanisms	 could	 be	 direct	 binding	 of	 ZF-CxxC	 domain	containing	 proteins	 that	 have	 been	 proposed	 to	 inhibit	 or	 counteract	 methyl	transferase	activity	(Ooi	et	al,	2007;	Cedar	&	Bergman,	2009).	Additionally,	also	TFs	like	Sp1	have	been	linked	to	keeping	CpGs	unmethylated	(Brandeis	et	al,	1994;	Macleod	et	al,	1994).	To	 distinguish	 between	 these	 two	 scenarios,	 the	 role	 of	 CpGs	 has	 to	 be	 tested	functionally.	Careful	mutation	of	CpGs	within	CpG	island	promoters	should	inform	on	whether	CpGs	themselves	contribute	to	transcriptional	activity	or	not.		Transcriptional	activity	is	mediated	by	motif	specific	TFs.	However,	the	majority	of	TF	motif	occurrences	within	the	genome	are	not	bound	by	corresponding	TFs	(Biggin,	2011).	CpG	density	is	a	good	predictor	for	promoters	(Ioshikhes	&	Zhang,	2000),	since	transcriptional	activity	is	mediated	by	TFs,	this	could	indicate	that	also	CpGs	play	a	role	for	TF	binding.	Since	CpGs	can	be	part	of	TF	motifs	it	is	hard	to	separate	the	contribution	of	the	two	to	transcriptional	activity	from	each	other	making	 functional	 testing	necessary.	 CpG	density	 can	be	 functionally	 tested	 by	mutating	sequence	components	of	CGI	promoters	and	quantifying	transcriptional	output	in	a	reporter	assay.	In	order	for	such	experiments	to	be	conclusive	a	high	number	 of	 mutations	 has	 to	 be	 assayed.	 Using	 high	 throughput	 sequencing	transcriptional	reporter	assays	have	recently	been	parallelized	(Patwardhan	et	al,	2009,	2012;	Shen	et	al,	2015;	Mogno	et	al,	2013;	Melnikov	et	al,	2012;	Kwasnieski	
et	al,	2012;	White	et	al,	2013).	Yet	in	higher	eukaryotes	such	assays	have	not	been	performed	 on	 genomic	 DNA	 with	 integration	 of	 the	 constructs	 in	 the	 same	genomic	site	in	every	cell.	Since	chromatin	environment	is	thought	to	contribute	to	 transcriptional	 activity	 of	 CGI	 promoters	 genomic	 integration	 is	 essential	 to	obtain	 conclusive	 results.	 Additionally,	 integration	 at	 the	 same	 genomic	 locus	allows	quantification	of	transcriptional	activity	independent	of	positional	effects.	To	 comprehensively	 address	 CpG	 contribution	 to	 transcriptional	 activity,	 we	monitored	binding	of	transcription	factors	assumed	to	play	a	role	for	CpG	island	activity	and	analyzed	the	relationship	of	binding	data	and	sequence	features.	To	functionally	test	the	role	of	CpGs	we	quantified	transcriptional	activity	of	a	large	number	of	promoter	mutants	including	artificial	promoter	sequences	in	murine	embryonic	stem	cells	as	a	model.	To	monitor	the	relationship	of	DNA	methylation	
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and	promoter	mutant	activity	we	assayed	 the	mutant	 libraries	 in	wildtype	and	DNA	methylation	deficient	cells.		
Results	
TFs	binding	motifs	in	CGIs	Transcriptional	activity	is	mediated	in	principle	by	TFs	that	bind	to	specific	motifs	on	 DNA.	 However,	 predicting	 TF	 binding	 from	 their	 preferred	motif	 generally	proofs	 to	 be	 difficult	 in	 higher	 eukaryotes.	 Only	 a	minor	 fraction	 of	 occurring	motifs	 tends	 to	 be	 bound	 at	 any	 given	 cell	 state	 (Biggin,	 2011)	 because	 local	chromatin	environment	is	thought	to	be	an	additional	determinant	of	occupancy	(Biggin,	 2011).	 This	 absence	 of	 correct	 prediction	 ultimately	 requires	 to	 map	binding	sites	in	vivo.	To	gain	insights	into	this	problem	at	CpG	islands,	we	mapped	a	set	of	four	TFs	that	are	broadly	expressed	across	many	different	cell	types	and	tissues	 making	 them	 candidates	 to	 control	 housekeeping	 gene	 activity	(Supplementary	Figure	1	a-d).	Of	these,	Sp1	and	Sp3	have	rather	low	complexity	motifs	 (Figure	 1c	 and	 d).	 The	 low	 complexity	 implies	 that	 the	 motif	 occurs	frequently	by	chance.	Indeed,	if	we	generate	random	sequences	with	the	length	of	CpG	islands	and	their	average	dinucleotide	composition,	half	of	these	“CGI	 like”	sequences	contain	Sp1	or	Sp3	motifs.	In	contrast,	Gabpa	and	Nrf1	motifs	display	higher	complexity	(Figure	1e	and	f)	and	consequently	their	motifs	only	occur	in	15%	 and	 10%	 of	 random	 sequences	 (matches	 to	 highest	 scoring	 7bp).	 This	randomization	 illustrates	 an	 intrinsic	 problem	 in	 that	 G+C	 rich	 motifs	 of	 low	complexity	occur	at	high	frequency	by	chance	in	any	CGI	sequence.	 In	turn	this	makes	 them	 frequent	 hits	 in	 any	motif	 prediction.	 Notably,	 Sp1	 and	 Sp3	 have	already	 been	 directly	 implicated	 in	 controlling	 CGI	 activity	 based	 on	 single	promoter	analysis	(Brandeis	et	al,	1994;	Macleod	et	al,	1994).	To	test	how	this	actually	 resembles	 and	 predicts	 binding,	we	 performed	 ChIP-Seq	 for	 Sp1,	 Sp3,	Gabpa	 and	 Nrf1	 in	 mouse	 embryonic	 stem	 cells	 using	 the	 'Rambio'	 approach	(Baubec	et	al,	2013).	This	system	of	controlled	expression	of	a	protein	of	interest	combined	with	a	strong	affinity	tag	generated	reproducible	high	quality	data	for	all	four	factors	(Figure	1b	and	Supplementary	Figure	1e	and	f).	In	case	of	NRF1,	we	 had	 previously	 generated	 ChIP	 with	 an	 antibody	 enabling	 us	 to	 directly	compare	tagged	versus	endogenous	protein,	which	revealed	a	highly	consistent	
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binding	 pattern	 (Supplementary	 Figure	 1g).	 In	 case	 of	 all	 three	 proteins,	 a	comparison	of	Bio-ChIP	signal	to	motif	strength	reveals	that	bound	sites	contain	the	motif	but	that	nevertheless	the	motif	itself	is	only	a	poor	predictor	of	actual	binding	due	to	many	motif	occurrences	that	are	unbound.	 In	total	only	~5%	of	high	scoring	Sp1	and	Sp3	sites	are	bound	while	~25%	of	high	scoring	Gabpa	and	Nrf1	motifs	are	bound.	Comparison	of	motif	strength	with	TF	binding	reveals	that	for	all	four	factors	only	high	scoring	motifs	are	robustly	bound.	This	suggests	that	these	factors	are	indeed	highly	specific	to	their	motif	(Figure	1g-j).	Importantly,	this	is	also	true	for	Sp1	and	Sp3	that	have	low	complexity	motifs	that	in	variations	might	also	occur	by	chance.		CpGs	 are	 enriched	 at	 the	 majority	 of	 promoters	 compared	 to	 the	 rest	 of	 the	genome	and	can	even	be	used	to	predict	promoters	(Ioshikhes	&	Zhang,	2000).	We	were	wondering	if	this	short	dinculeotide	has	predictive	power	for	TF	binding.	For	such	a	short	sequence	the	motif	itself	cannot	be	used	but	rather	the	local	frequency	at	which	it	occurs.	Consequently,	we	focused	on	CpG	density	that	we	calculated	by	normalizing	to	the	expected	frequency	based	on	G	and	C	content	in	the	sequence.	We	then	contrasted	CpG	density	with	TF	binding.	For	all	four	factors	the	relative	number	 of	 bound	 sites	 starts	 to	 rise	 at	 normalized	 CG	 density	 (Observed	 over	expected=OE)	of	~0.6	and	then	gradually	increases	(Supplementary	Figure	1i-l).	We	 note	 that	 an	 OE	 of	 0.6	 is	 also	 the	most	 commonly	 used	 threshold	 for	 the	definition	of	CGIs	(Gardiner-Garden	&	Frommer,	1987).	CpG	 density	 of	 OE	 >0.6	 and	 no	 motif	 information	 performs	 slightly	 better	 in	predicting	binding	than	a	high	scoring	motif	alone.	For	Sp1	and	Sp3	~20%	and	for	Gabpa	 ~40%	 of	 windows	 with	 high	 CpG	 densities	 are	 bound	 (Figure	 1k-m,	Supplementary	Figure	1i-l).	How	can	it	be	explained	that	high	frequency	of	a	low	information	 dinucleotide	 predicts	 binding	 better	 than	 individual	 occurrence	 of	more	 complex	 binding	 sites?	 One	 possibility	 is	 that	 either	 CpG	 density	 itself	directly	or	indirectly	increases	affinity	for	Sp1,	Sp3	and	Gabpa.	Alternatively,	CpG	density	 could	 correlate	with	 another	 genomic	 feature	 such	 as	 open	 chromatin	which	defines	the	accessible	part	of	 the	genome.	 Indeed,	when	comparing	both	CpG	 density	 does	 correlate	 with	 accessibility	 (Supplementary	 Figure	 1h).	Accessibility	 performs	 better	 as	 a	 predictor	 arguing	 that	 all	 binding	 events	 of	
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above	factors	occur	in	open	chromatin	(Supplementary	Figure	1m-p).	While	this	correlation	does	not	allow	to	infer	causality,	it	is	tempting	to	speculate	that	CpGs	play	 a	 role	 since	 at	 CpG	 densities	 bigger	 than	 ~0.6	 most	 regions	 are	 indeed	accessible	(Supplementary	Figure	1h).		Interestingly	CpG	density	performs	much	worse	in	predicting	Nrf1	binding	than	the	motif	of	this	factor	itself	(Figure	1n,	Supplementary	Figure	1l).	This	could	be	a	direct	reflection	of	motif	complexity.	If	all	binding	events	occur	in	open	chromatin	and	at	a	correct	motif,	the	variable	with	the	least	occurrences	will	perform	better	in	the	predictor.	In	case	of	a	low	complexity	motif	this	might	be	open	chromatin	but	not	in	case	of	a	high	complexity	motif.	To	 test	 the	 predictability	 of	 CpG	 density	 and	 high	 scoring	 motif	 together	 we	combined	the	two.	Indeed,	windows	with	high	CpG	density	that	contain	the	motif	are	most	likely	to	be	bound	for	all	factors.	~20%	are	bound	by	Sp1	and	Sp3	while	Nrf1	and	Gabpa	with	their	higher	complex	motifs	bind	~80%	and	~90%	of	the	windows	respectively	(Figure	1k-n).	One	possible	interpretation	of	this	result	is	that	high	CpG	density	facilitates	binding	for	all	four	factors.	CpG	rich	regions	often	co-occur	 with	 CpG	 island	 promoters	 that	 tend	 to	 be	 active.	 Therefore,	 an	alternative	explanation	would	be	that	increased	binding	is	simply	based	on	non-functional	 co-occurrence,	 rather	 than	 on	 a	 functional	 relationship	 of	 increased	binding	and	CpG	density.	This	would	be	also	in	agreement	with	the	fact	that	the	fraction	of	bound	sites	starts	to	increase	from	a	CpG	density	of	0.6,	which	is	the	lower	 limit	of	 the	CpG	 island	definition	 (Supplementary	Figure	1i-l)	 (Gardiner-Garden	&	 Frommer,	 1987).	 Indeed,	within	 active	 promoters	 the	 differences	 in	bound	sites	of	promoters	with	the	motif	versus	promoters	with	both,	motif	and	high	CpG	density,	are	lower	for	all	factors	(Figure	1o-r)	compared	to	the	data	in	windows	tiling	chromosome	19	(Figure	1k-n).	While	this	could	suggest	that	the	contribution	 of	 CpG	 density	 does	 not	 play	 a	 major	 role	 here,	 we	 also	 cannot	exclude	that	high	CpG	density	is	required	for	TF	binding	and	promoter	function.	Taken	 together	 we	 cannot	 conclude	 from	 this	 data	 whether	 CpG	 density	functionally	contributes	to	binding	of	the	tested	TFs.	CpG	rich	regions	tend	to	be	more	accessible	and	are	more	likely	to	be	transcriptionally	active	than	CpG	poor	regions.	To	control	for	such	confounders	in	genomics	analysis,	one	would	usually	compare	sequences	of	similar	base	composition	but	different	regulatory	potential.	
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This	however	is	not	possible	for	CGIs	since	all	of	these	are	regulatory	regions	that	are	 under	 functional	 selection.	 This	 makes	 it	 difficult	 to	 elucidate	 if	 CpGs	themselves	 aid	 TF	 binding	 or	 if	 this	 is	 just	 a	 coincidence	 of	 their	 evolutionary	origin.	Factors	 like	Sp1	 that	have	a	G	and	C	 rich,	 low	complexity	motif	 are	even	more	prone	to	this	bias	which	explains	why	they	are	so	frequently	enriched	upon	motif	enrichment	on	genomic	events	that	occur	on	CGIs	such	as	transcription	but	also	Polycomb	repression.	The	 absence	 of	 control	 sequences	 that	 lack	 regulatory	 activity	 excludes	 to	elucidate	the	role	of	CpGs	for	TF	binding	and	transcriptional	activity	by	correlative	studies.	 Rather	 this	 requires	 rigorous	 experimental	 testing	 of	 functionality	 in	transcription	upon	sequence	variation.	
	
Accessing	reporter	assay	at	a	defined	chromosomal	site	Dissecting	what	DNA	sequence	components	define	the	transcriptional	activity	of	CGIs	requires	an	experimental	approach	that	allows	systematic	iteration	to	test	many	different	promoter	sequences	in	parallel	and	on	chromosomal	DNA.	This	in	turn	requires	parallel	analysis	of	sequence	 libraries	and	the	ability	 to	 link	RNA	molecules	to	a	specific	regulatory	region	that	is	not	part	of	the	transcript.	Towards	this	goal	we	designed	a	reporter	cassette	that	allows	cloning	of	promoter	sequences	as	a	pool.	In	order	to	assign	transcripts	to	their	specific	promoter	we	added	barcodes	(BCs)	to	the	transcribed	region.	Such	strategy	has	already	been	performed	 successfully	 in	 transient	 reporter	 assays	 (Patwardhan	 et	 al,	 2009,	2012;	Shen	et	al,	2015;	Mogno	et	al,	2013;	Melnikov	et	al,	2012;	Kwasnieski	et	al,	2012;	White	et	al,	2013)	(Figure	2a).	To	account	for	the	contribution	of	chromatin	to	transcriptional	regulation,	we	integrate	the	promoter-barcode	constructs	into	a	defined	chromosomal	context	using	recombinase	mediated	cassette	exchange	(RMCE)	(Lienert	et	al,	2011;	Arnold	et	al,	2013;	Krebs	et	al,	2014;	Jermann	et	al,	2014).	Specifically,	we	integrated	the	libraries	into	the	b-globin	locus	in	ESCs	that	was	shown	to	be	epigenetically	and	transcriptionally	inactive	in	most	cells	besides	the	 erythroid	 lineage	 of	 the	 blood	 (Fromm	 &	 Bulge,	 2009).	 This	 allows	quantification	of	transcriptional	activity	on	chromatin	independent	of	positional	effects.	BC	frequencies	can	be	quantified	by	isolating	RNA	and	DNA,	amplification	
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of	BCs	 followed	by	next	generation	sequencing	of	 the	BCs	 in	 the	 two	 fractions.	Frequencies	of	individual	barcodes	in	the	RNA	fraction	are	then	normalized	to	the	representation	of	every	promoter-barcode	construct	in	the	cell	population	(Figure	2a).	Averaging	the	signal	of	all	barcodes	corresponding	to	one	promoter	mutant	(at	least	3,	median	across	all	BCs)	allows	us	to	accurately	and	reproducibly	quantify	activity	 of	 individual	 promoter	 mutants	 (Supplementary	 Figure	 2a-b,	Supplementary	Figure	3a,d-f,	Supplementary	Figure	4	and	5).	We	utilized	this	assay	to	measure	up	to	~3100	Promoter-BC	constructs	within	a	single	experiment.	 In	total	we	tested	more	than	10000	Promoter-BC	constructs	representing	~	270	unique	sequences.	To	our	knowledge	this	is	by	far	the	highest	number	of	sequences	tested	for	their	transcriptional	potential	at	a	single	genomic	site	in	a	higher	eukaryote.		
High	CpG	density	alone	is	insufficient	for	CGI	activity	CpG	 density	 performs	 remarkably	 well	 in	 predicting	 binding	 of	 Sp1,	 Sp3	 and	Gabpa.	If	this	is	a	direct	consequence	of	CpG	density	is	unclear.	It	has	been	shown	that	high	CpG	density	coincides	with	transcriptionally	permissive	chromatin,	such	as	 trimethylation	 at	 lysine	 4	 of	 histone	 H3	 (H3K4me3)	 and	 lack	 of	 DNA	methylation	also	at	artificial	sequences	(Wachter	et	al,	2014;	Lienert	et	al,	2011;	Krebs	et	al,	2014).		To	 test	 if	 high	 CpG	 density	 alone	 is	 sufficient	 for	 transcriptional	 activity	 we	quantified	transcriptional	activity	of	DNA	sequences	containing	high	CpG	density	but	 that	are	not	under	 functional	 selection	 for	 regulation	and	 thus	should	only	contain	TF	binding	sites	by	chance.	More	specifically,	we	chose	sequences	from	the	prokaryotic	E.	 coli	 genome	which	were	amplified	and	 inserted	 in	 front	of	a	minimal	promoter	and	inserted	them	into	the	mouse	genome.	When	quantifying	activity	of	these	constructs	we	observed	no	or	very	little	transcriptional	activity	(Figure	2b).	This	suggests	that	high	CpG	density	is	not	sufficient	for	transcriptional	activity	 when	 assayed	 on	 chromatin.	 To	 ask	 if	 this	 reflects	 repression	 by	chromatin	we	 tested	 the	 same	 library	 transiently	 without	 integration	 into	 the	genome.	However,	also	on	a	plasmid	only	low	to	no	transcriptional	activity	could	be	observed	(Figure	2C).	
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Taken	together,	this	data	suggest	that	CGIs	are	not	transcriptionally	active	based	on	 their	 CpG	 density	 alone.	 However,	 even	 if	 CpGs	 are	 not	 sufficient	 for	transcriptional	activity,	they	might	still	be	a	necessary	feature	for	functional	CGIs.	Alternatively,	they	could	be	only	a	footprint	of	evolution.	Methylated	CpGs	show	faster	mutation	rates	than	the	unmethylated	form.	Since	CGIs	are	unmethylated	in	the	germline	this	could	lead	to	a	decreased	loss	of	CpGs.	This	is	supported	by	the	fact	 that	most	 of	 the	 CpG	 islands	 do	 indeed	 have	 a	 lower	 CpG	 frequency	 than	expected	 by	 chance	 based	 on	 G	 and	 C	 content	 (OE<1).	 Therefore,	 lack	 of	 DNA	methylation	would	pose	a	plausible	explanation	 for	higher	CpG	density	at	CGIs	compared	to	the	rest	of	the	genome.	Independent	of	this	explanation,	CpGs	could	also	serve	as	a	signaling	module.	CpG	rich	promoters	tend	to	be	transcriptionally	more	active	than	CpG	poor	promoters	and	as	shown	above,	CpGs	positively	correlate	with	TF	binding.	To	directly	test	for	CpG	contribution,	CpGs	within	active	CGI	promoters	have	to	be	carefully	mutated	to	decrease	CpG	density	followed	by	monitoring	of	their	transcriptional	activity.		
Identification	of	CGI	promoters	that	are	autonomously	active	Having	established	that	CpG	density	alone	does	not	confer	transcriptional	activity,	we	wanted	to	next	test	endogenous	CGIs	for	their	ability	to	drive	reporter	activity.	We	 chose	 promoters	 that	 are	 broadly	 active	 (based	 on	 data	 from	 (Shen	 et	 al,	2012))	and	that	are	bound	by	the	TFs	Sp1,	Sp3,	Gabpa	and	Nrf1.	We	used	DNase	hypersensitive	regions	to	define	borders	of	the	promoters	(data	from	(Domcke	et	
al,	 2015)).	 Based	on	 these	 sequences	we	 generated	 libraries	 of	 promoters	 and	tested	their	transcriptional	activity	in	the	reporter	assay.	About	half	of	the	tested	promoters	displayed	transcriptional	activity	when	inserted	in	the	same	locus	on	genomic	DNA	(Supplementary	Figure	3b	and	c).	This	provided	us	with	sufficient	candidate	promoters	for	further	studies.		
CpG	density	contributes	to	CGI	activity	Having	identified	functional	CGIs	that	drive	promoter	activity,	we	wanted	to	test	if	 high	CpG	density	 is	 a	 required	 feature	 for	 transcriptional	 activity	 of	 CGIs.	 In	order	to	do	so	we	systematically	mutated	CpGs	within	CGI	promoter	sequences	and	quantified	the	effect	on	transcriptional	activity.	More	specifically	we	mutated	
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CpGs	 within	 two	 housekeeping	 gene	 promoters	 (Snx3	 and	 Pwp2)	 that	 are	autonomously	active	in	our	reporter	assay	(Supplementary	Figure	3b	and	c).	Since	mutations	of	CpGs	within	TF	motifs	would	lead	to	effects	unrelated	to	CpG	density,	we	 used	 previously	 published	 TF	 binding	 data	 (see	 methods)	 and	 our	 set	 of	mapped	TFs	to	avoid	changing	CpGs	within	TF	motifs.	We	mutated	CpGs	in	four	(Pwp2)	or	five	(Snx3)	tiling	windows	and	generated	all	possible	combinations	of	WT	 and	mutant	 windows.	 The	 resulting	 promoter	mutant	 libraries	 were	 then	tested	 for	 transcriptional	 activity	 in	 the	 reporter	 assay	 after	 chromosomal	insertion	(Figure	3a).	This	 revealed	 that	 presence	 of	 CpGs	 positively	 correlates	 with	 transcriptional	activity	 for	 both	 promoters	 (Figure	 3b,	 c).	 For	 both	 tested	 promoters	 activity	decreases	rapidly	between	the	normal	CpG	density	and	roughly	~0.6	(Figure	3b,	c).	Further	decrease	does	not	cause	further	reduction	but	activity	plateaus	at	a	low	level	for	the	Snx3	promoter	likely	suggesting	that	the	promoter	is	off	(Figure	3b).	Strikingly,	this	also	coincides	with	the	lower	limit	of	CGI	CpG	density	(Figure	1a).	In	case	of	the	Pwp2	promoter	we	did	not	recover	constructs	with	very	low	CpG	densities	(Figure	3c).	Theis	 data	 argues	 that	 CpG	 density,	 while	 not	 alone	 sufficient	 for	 activity	nevertheless	contributes	to	CGI	activity.	In	order	to	test	if	this	is	a	general	feature	we	 mutated	 ten	 additional	 CGI	 promoters	 but	 with	 a	 lower	 number	 of	permutations.	We	chose	CGI	promoters	that	span	a	range	of	CpG	densities	(0.71	and	1.06)	and	transcriptional	activity	in	the	reporter	assay	(24-fold)	(Figure	3d	and	Supplementary	Figure	3g).	As	before,	we	mutated	CpGs	outside	of	identified	or	 predicted	 TF	 motifs.	 Five	 different	 CpG	 densities	 were	 generated	 for	 each	promoter	using	random	combinations	of	CpGs.	This	more	comprehensive	set	of	 tested	promoters	shows	the	same	response	to	loss	of	CpGs.	The	more	CpGs	were	mutated	the	lower	the	transcriptional	activity	of	the	promoter	(Figure	3c).	Even	with	this	lower	number	of	tested	CpG	densities	per	 promoter	 it	 becomes	 again	 apparent	 that	 at	 a	 CpG	 density	 of	 ~0.6	 most	promoters	show	strongly	reduced	activities	(Figure	3c).		While	this	argues	for	a	general	contribution	of	CpGs	to	CGI	transcriptional	activity,	we	 cannot	 formally	 exclude	 that	 the	 performed	 mutations	 of	 CpGs	 affected	unknown	TF	motifs	 and	 thereby	 causing	 a	 decrease	 in	 transcriptional	 activity.	
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While	 this	 might	 seem	 unlikely	 given	 how	 mutated	 CpGs	 were	 chosen,	 we	nevertheless	 wanted	 to	 explore	 this	 scenario	 using	 a	 different	 permutation	approach.	
	
Dissecting	CpGs	from	TF	motifs	We	 reasoned	 that	 mutating	 CpGs	 that	 are	 critical	 components	 of	 complex	 TF	motifs	should	have	direct	effects	on	promoter	output.	To	identify	such	CpGs	we	generated	 mutants	 of	 short	 regions	 throughout	 the	 entire	 promoter	 and	monitored	 their	 transcriptional	 activity.	 More	 specifically,	 we	 mutated	 10	 bp	windows	covering	the	entire	Pwp2	promoter	and	in	each	case	replaced	the	10	bp	with	a	random	CpG	free	sequence.		Measuring	 the	 resulting	 42	 mutants	 after	 genomic	 insertion	 revealed	 indeed	highly	 variable	 effects	 on	 promoter	 function.	 About	 half	 of	 the	 mutated	 10bp	windows	do	not	have	an	effect	on	transcriptional	activity	(Figure	4b).	When	we	focus	on	a	region	with	predicted	and	high	scoring	TF	motifs	we	see	that	many	but	not	all	of	these	have	an	effect	on	transcriptional	activity	(Figure	4a,	b).	This	agrees	with	mutations	of	 individual	motifs	 that	correspond	to	TFs	 that	bind	the	Pwp2	promoter	 (Figure	4d).	 Comparison	of	ChIP-seq	 signal	 at	 the	 endogenous	Pwp2	promoter	 and	 transcriptional	 activity	 of	 mutants	 shows	 that	 ChIP-seq,	 as	expected,	 lacks	 the	 spatial	 resolution	 to	 correctly	 predict	 if	 a	 specific	 motif	 is	bound	and	in	turn	contributes	to	activity	of	the	promoter.	Additionally,	we	observe	a	decrease	 in	activity	when	mutating	regions	 that	are	downstream	 of	 the	 highest	 signal	 for	 initiation	 as	 measured	 by	 CAGE	 in	 the	endogenous	 promoter	 -(cap	 analysis	 by	 gene	 expression)	 (Forrest	 et	 al,	 2014)	(Figure	4b,c).	This	could	indicate	that	these	regions	are	important	for	initiation,	leading	to	decreased	transcriptional	activity	when	mutated.	Taken	 together	we	were	 able	 to	 characterize	 regulatory	 function	 of	 the	 Pwp2	promoter	 at	 a	 10bp	 resolution.	 Knowledge	 about	 regions	 important	 for	transcriptional	activity	allows	us	to	generate	mutants	in	a	more	educated	manner	without	unintentionally	disrupting	CpGs	critical	for	transcriptional	activity	since	they	are	part	of	a	complex	motif.	
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Mutation	 of	 CpGs	 within	 regions	 that	 themselves	 do	 not	 contribute	 to	
transcriptional	activity	To	assess	the	contribution	of	CpGs	outside	of	TF	motifs,	we	subsequently	mutated	only	those	CpGs	located	within	regions	of	the	Pwp2	promoter	that	showed	no	or	only	minor	effects	on	transcriptional	activity.	We	randomly	mutated	these	CpGs	to	obtain	mutants	with	different	levels	of	CpG	density	(Figure	5a).	Following	 insertion	 of	 the	 resulting	 11	 tested	 sequences	 we	 measured	 their	transcription	output.	The	resulting	data	reveal	that	mutating	CpGs	outside	of	TF	motifs	decreases	activity.	More	specifically,	CpG	densities	lower	than	~0.7	showed	decreased	 activity	 compared	 to	 the	 WT	 (Figure	 5b).	 This	 indicates	 that	 CpGs	outside	of	 important	 regions	 in	 the	Pwp2	promoter	nevertheless	 contribute	 to	transcriptional	activity.	Interestingly,	we	do	observe	an	initial	increase	in	activity	at	 CpG	densities	 between	1	 and	0.8	 (Figure	5b).	 This	 increase	occurred	 across	different	mutated	 sets	 of	CpGs,	 therefore	we	do	 think	 this	 is	 a	 function	of	CpG	density	rather	than	a	mutation	specific	effect.	At	this	point	we	cannot	determine	if	this	is	a	promoter	specific	effect.	However,	among	the	12	tested	promoters,	this	was	the	only	one	that	displayed	a	clear	increase	upon	a	specific	CpG	mutation.	Taken	together,	deletion	of	CpGs	that	are	not	part	of	TF	motifs	also	causes	reduced	activity.	We	next	wondered	 if	adding	CpGs	 into	an	artificial	promoter	would	 in	turn	increase	activity.	
	
Effect	of	increasing	CpG	density	of	an	artificial	promoter	To	further	test	if	CpG	density	leads	to	increased	activity	we	increased	CpG	at	an	artificial	promoter.	We	replaced	all	regions	of	the	Pwp2	promoter	that	showed	no	or	only	minor	effects	on	transcriptional	activity	with	the	CpG	free	sequence	used	for	the	mutants	described	above	(Figure	5c).	This	allowed	us	to	replace	~60%	of	the	sequence	and	to	decrease	CpG	density	from	~1	to	~0.6.	We	then	added	CpGs	into	this	random	sequence	at	the	same	position	as	in	the	WT	promoter.	This	lead	to	 a	 gradual	 increase	 in	 activity,	 depending	 on	CpG	density.	We	 reached	up	 to	~53%	of	wildtype	Pwp2	activity	and	an	activity	of	around	25%	of	WT	Pwp2	when	adding	the	same	number	of	CpGs	as	in	the	WT	(Figure	5d).	These	data	argue	again	that	CpG	density	itself	does	contribute	to	CGI	activity.		
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DNA	methylation	decreases	activity	of	mutants	with	low	CpG	density	Several	mechanisms	how	CpGs	could	contribute	to	promoter	activity	have	been	suggested.	 High	 CpG	 density	 has	 been	 shown	 to	 antagonize	 DNA	methylation,	therefore	one	explanation	for	decrease	in	activity	when	mutating	CpGs	could	be	the	resulting	increased	DNA	methylation	(Lienert	et	al,	2011;	Krebs	et	al,	2014).	This	 effect	 is	more	 likely	 to	 play	 a	 role	 for	mutants	 in	 the	 lower	 range	 of	 CpG	density	as	mutants	with	higher	CpG	density	are	expected	to	be	still	unmethylated	(Lienert	et	al,	2011;	Krebs	et	al,	2014).	Such	de	novo	methylation	might	lead	to	decreased	binding	of	methylation	sensitive	TFs	such	as	Nrf1	(Domcke	et	al,	2015)	or	recruit	MBD	proteins	(Baubec	et	al,	2013).	In	 order	 to	 test	 directly	 if	 de	 novo	 DNA	 methylation	 accounts	 for	 reduced	transcriptional	activity	of	CpG	depleted	mutants	we	repeated	these	experiments	in	cells	that	lack	DNA	methylation.	More	specifically,	we	integrated	CpG	mutants	into	 Dnmt1,	 Dnmt3a	 and	 Dnmt3b	 triple-knockout	 (TKO)	 ESCs	 (Domcke	 et	 al,	2015)	 but	 at	 the	 same	 genomic	 site.	 We	 similarly	 tested	 their	 transcriptional	activity	and	compared	it	to	that	of	the	methylation	competent	cells.	This	revealed	that	 presence	 of	 DNA	 methyltransferases	 has	 no	 significant	 effect	 on	transcriptional	activity	for	those	mutated	promoters	that	show	high	CpG	density	(>0.6),	which	seems	in	agreement	with	our	expectations	that	sequences	with	high	CpG	density	stay	unmethylated	in	any	case.		Sequences	with	lower	CpG	densities,	however,	behave	differently	as	they	tend	to	show	higher	activity	in	cells	without	DNA	methylation	than	in	wildtype	cells	(WT)	(Figure	 6a).	 Importantly,	 the	 difference	 in	 activity	 between	WT	 cells	 and	 cells	lacking	DNA	methylation	 increases	with	decreasing	CpG	density	 (Figure	6a,	b).	Consistent	 with	 this	 result,	 activity	 starts	 to	 deviate	 between	 WT	 and	 TKO	significantly	 at	 a	 CpG	 density	 of	 about	 0.6	 which	 nicely	 aligns	 with	 the	 CGI	definition.	 One	 potential	 interpretation	 of	 this	 result	 is	 that	 DNA	 methylation	might	partially	contribute	to	the	decrease	in	transcription	upon	CpG	mutation.	The	difference	is	CpG	density	dependent.	This	supports	a	model	where	decreased	CpG	density	leads	to	increased	DNA	methylation.	This	in	turn	could	prevent	binding	of	TFs	 sensitive	 to	 DNA	 methylation	 to	 the	 promoter,	 leading	 to	 decreased	transcriptional	 activity.	 Removal	 of	 the	 DNA	methylation	machinery	 therefore	
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leads	to	an	increase	in	binding	and	therefore	increased	transcriptional	activity	at	lower	CpG	densities	(Figure	6c).	In	order	to	test	whether	decreased	activity	of	promoter	mutants	correlates	with	DNA	methylation	we	plan	to	monitor	DNA	methylation	levels	(work	in	progress).	
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Discussion	This	study	discloses	a	functional	role	of	CpG	density	for	the	transcriptional	output	of	CpG	 island	promoters.	By	 combining	genome	wide	profiling	of	 transcription	factors	with	high	 throughput	genomic	 insertion	of	promoter	mutants	we	 show	that	a	high	CpG	density	is	not	sufficient	yet	necessary	for	full	activity	of	CGIs.		In	 order	 to	 obtain	 comprehensive	 data,	 development	 of	 an	 improved	 parallel	reporter	 assay	 proved	 essential.	 Previous	 studies	 described	 substantial	differences	in	transcriptional	activity	of	constructs	depending	on	chromosomal	or	episomal	context	(Inoue	et	al,	2017)	or	genomic	location	(Akhtar	et	al,	2013).	In	this	 study,	 highly	 reproducible	 and	 sensitive	 measurements	 were	 enabled	 by	assaying	constructs	after	insertion	in	the	same	genomic	locus.	As	a	result,	only	one	construct	was	tested	per	cell	but	multiple	measurements	for	each	fragment	within	the	 cell	 population.	 This	 sensitivity	 allowed	 proper	 quantification	 of	 subtle	changes	 in	 transcriptional	 activity.	 To	 our	 knowledge	 such	 throughput	 and	sensitivity	has	not	been	achieved	before	in	a	higher	eukaryote.	Importantly,	this	assay	can	also	be	utilized	to	explore	other	sequence	features	of	promoters	and	can	directly	be	adapted	for	enhancers.		The	 data	 in	 this	 study	 reveals	 that	 CpG	 density	 functionally	 contributes	 to	transcriptional	 activity	 of	 promoters	 in	 combination	 with	 more	 complex	 TF	motifs.	This	finding	agrees	with	correlative	evidence	linking	high	CpG	density	to	active	chromatin	and	transcriptional	activity	(Weber	et	al,	2007;	Guenther	et	al,	2007;	 Thomson	 et	 al,	 2010;	 Deaton	 &	 Bird,	 2011;	 Fenouil	 et	 al,	 2012;	 van	Arendsbergen	et	al,	2016)	as	well	as	 functional	assays	showing	that	CpG	dense	sequences	are	free	of	DNA	methylation	(Lienert	et	al,	2011;	Krebs	et	al,	2014).	In	contrast	to	our	results,	a	recent	study	suggested	based	on	four	artificial	constructs	that	activity	of	CGIs	depends	on	high	G	and	C	content	rather	than	high	CpG	density	(Wachter	et	al,	2014).	Wachter	et	al	monitored	activity	based	on	chromatin	status	while	transcripts	were	not	quantified.	We	cannot	formally	exclude	a	contribution	of	G	and	C	content	 to	 transcriptional	activity	as	we	 focused	on	CpGs.	However,	given	 the	 large	 number	 of	 mutants,	 high	 resolution	 of	 mutated	 CpGs	 and	
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coinciding	 minimal	 changes	 of	 G	 and	 C	 content	 within	 CpG	 mutants	 strongly	argues	that	it	is	primarily	CpG	density	that	contributes	to	transcriptional	activity.		 CpGs	could	support	 transcriptional	activity	 indirectly	by	 increasing	DNA	accessibility	and	thereby	facilitating	TF	binding.	Such	increase	in	openness	likely	depends	 on	 local	 concentration	 of	 CpGs.	 In	 agreement	 with	 this	 hypothesis,	accessibility	of	genomic	regions	correlates	with	CpG	density	genome	wide.	This	is	consistent	with	published	data	showing	that	CpG	rich	artificial	sequences	display	marks	of	open	chromatin	(Wachter	et	al,	2014;	Lienert	et	al,	2011;	Krebs	et	al,	2014)	and	that	the	TFs	tested	in	our	study	preferentially	bind	their	motif	when	located	in	CpG	rich	regions.	This	relationship	raises	the	question	if	accessibility	decreases	 upon	 CpG	 depletion	 in	 promoter	mutants.	 To	 answer	 this	 question,	accessibility	could	be	monitored	at	mutant	constructs	using	NOMe-seq	(Kelly	et	
al,	2012;	Nabilsi	et	al,	2014;	Krebs	et	al,	2017).	One	possible	 explanation	how	CpGs	mediate	 accessible	 chromatin	 could	be	via	direct	recruitment	of	CpG	binders	such	as	ZF-CxxC	domain	containing	proteins.	These	bind	only	unmethylated	CpGs	and	have	been	correlated	 to	an	accessible	chromatin	environment	before	(Blackledge	et	al,	2010;	Clouaire	et	al,	2012,	2014;	Boulard	 et	 al,	 2015).	 One	 candidate	 for	 translating	 CpG	 density	 into	 open	chromatin	is	Cfp1	which	is	part	of	the	H3K4	methyltransferase	complexes	Setd1A	and	Setd1B	(Clouaire	et	al,	2012).	H3K4me3	occurs	around	the	TSS	of	promoters	and	 can	 be	 bound	 by	 the	 chromatin	 remodeler	 Chd1	 (Clouaire	 et	 al,	 2012;	Flanagan	et	al,	2005).	Consequently,	ZF-CxxC	domain	containing	proteins	could	interpret	CpG	density	and	indirectly	 lead	to	chromatin	remodeling,	allowing	TF	binding	and	thereby	resulting	in	transcriptional	activity.	Such	putative	role	of	ZF-CxxC	domain	containing	proteins	could	possibly	be	tested	by	protein	reduction	in	cells	containing	promoter	mutant	 libraries	and	quantification	of	 transcriptional	activity.	Changes	 in	H3K4me3	can	be	monitored	performing	ChIP	on	 individual	constructs	with	and	without	knock-downs.		Importantly,	 the	 effects	 of	 mutating	 CpGs	 were	 rather	 uniform	 regardless	 if	positioned	distal	or	within	the	site	of	transcriptional	initiation.	This	was	similarly	the	case	in	the	artificial	promotor	constructs.	This	result	argues	that	CpGs	have	no	particular	local	function.	Nevertheless,	overall	CpG	density	in	the	promoter	could	indirectly	affect	initiation.	It	was	shown	that	CpG	island	promoters	are	depleted	
		 46	
in	H3K36me2,	a	chromatin	mark	that	can	interfere	with	transcriptional	initiation	(Carrozza	 et	 al,	 2005;	 Li	 et	 al,	 2009;	 Strahl	 et	 al,	 2002;	 Youdell	 et	 al,	 2008).	Removal	 of	H3K36me2	 is	 catalyzed	 by	 the	 ZF-CxxC	domain	 containing	 protein	KDM2A	(Blackledge	et	al,	2010).	Therefore,	KDM2A	binding	as	a	result	of	high	CpG	density	could	protect	the	promoter	from	H3K36me2	thus	preventing	interference	with	 transcriptional	 initiation	 (Blackledge	 et	 al,	 2010).	 To	 test	 presence	 of	H3K36me2	at	promoter	mutants	with	low	CpG	density	ChIP	can	be	performed	on	individual	constructs.	In	 non-transformed	 cells	 DNA	 methylation	 does	 not	 occur	 at	 CpG	 rich	 DNA	sequences	but	only	at	low	CpG	densities	(Lienert	et	al,	2011;	Krebs	et	al,	2014).	We	 showed	 here	 that	 removal	 of	 DNA	 methyltransferases	 leads	 to	 increased	transcriptional	activity	of	mutants	with	low	CpG	densities.	This	data	indicates	that	DNA	 methylation	 causes	 part	 of	 the	 decreased	 transcriptional	 activity	 upon	depletion	 of	 CpGs.	 The	 change	 at	 low	 CpG	 densities	 exclusively	 agrees	 with	previously	published	data	showing	 that	CpG	dense	regions	do	not	display	DNA	methylation	(Krebs	et	al,	2014).	In	order	to	test	whether	decreased	transcriptional	activity	of	promoter	mutants	correlates	with	DNA	methylation	we	plan	to	monitor	DNA	methylation	levels	(work	in	progress).	It	is	tempting	to	speculate	that	high	CpG	density	is	required	at	CGIs	to	prevent	DNA	methylation	(Lienert	et	al,	2011;	Krebs	 et	 al,	 2014)	which	 allows	 binding	 of	methylation	 sensitive	 TFs	 (Watt	 &	Molloy,	1988;	Iguchiariga	&	Schaffner,	1989;	Prendergast	&	Ziff,	1991;	Campanero	
et	al,	 2000;	Domcke	et	al,	 2015)	 (Figure	6c).	A	protective	 function	of	high	CpG	density	against	DNA	methylation	is	a	potential	explanation	why	high	CpG	density	together	with	motif	occurrence	is	such	a	good	predictor	for	TF	binding.	Protection	from	DNA	methylation	at	CGIs	could	be	mediated	by	ZF-CxxC	domain	containing	proteins	like	KDM2B.	Genetic	deletion	of	this	protein	has	indeed	been	shown	to	result	in	rather	slow	but	cumulating	DNA	methylation	at	inactive	CGIs	in	stem	cells	(Boulard	et	al,	2015).	How	 does	 our	 observation	 of	 a	 functional	 link	 between	 CpG	 density	 and	transcriptional	activity	relate	to	existing	models	of	the	evolutionary	origin	of	CpG	islands?	Previous	theoretical	analysis	indicated	that	the	high	CpG	content	in	CGIs	can	be	explained	by	a	neutral	effect	of	slow	deamination	associated	with	the	lack	of	 methylation	 revealing	 no	 evidence	 for	 purifying	 selection	 on	 CpG	 densities	
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(Cohen	et	al,	2011).	The	study	by	Cohen	et	al	are	fully	compatible	with	our	data	that	 argues	 that	 overall	 density	 rather	 than	 individual	 positions	 is	 relevant.	Morever,	 the	 observed	 and	 evolutionary	 maintained	 CpG	 density	 at	 CGIs	 is	sufficiently	high	to	mediate	transcriptional	activity	without	the	need	for	classical	natural	selection.	For	this	model	to	be	true	the	equilibrium	between	spontaneous	deamination	and	gain	of	CpGs	within	CGIs	has	to	be	higher	than	the	threshold	of	CpG	 density	 for	 transcriptional	 activity,	which	we	 estimate	 to	 be	~0.6.	Within	unmethylated	genomes	like	the	invertebrate	Drosophila	melanogaster	CpG	density	is	 ~1	 which	 most	 likely	 also	 represents	 the	 equilibrium.	 We	 assume	 that	 the	balance	point	between	spontaneous	deamination	and	gain	of	CpGs	is	lower	within	CGIs	 since	 they	 reside	 in	methylated	 genomes.	Although	CGIs	 generally	 do	not	display	DNA	methylation,	stochastic	methylation	events	in	the	germline	could	lead	to	a	lower	equilibrium	than	in	unmethylated	genomes.	The	exact	number	remains	to	be	investigated	but	we	expect	the	equilibrium	to	be	higher	than	0.6	as	otherwise	CGIs	with	lower	CpG	densities	would	be	under	selective	pressure.	Taken	together	the	data	in	this	study	underlines	the	importance	and	complexity	of	sequence	context	for	transcriptional	activity.		The	 here	 reported	 functional	 link	 between	 CpG	 density	 and	 transcriptional	activity	at	CGI	promoters	exposes	a	function	of	dinucleotide	frequencies.	Given	the	different	 structure	 of	 CpG	 poor	 promoters	 and	 enhancers	 it	 is	 tempting	 to	speculate	that	other	low	complexity	motifs	might	function	at	these	elements	as	an	additional	means	of	 regulation.	Our	study	should	serve	as	a	starting	point	as	 it	provides	the	experimental	framework	for	rigorous	testing	of	putative	regulatory	roles	of	dinucleotides	in	promoters	and	enhancers.	
	 	
		 48	
Materials	and	Methods	
Cell	culture	Mouse	ES	cells	were	cultured	on	cell	culture	plates	coated	with	0.2%	gelatine	in	DMEM	medium	with	15%	fetal	calf	serum,	2mM	L-glutamine,	1	x	non-essential	amino	acids,	LIF	and	0.001%	b-mercaptoethanol.	Cells	were	 incubated	at	37	°C	with	7%	CO2.	TC-1	cells	with	a	RMCE	site	in	the	beta-globin	locus	were	used	for	integration	of	expression	libraries	for	the	transcriptional	reporter	assay	(Lienert	et	al,	2011).Dnmt1,	Dnmt3a	and	Dnmt3b	was	deleted	in	these	cells	using	CRISPR-Cas9	gene	editing	as	previously	described	(Domcke	et	al,	2015).	Mouse	HA36	ES	cells	(mixed	129-C57Bl/6	strain)	were	used	for	Bio-ChIP	(Baubec	
et	al,	2013).		
Reporter	Assay	
Generation	of	barcoded	reporter	vector	A	cassette	containing	 loxP	site,	multiple	cloning	site,	poly-A	signal	and	another	loxP	 site	 was	 synthetized	 and	 cloned	 into	 a	 plasmid	 backbone	 containing	ampicillin	resistance	(Lienert	et	al,	2011).	Barcodes	were	generated	by	annealing	CGCCGAANNNNWNNNNWNNNNNAGCTCGG	 and	TCGACCGAGCTNNNNNWNNNNWNNNNTTCGGCGCATG.	 Vector	 was	 cut	 using	SphI	and	SalI	and	ligated	with	the	annealed	barcodes	with	T4	ligase.	Ligation	was	precipitated	 and	 100	 ng	 were	 transformed	 into	 MegaX	 DH10BTMT1R	ElectrocompTM	Cells	(Thermo	Fisher).	1:10	000	dilution	was	distributed	on	a	LB	agar	 plate	 containing	 50mg/L	 ampicillin	 to	 estimate	 transformation	 efficiency.	The	rest	was	incubated	in	50ml	LB	containing	50mg/L	ampicillin	shaking	at	300	rpm	at	37	°C	over	night.	Plasmids	were	isolated	using	Quiagen	Plasmid	Midi	Kit.		
Library	cloning	and	RMCE	Promoter	libraries	were	cloned	into	the	expression	vector	using	ClaI	and	NheI	aiming	for	at	least	ten	times	more	colonies	than	unique	promoters.	To	link	barcodes	and	promoters	 the	Promoter-BC	 fragment	was	amplified	with	Primer	DH.P39	 and	 one	 of	 the	 Indexing	 Primers	 containing	 the	 Illumina	 flow	 cell	annealing	sequences	using	Phusion	Hot	Start	II	polymerase	(Thermo	Scientific).	PCR	products	were	purified	using	AmPure	XP	beads	(Beckman	Coulter,	#A63880)	
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and	directly	sequenced	using	MiSeq	500	or	600	cycle	Kits.	The	vector	was	cut	with	SphI	 and	 PacI	 or	 NheI	 and	 a	 sequence	 containing	 a	 CpG	 free	 eGFP	 and	 the	annealing	sequence	for	Primer	DH.P6	was	cloned	in	optional	the	insert	contained	a	31bp	minimal	promoter	in	front	of	eGFP.	RMCE	was	performed	as	previously	described	(Krebs	et	al,	2014).		
RNA	/	DNA	isolation	and	preparation	for	next-generation	sequencing	RNA	was	isolated	from	cell	lines	containing	the	expression	libraries	with	Quiagen	RNeasy®	Mini	Kit	with	on-column	DNase	digestion	and	reverse	transcribed	using	Takara	PrimeScript	RT	Reagent	Kit	(#RR047A).	For	DNA	isolation	cell	pellet	was	resuspended	in	Bradleys-Buffer,	6	µl	RNaseA	(10mg/ml)	was	added	and	samples	were	 incubated	 for	1h	at	37	°C.	Subsequently	30	µl	protease	K	was	added	and	samples	were	incubated	at	50	°C	over	night.	Then	DNA	was	extracted	using	Phenol	and	Chloroform.	DNA	and	cDNA	barcodes	were	amplified	with	KAPA	HIFI	Hotstart	using	Primer	DH.P6	and	indexing	primer	(Table	1).	PCR	products	were	purified	using	AmPure	XP	beads	(Beckman	Coulter,	#A63880)	and	sequenced	using	50	cycle	Kit	on	HiSeq	2500.		
Generation	of	Biotin-Tagged	TF	cell	lines	Biotin-tagged	TF	cell	lines	were	generated	as	previously	described	(Baubec	et	al,	2013).	Bio-Gabpa	was	expressed	using	a	Cag	as	well	as	a	CMV	promoter	while	Bio-Sp1	 and	 Bio-Sp3	 were	 expressed	 using	 Tet-inducible	 promoters	 induced	 with	1mg/L	Doxorubicin	for	24h.		
ChIP	Bio-ChIP	was	performed	as	previously	described	(Baubec	et	al,	2013).		
Reporter	Assay	Data	Analysis	
Barcode	to	Promoter	assignment	Fastq	files	were	trimmed	to	the	promoter	sequence	and	aligned	using	bowtie.	If	design	of	mutants	did	not	allow	alignment	reads	were	matched	to	the	reference	sequences	 using	 "stringdistmatrix"	 function	 in	 R.	 We	 allowed	 100	 errors	
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throughout	 the	 read	 and	 a	 minimum	 distance	 to	 the	 next	 closest	 reference	sequence	 of	 n-1	where	n	 is	 the	minimum	distance	 to	 the	next	 closest	 distance	within	 the	 reference	 sequences.	 Sequences	 from	 Read2	 between	“CGTTTAAACTGTCGACCGAGCT”	 and	 'TTCGGCGCATG”	 were	 extracted	 as	barcodes	and	the	reverse	complement	was	generated.	Barcodes	and	aligned	reads	were	 matched	 by	 read	 ID.	 Barcodes	 that	 were	 associated	 with	 one	 unique	sequence	or	with	a	sequence	that	represents	>90%	of	all	reads	of	a	barcode	were	used	for	the	analysis,	the	rest	was	discarded.		
Quantification	of	transcriptional	activity	Analysis	was	performed	on	triplicates.	Barcode	sequences	were	extracted	 from	50bp	reads	by	taking	only	reads	starting	with	the	expected	backbone	sequence:	“TCCTGCTGGAGTTCGTGACCTGCATGCGCCGAA”.	From	 these	 reads	 the	 sequence	at	 position	34-48	was	 extracted.	 The	 frequency	 of	 each	barcode	 sequence	was	calculated	to	get	counts	for	each	sample.	Counts	of	barcodes	were	normalized	to	library	size.	Enrichment	of	barcodes	in	the	RNA	sample	was	calculated	over	their	representation	in	genomic	DNA.	Only	barcodes	that	were	sufficiently	represented	on	genomic	DNA	were	used	for	further	analysis	(depending	on	sequencing	depth	10-50	reads).	In	case	a	barcode	was	sufficiently	represented	on	genomic	DNA	but	not	 sequenced	 in	 the	 RNA	 fraction	 we	 assumed	 that	 this	 was	 caused	 by	 low	expression	levels	and	assigned	0	counts	to	the	RNA	barcode.	The	median	activity	of	all	barcodes	per	CRE	was	calculated.	Only	CREs	that	were	covered	in	at	least	2	out	 of	 3	 replicates	 with	 at	 least	 three	 barcodes	 were	 used	 for	 downstream	analysis.		
ChIP	Data	Analysis	Reads	were	aligned	using	bowtie	(Langmead	et	al,	2009)	to	mm9	and	peaks	were	called	using	Peakzilla	with	default	parameters	(Bardet	et	al,	2013).	Position	weight	matrices	of	motifs	were	generated	based	on	called	peaks	in	bio-ChIP-seq	data	using	HOMER	(Heinz	et	al,	2010).		
Published	data	sets	The	following	ChIP-seq	datasets	were	downloaded	from	GEO:	
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Nanog,	Mycn,	Oct4,	Smad1,	Sox2,	STAT3,	TCFCP2l1,	Zfx	(GSE11431)	(Chen	et	al,	2008),	Rex1	(GSE36417)	(Gontan	et	al,	2012),	Tbx3	(GSE19219)	(Han	et	al,	2010),	Tcf3	(GSE11724)	(Marson	et	al,	2008),	YY1	(GSE31786	)	(Vella	et	al,	2012),	Zic2	(GSE61188)	 (Luo	 et	 al,	 2015),	 CTCF	 (GSE30206/GSM747534)	 (Stadler	 et	 al,	2011),	 NFYA	 (GSE25533/GSM632038)	 (Tiwari	 et	 al,	 2011),	 NRF1	(GSE67867/GSM1891641)	(Domcke	et	al,	2015),	REST	(GSE27148/GSM671093)	(Arnold	et	al,	2013)	DNase	 hypersensitivity	 dataset	 was	 received	 from	 GEO	 under	 the	 accession	number	(GSE67867)	(Domcke	et	al,	2015)	The	 Cage	 dataset	 was	 downloaded	 from	 FANTOM	 Consortium	 homepage	(http://fantom.gsc.riken.jp)	(Forrest	et	al,	2014)		
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Figure 1: TF binding can be predicted by CpG density and TF motif occurence
(a) Histogram of CpG densities of all mouse promoters. CpG density is distributed in a bimodal fashion. 400bp 
upstream to 200bp downstream of TSS were dened as the promoter region. CpG density was calculated as 
Observed to Expected ratios (OE = number of CpGs / (number of Cs x number of Gs) x length of the region in 
nucleotides). The red line indicates the threshold in OE for CpG islands (Gardiner-Garden & Frommer, 1987).
(b) Browser screenshot of Sp1, Sp3, Gabpa and Nrf1 Rambio ChIP-seqs.
(c)-(f) Position weight matrices of Sp1 (c), Sp3 (d), Gabpa (e) and Nrf1 (f ). 
(g)-(j) Tested TFs are highly specic to their motifs. Scatterplots of motif strength versus ChIP enrichment (fold 
enrichment over input) in tiling 600bp windows across chromosome 19 (lower panel) and percent of windows that 
overlap with ChIP-seq peaks of corresponding TFs (upper panel) for each of the four TFs.
(k)-(n) High CpG density and TF motif occurrence together perform best for TF binding prediction. Barplots showing 
percent of windows that overlap with ChIP-seq peaks in the dierent categories (upper panel) and boxplots of ChIP 
enrichment (fold enrichment over input) versus sequence features in 600bp windows across chromosome 19 (lower 
panel) for each of the four TFs. 'All' displays data from all 600bp windows on chromosome 19, 'motif' depicts data 
from windows containing a motif that is > 90% of the maximum motif score, 'CpG > 0.6' shows data from windows 
having an OE of 0.6 or bigger and motif + CpG>0.6 shows data from windows containing a high scoring motif and 
high CpG density.
(o)-(r) Same as in (k)-(n) but within active promoters (TSS -400bp to +200bp).
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Figure 2: High CpG density alone is not sucient for transcriptional activity
(a) Schematic representation of the procedure used to perform parallel reporter assays in a dened genomic locus. 
Promoter mutants are batch-cloned in front of GFP as a spacer sequence and an unique barcode. The expression 
cassette is anked by loxP sites that allow integration into the β-globin locus of the used embryonic stem cell line 
replacing a selection cassette. After selection for cells containing the reporter construct DNA and RNA is isolated 
and the latter reverse transcribed. Barcodes are PCR amplied and sequenced using next-generation sequencing. 
Normalization of RNA barcode frequency to DNA barcode frequency results in transcriptional activity of the 
construct.
(b) A high CpG density alone is not sucient for transcriptional activity. Scatterplot of CpG density versus transcrip-
tional activity of sequences from the E. coli genome (black dots) and active housekeeping genes (red dots) on 
genomic DNA. The line above the scatter plot depicts CpG density distribution within promoters overlapping with 
CGIs. 
(c) Same as in (b) but on plasmidic DNA.
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(c) Same as in (b) for the Pwp2 promoter.
(d) Correlation of CpG density with transcriptional activity is a general feature. Scatterplot showing CpG 
density versus transcriptional activity in the reporter assay for 10 promoters. Mutants were generated by 
random mutation of Cs within CpGs to As if they were not part of TF motifs that have a ChIP-seq peak at the 
promoter. Dierent numbers of CpGs were mutated to generate ve dierent CpG densities per promoter.
Figure 3: CpG density correlates with transcrip-
tional activity
(a) Scheme of the mutation strategy. Promoters were 
mutated in blocks, all Cs within CpGs that were not 
part of TF motifs that have a ChIP-seq peak at the 
promoter were mutated in each block to Ts (Snx3) or 
As (Pwp2). WT and mutant blocks were then assem-
bled in all possible combinations and assayed for 
transcriptional activity.
(b) Presence of CpGs positively correlates with 
transcriptional activity. Scatterplot of CpG density 
versus transcriptional activity of Snx3 promoter 
mutants. The line above the scatterplot depicts CpG 
density distribution within promoters overlapping 
with CGIs. Pearson correlation coecient is indicated 
in the upper left part of the scatterplot.
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(c) Genomic features overlap with regions important for transcriptional activity. Barplots displaying reads 
per 10 bp window for mRNA 5'ends (Cage), Gabpa, Nrf1, Sp1, Sp3 ChIP-seq and DNAseI hypersensitivity 
mapping at the endogenous Pwp2 promoter.
(d) Mutation of specic TF motifs leads to decreased transcriptional activity. Barplots showing log2 activity 
relative to WT of constructs with single TF motif mutations or mutations of all TF motifs of one TF.
Figure 4: Characterization of the Pwp2 promoter
(a) Schematic view of a region of the Pwp2 promoter that 
contains TF motifs and the TSS.
(b) Mutation of 10 bp windows revealed highly variable eects 
on promoter function. Barplots showing transcriptional 
activity relative to the WT construct of promoters with mutated 
windows, in a zoom-in of the part of the promoter where TFs 
bind and the whole promoter respectively. Tiling 10 bp 
windows were mutated to a random CpG free sequence to 
assess contribution of each window to transcriptional activity.
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
CpG
insert CpGs at same position as in WT
replace sequences that have no eect on 
transcription with ‘random’ sequence
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
CpG
mutate CpGs in sequences that have no eect
on transcription
0.4 0.6 0.8 1.0 1.2
0.
8
1.
0
1.
2
1.
4
 
r=0.68
0.4 0.6 0.8 1.0 1.2
0.
1
0.
2
0.
3
0.
4
0.
5
 
r=0.68
CpG density (O/E)
ac
tiv
ity
density CGIs
CpG density (O/E)
ac
tiv
ity
density CGIs
a b
c d
Figure 5: CpGs outside of TF motifs contribute to transcriptional activity of CGIs
(a) Scheme of the mutation strategy for CpG mutants. Cs in CpGs were mutated to As within 10bp windows that 
showed > 85% activity of WT activity when mutated. Dierent amounts of CpGs were mutated in dierent 
combinations 
(b) CpGs outside of important regions in the Pwp2 promoter contribute to transcriptional activity. Scatterplot of 
CpG density versus transcriptional activity relative to WT Pwp2 for promoter mutants. CpG density correlates 
with transcriptional activity. Pearson correlation coecient is indicated in the upper left part of the scatterplot.
(c) Scheme of the mutation strategy to generate an articial promoter and strategy for adding CpGs. Sequences 
within windows that had > 85% activity of WT when mutated were replaced with a random CpG free sequence to 
generate an articial chimeric promoter. Then dierent numbers of CpGs were introduced into the replaced 
sequence at the same location as in WT Pwp2.
(d) CpGs density itself does contribute to CGI activity. Scatterplot of CpG density versus transcriptional activity 
relative to the activity of WT Pwp2 for articial promoters. CpG density correlates with transcriptional activity. 
Pearson correlation coecient is indicated in the upper left part of the scatterplot.
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Figure 6: DNA methylation decreases transcriptional activity at mutants with low CpG density
(a) Constructs are more active in TKO than in WT at lower CpG densities. Scatterplot showing CpG density of 
promoter mutants versus log2 activity relative to corresponding WTs. Libraries were assayed in WT (black) and 
methylation free mouse embryonic stem cells (TKO) (red). 
(b) TKO activity deviates stronger from WT activity at lower CpG densities. Scatterplots showing CpG density 
versus log2 activity of WT/TKO. 
(c)Model how decrease in activity upon CpG mutation could be explained. Mutation of CpGs leads to 
decreased activity, this could be due to decreased concentration of ZF-CxxC domain containing proteins at the 
promoter. Further decrease in CpG density leads to methylation which could inhibit TF binding resulting in very 
low to no transcriptional activity.
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Supplementary Figure 1:
(a)-(d) Tested TFs are broadly expressed. Barplots of expression levels (reads per kilobase per million) of 
Sp1 (a), Sp3 (b), Gabpa (c) and Nrf1 (d) across 19 dierent tissues. All four factors are broadly expressed.
(e)-(f) Pairplots showing correlations of ChIP-seq samples. 
(g) Pairplot showing correlation Biotin-tagged Nrf1 ChIP versus antibody Nrf1 ChIP. Antibody and Biotin 
ChIP-seq data is highly similar.
(h) CpG density correlates with accessibility. Scatterplot showing CpG density versus accessibility as 
measured by DNAse hypersensitivity. 
(i)-(l) High CpG density correlates with TF binding. Scatterplots of CpG density versus ChIP enrichment 
over input in 600bp windows across chromosome 19 (lower panel) and percent of windows within each 
bin that overlap with ChIP-seq peaks of corresponding TFs (upper panel) for each of the four TFs.
(m)-(p) Accessibility correlates with TF binding. Scatterplots of DHS signal versus ChIP enrichment over 
input in 600bp windows across chromosome 19 (lower panel) and percent of windows within each bin 
that overlap with ChIP-seq peaks of corresponding TFs (upper panel) for each of the four TFs.
Sp1-
clone3_
rep1
Sp1-
clone3_
rep2
Sp1-
clone2
Sp3-
clone2
Sp3-
clone3
Sp3-
clone5
Cag_
Gabpa_
clone3_1
Cag_
Gabpa_
clone3_2
Cag_
Gabpa_
clone6
CMV_
Gabpa_
clone2
genomic_rep1
−5 −3 −1 0
0.94 0.87
−3 −2 −1 0
0.94 0.76
−4 −3 −2 −1 0 1
−6
−4
−2
0
2
0.86
−5
−3
−1
genomic_rep2 0.86 0.94 0.58 0.80
genomic_rep3 0.94 0.58
−7
−5
−3
−1
0.85
−3
−2
−1
0
genomic_rep4 0.84 0.96
plasmid_rep1
−2
.0
−0
.5
1.
0
0.74
−6 −4 −2 0 2
−4
−2
0
1
−7 −5 −3 −1 0 −2.0 −1.0 0.0 1.0
plasmid_rep2
−14 −12 −10 −8 −6
−8
−6
−4
−2
0
log2(activity qPCR)
lo
g2
(a
ct
iv
ity
 e
xp
re
ss
io
n 
as
sa
y)
r=0.89
a
b
Supplementary Figure 2:
(a) Scatterplot displaying activity of promoter mutants measured by qPCR in single clones on cDNA with 
primers targeting the GFP transgene versus activity in the reporter assay. Spearman correlation coecient 
indicates a high agreement between the two types of measurements (0.89).
(b)Pairplot displaying correlation of replicates of libraries used in Figure 2.
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Supplementary Figure 3:
 (a) Pairplot displaying correlation of replicates of one of the libraries containing CGI promoters to identify 
candidates for mutation analysis.
(b)-(c) Histograms of activity of two libraries containing CpG island promoters, activities of Snx3 (b) and Pwp2 
(c) are indicated to compare to activities of all promoters in the library.
(d) Pairplot displaying correlations of replicates of Snx3 promoter CpG mutants.
(e) Pairplot displaying correlations of replicates of Pwp2 promoter CpG and TF motif mutants.
(f ) Pairplot displaying correlations of replicates of the library with CpG mutants of 10 dierent promoters.
(g)Histogram of WT activities of the 10 tested promoters.
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Supplementary Figure 4:
Pairplot displaying correlations of replicates of library containing Pwp2 10bp window mutants.
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Supplementary Figure 5:
Pairplot displaying correlations of replicates of library containing articial promoters
Name Sequence
DH.P6 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT BC	amplification	Primer
DH.P8 CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Indexing	Primer	NEB	2	Index
DH.P26 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Indexing	Primer	NEB	6	Index
DH.P27 CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Indexing	Primer	NEB	12	Index
DH.P30 CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Indexing	Primer	NEB	4	Index
DH.P31 CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Indexing	Primer	NEB	7	Index
DH.P32 CAAGCAGAAGACGGCATACGAGATGACTGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Indexing	Primer	NEB	5	Index
DH.P33 CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Indexing	Primer	NEB	8	Index
DH.P34 CAAGCAGAAGACGGCATACGAGATGTGATCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT Indexing	Primer	NEB	9	Index
DH.P39 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTCCACTGG
GAGAAGAGGAAGTCAAA
BC	to	Promoter	amplification	Primer
Table	1:	Primers	used	for	the	high	throughput	reporter	assay.
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ABSTRACT
The retina is composed of ∼50 cell-types with spe-
cific functions for the process of vision. Identifica-
tion of the cis-regulatory elements active in retinal
cell-types is key to elucidate the networks control-
ling this diversity. Here, we combined transcriptome
and epigenome profiling to map the regulatory land-
scape of four cell-types isolated from mouse retinas
including rod and cone photoreceptors as well as
rare inter-neuron populations such as horizontal and
starburst amacrine cells. Integration of this informa-
tion reveals sequence determinants and candidate
transcription factors for controlling cellular special-
ization. Additionally, we refined parallel reporter as-
says to enable studying the transcriptional activity
of large collection of sequences in individual cell-
types isolated from a tissue. We provide proof of
concept for this approach and its scalability by char-
acterizing the transcriptional capacity of several hun-
dred putative regulatory sequences within individual
retinal cell-types. This generates a catalogue of cis-
regulatory regions active in retinal cell types and we
further demonstrate their utility as potential resource
for cellular tagging and manipulation.
INTRODUCTION
The retina is a complex neural tissue within the eye. It is
comprised of a large number of cell types with specialized
functions that together enable visual perception (1,2). Reti-
nal cell types include two types of image forming photore-
ceptors, rods and cones, horizontal cells as well as many
types of bipolar, amacrine, ganglion and glial cells. Cone
photoreceptors are active at higher light levels and medi-
ate high-resolution color vision, while rod photoreceptors
are active at low light condition. Signals sensed by pho-
toreceptors are subsequently integrated and processed by
interneurons such as, horizontal cells (HCs), bipolar cells
and amacrine cells (i.e. starburst amacrine cells (SACs))(1)
and finally converge to ganglion cells, the output neurons of
the retina. Some retinal cell types can be uniquely identified
by morphology and localization within the different retinal
layers, while others require identification by genetic mark-
ers (3). Retinal function is affected in a multitude of genetic
disorders, a number of which are cell type specific (4). These
diseases lead to vision impairment or blindness (5–7).
In mammals, cellular identity is conferred by the activa-
tion and repression of specific gene expression programs.
This process is principally controlled through the binding
of transcription factors (TF) to distal cis-regulatory regions
(CRE) named enhancers. Enhancer activity is highly vari-
able across cell types in line with the concept that these el-
ements are central in regulating cell-type specific gene ex-
pression (8–11). Systematic mapping of active enhancers
based on their characteristic chromatin states has provided
a large catalog of putative regulatory regions in a plethora
of tissues and cell lines (12–14). In turn, cataloging CREs
at the resolution of individual cell types is a prerequisite
for understanding the transcriptional regulatory principles
that controls cell-type specification within a tissue. Activa-
tion of regulatory regions entails binding of transcription
factors and coinciding changes in chromatin. This includes
increased accessibility (15), specific histone modifications
(11,16) and locally reduced DNA methylation (17–20). Hi-
stone modification such as acetylation is a direct reflection
of transcriptional co-activator activities. It appeared to be
one of the best predictor for CRE activity (21) and has
been successfully used to identify active CREs in various tis-
sues (22,23). Chromatin accessibility indirectly reflects TF
binding activity and thus represents another feature that
has been successfully used to identify active CREs in the
genome (13,21,24,25). Additionally, in most tested tissues
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and cell types DNAmethylation and accessibility appeared
to be tightly anti-correlated (17–20), making low methyla-
tion regions (LMRs) a useful proxy to detect activeCREs.A
notable exception to this rule was found in rod photorecep-
tors, where a fraction of low methylated regions appeared
to be located within a closed chromatin environment (26).
This unusual feature adds to the notion of a unique chro-
matin organization in rods, that has been associated with
its cellular function (27).
While useful to identify putative CREs, chromatin based
predictions do not inform on functional relevance nor on
the ability of putative sequences to efficiently drive tran-
scription in an ectopic context. Indeed a large fraction of
putative enhancers fail to drive detectable expression levels
when tested in an ectopic context irrespective of the feature
used for their identification (21,25,28–31). Enhancers vary
largely in size, yet even within very large regions such as the
beta globin LCR most activation is conferred by smaller
sub-fragments (32), which have proven powerful tools for
ectopic gene expression. Thus testing the activity of iso-
lated DNA pieces using transcriptional reporter systems
not only informs on the features of cis-regulatory regions
able to drive transcriptional activity in different cell types
but also identifies potent elements for transgenic gene ex-
pression. Using high-throughput sequencing, such assays
have recently been parallelized (23,33–38), which enables
to quantify the ectopic activity of thousands of DNA se-
quence variants in a single experiment (39). Yet in vivo such
approach was only applied at the resolution of entire tissues
(23,38,40), which ignores cellular heterogeneity and thus
lacks the resolution required to understand transcriptional
regulation at the level of single cell-types.
To characterize the cis-regulatory landscape of the retina,
we generated expression profiles and genome-wide DNA
methylation maps for four cell types isolated from mouse
retinas: cones, rods, HCs and SACs. These datasets identify
large collections of putative CREs in each cell type, reveal-
ing sequence determinants and transcription factors (TF)
potentially involved in the control of identity of these cells.
To enable efficient characterization of the activity of the
identified CREs, we adapted the principles of parallel re-
porter assays to in vivo measures at the resolution of single
cell-types. As a proof of concept, we measured the activity
of hundreds of CREs and defined their activity profile in
the four individual retinal cell types. Additionally, we gen-
erated libraries of sequence mutants to probe the functional
contribution at sequence level of enriched TF motifs. This
revealed the co-existence in cis of active and repressive sig-
nals at highly active photoreceptor CREs and demonstrates
how rational CRE editing can be used to modulate trans-
gene expression levels in a desired cell type.
MATERIALS AND METHODS
Animal handling
All animal experiments and procedures were approved
by the Swiss Veterinary Office. Cell type-specific Cre re-
combinase driver lines: D4-cre (41) for cones, B2-cre (42)
for rods, Gja10-cre (4) for HCs and ChAT-cre (Jack-
son, stock: #006410) for SACs; were in-house crossed
to the floxed tdTomato reporter line Ai9 (JAX mice
B6.Cg-Gt(ROSA)26Sortm9(CAGtdTomato) Hze/J, Jack-
son stock: #007909) to generate retinas with one cell type
fluorescently labelled. The age of mice was between 50
days and 150 days, sexes were all female for RNA-seq and
WGBS and chosen randomly for PRA. Adult wild-type
mice (C57BL/6) purchased from Charles River were used
for single enhancer testing experiments.
RNA-seq library preparation and sequencing
After retina dissection and dissociation, cells were FACS-
sorted directly in lysis buffer of the RNA-easy mini kit
(Quiagen) that was used for RNA extraction. RNA-seq li-
braries were prepared using theNorgen single cell RNA-seq
preparation kit (51 800). Each of the three biological repli-
cates were prepared using independent sorts on individual
retinas. The samples were run on an Illumina HiSeq2500
generating 50 bp single-end reads.
WGBS library preparation and sequencing
DNA was extracted from cells sorted from single reti-
nas. 50–100 ng of DNA was used as an input for bisul-
fite conversion (Zymo Gold Kit). The converted DNA
was used to prepare whole genome bisulfite libraries us-
ing Illumina Truseq DNA methylation preparation kit
(EGMK81312) following manufacturer recommendation.
PCR product was purified using AMPureXP beads (Beck-
man Coulter––A63880) and controlled on Bioanalyser
High sensitivity (Agilent 5067-4626). The samples were run
on an Illumina HiSeq2500 generating 100 bp paired-end
reads (rapid-run).
Library generation
Fragments were PCR amplified in 384-well format using
Phusion Hot Start II polymerase (Thermo Scientific, #F-
549S), pooled, gel purified and cloned blunt ended us-
ing an EcoRV site into a vector containing the expres-
sion cassette. The expression cassette consists of a multi-
ple cloning site, and a random 15 bp barcode sequence
(NNNNWNNNNWNNNNN) and a polyA signaling se-
quence (pA). In order to average out the contribution of
barcode specific biases to the signal we aimed for at least
ten different barcodes per unique fragment. To linkCREs to
barcodes the CRE-barcode sequences were amplified using
Primer #2 (see Supplementary for sequences) and one of the
Indexing primers (Primers #3–11) containing the Illumina
flow cell annealing sequences. PCR products were puri-
fied using AmPure XP beads (Beckman Coulter, #A63880).
PCR products were directly sequenced using MiSeq 500 or
600 cycle Kits. Next the vector was cut with SphI and PacI
and a sequence containing a 31bp minimal promoter, CpG
free eGFP and the annealing sequence for Primer #1 was
cloned in (Supplementary Figure S3A). This construct was
cut out of the cloning vector using NotI and inserted into
the AAV vector.
AAV production
AAV production was performed as previously described
(43). Briefly, HEK293T cells were transfected with a plas-
mid containing the transgene between the internal terminal
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repeats of AAV2, the AAV-helper plasmid encoding Rep2
and Cap for serotype 8, and the pHGTI-Adeno1 plasmid
harboring helper adenoviral genes (both kindly provided by
C. Cepko, Harvard Medical School, Boston, MA, USA)
using polyethylenimine (Polysciences, no. 23966). Vectors
were purified by iodixanol gradient (Sigma, Optiprep).
Genome titer (genome copies/ml) of AAV vectors were de-
termined by real-time PCRusing TaqMan primer/probe set
corresponding to the WPRE (Woodchuck Hepatitis Virus
Posttranscriptional Regulatory Element) region of the vec-
tor and linearized plasmid standards. Titers were between
1 × 1014 and 5 × 1014 GC/ml for viral enhancer libraries
and between 7 × 1011 and 6 × 1012 GC/ml for individual
enhancer validation experiments.
Subretinal AAV delivery
Viral particles were injected as previously described (44).
Briefly, animals were anesthetized using 3% isoflurane. A
small incision was made with a sharp 30-gauge needle in
the sclera near the lens. 2l of AAV suspension was injected
through this incision into the subretinal space using a blunt
5l Hamilton syringe held in a micromanipulator.
Dissociation of retina and fluorescence-activated cell sorting
(FACS)
Biological triplicates of one genotype were always done in
the morning at the same time and with maximum two hours
delay between the first and the last sample. Retinas were iso-
lated and dissociated to single cells by papain digestion as
previously described (45). For rare cell types (HCs, SACs)
retinas from both eyes were pooled to have enough mate-
rial. Cells positive for tdTomato were sorted by FACS (BD
FACS Aria III (Becton Dickinson) using a 100-m noz-
zle with the bandpass filter for RFP HQ616/26. Cells were
gated based on their forward- and sideward-scatter. Pulse-
width was used to exclude doublets. Fluorescence positive
cells were sorted at RT into a low binding tube (Eppen-
dorf) containing 350 l RLT extraction buffer (RNAeasy,
Qiagen) for PRA, 250 l lysis buffer (50 mM Tris, 10mM
EDTA, 4% SDS, adding 10 l Proteinase K) for WGBS
and 300l RL buffer (Norgen) for RNA seq. Collected cells
were immediately processed or stored at –80◦C.
Sample preparation for PRA
After injection, RNA was isolated from sorted cells of the
three biological replicates using independent sorts on indi-
vidual retinas with Quiagen RNeasy® Mini Kit with on-
column DNase digestion. After reverse transcription using
Takara PrimeScript RT Reagent Kit (#RR047A) barcodes
were amplified with KAPA HIFI Hotstart using Primer #1
and indexing primers (Primers #3–11). Since isolation of
the AAV DNA from the cellular material turned out to be
difficult we isolated DNA from the input AAV for normal-
ization of barcode abundance.DNA fromAAVwas isolated
and barcodes amplified as in the cDNA samples. PCRprod-
ucts were purified usingAmPureXP beads (BeckmanCoul-
ter, #A63880) and sequenced using 50 cycle Kit on HiSeq
2500.
Adeno-associated virus (AAV) construct for individual en-
hancer validation
For individual enhancer testing, the sequence of interest was
PCR amplified from genomic mouse DNA (129S5) and in-
serted in front of a minimal promoter (pDis1.2). Clone ori-
entation was determined by sanger sequencing. The CRE-
minimal promoter cassette was PCR amplified with MluI
and BclI flanking restriction sites and inserted into pAAV2-
EF1a-ChR2-EGFP via the same restriction enzymes.
Immunohistochemistry
For individual enhancer testing, mice were euthanized by
CO2 and rapid cervical dislocation 3 weeks post AAV in-
jections. Retinas were dissected from the eyecup and fixed
for 20–30 min in 4% paraformaldehyde (PFA) (wt/vol) in
PBS and washed overnight in PBS. To aid penetration of
the antibodies, retinas were frozen and thawed three times
after cryoprotection with 30% (wt/vol) sucrose. The retina
was incubated in blocking solution: 10% donkey serum
(vol/vol),Millipore, 1% bovine serum albumin (wt/vol) and
0.5% Triton X-100 (vol/vol, in PBS, pH 7.4) for 1 h. Pri-
mary and secondary antibody applications were done in 3%
normal donkey serum, 1% bovine serum albumin, 0.02%
sodium acid (wt/vol) and 0.5% Triton X-100 in PBS. Pri-
mary antibodies were applied for 3–7 days. After washing
the retina three times for at least 10 minutes in PBS, the
retina was incubated in fluorescence-conjugated secondary
antibodies and 10 g/l Hoechst 33342, trihydrochloride,
trihydrate at a dilution of 1:200 for 2 h, followed by three
washes in PBS, and mounting on slides with ProLong
Gold antifade reagent (Molecular Probes). Retinas for vi-
bratome section were embedded in 3% agarose (wt/vol)
(SeaKem Le Agarose, Lonza) in PBS, and 150m vertical
sections were cut with a Leica VT1000S vibratome. Anti-
body staining procedure was the same as in whole mounts.
The following primary antibodies were used: rat anti-GFP
(1:500; Nacalai/Brunschwig), rabbit anti-mouse cone ar-
restin, mCAR (1:200; Millipore). For the secondary anti-
bodies, we used in donkey serum raised antibodies from In-
vitrogen (Alexa Fluor 488, Alexa Fluor 555, Alexa Fluor
633).
Microscopy
Zeiss LSM700 laser scanning confocal microscope was used
to acquire images of antibody-stained retinas with an EC
Plan-Neofluar 40×/1.30 oil M27 and a Plan-Acro Achro-
mat 10×/0.45 objectives at three excitation laser lines (405
nm forHoechst, 488 nm forGFP, 555 nm formCAR).Mor-
phologies of cell types were assessed from 512 × 512 pixel
images in a z-stack with 0.85 m z-steps. Images were pro-
cessed using Imaris (Bitplane).
Bioinformatics procedures
All analyses were performed using R-Bioconductor. Ad hoc
R scripts are available upon request.
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WGBS alignment and data extraction
Methylation data processing. Raw sequence files were
pre-processed using Trimmomatic (46) to remove Il-
lumina adaptor sequences, discard low quality reads
and trim low quality bases. The trimmed reads were
then aligned using QuasR (using Bowtie as an aligner)
(47,48) against a bisulfite index of the Mus Muscu-
lus genome (BSgenome.Mmusculus.UCSC.mm9). CpG
methylation call was performed using QuasR. Conversion
rates were determined (and controlled to be >95%) by call-
ing methylation of mitochondrial DNA and non-CG con-
text Cs. Methylation was called genome wide for CpGs cov-
ered at least 8 times. Since most datasets arise from female
mice, sex chromosomes were excluded from themethylation
analysis. Genomic tracks were obtained by smoothing data
using a sliding window over 10 CGs.
Identification of putative CREs using genome segmentation.
Methylation data from each cell type was used to segment
the genome usingMethylSeeker (49) to identify regions con-
taining at least four consecutive CGs below 50% methyla-
tion (False Discovery Rate < 5% in all samples). The to-
tal set of CREs (n = 104 322) was defined by merging low
methylated regions (LMRs) smaller than 2000 bp from the
four retinal cell types. CREs were classified in the (24) 16
possible combinations based on the average CRE methy-
lation in each cell type (considering methylation < 60% as
positive).
Generation of CRE libraries
Putative enhancer regions were defined based on LMRdefi-
nition. Putative specific sequences were nominated by com-
paring methylation in regions that are LMRs in one but
not the other tested cell types. Since any application would
require that functional elements are compact we limited
fragment sizes of all libraries to maximum ∼700 bp (Sup-
plementary Figure S3C). Tested regions were mostly distal
(Supplementary Figure S3B). Primers were batch designed
using a custom R function based on Primer3.
We generated four libraries. Library 1was designed to test
the system and contained regions hypomethylated in rods
independent of methylation in other cell types. Library 2
was designed to find rod or cone specific elements, there-
fore we chose sequences displaying differential methylation
in rods and cones. To extend our approach tomore cell types
we generated a library with sequences hypomethylated in
HCs and/or SACs in library 3. All three libraries contained
a set of verified sequences with different activities discov-
ered in Library 1. To test contributions of TF motifs to en-
hancer activity we generated Library 4 in which different
motifs of two enhancers were mutated. For the pilot library
in rods (Library 1), we randomly selected a subset of the
putative rod CREs (LMRs). We also included as negative
controls a set of fully methylated regions in rods (>75%)
without DHS signal in whole retina (24). The Cone/Rod li-
brary (Library 2) was designed based on differential methy-
lation between cones and rods. We required cone specific
regions to be at least 75% methylated in rods and less than
75% methylated in cones and vice versa. Additionally we
included regions that are similarly methylated (>75%) or
unmethylated (<75%) to serve as controls to compare mea-
surements as well as the CREs from the validation experi-
ments. The SAC/HC library (Library 3) was designed using
LMRs that are hypomethylated in only one cell type and at
least 80%methylated in the other three cell types. Addition-
ally the library contained the same set of negative controls
negative controls and regions unmethylated inHC and SAC
for normalization (<50% in both cell types) as well as the
CREs from the validation experiments.
For the mutant library. Motifs present within fragments
were identified by scanning known TF position weight ma-
trices (50,51; score> 9).Motifs matches were then random-
ized. If multiple motifs for one TF were present within a
fragment, all motifs instances were mutated together. The
CREmutants were synthesized (gblocks-IDT technologies,
for sequences see Supplementary Information) and cloned
into the PRA vector.
RNA-seq alignment and data extraction
Raw sequence files were aligned using QuasR (using Bowtie
as an aligner; 47,48) against the Mus Musculus genome
(BSgenome.Mmusculus.UCSC.mm9). Reads in genes were
collected using QuasR based on UCSC transcript annota-
tion for mm9 and RPKM were calculated.
Motif enrichment analysis
For motif analysis on methylome based classification: Puta-
tive CREs classified based on their average DNA methyla-
tion (see above) were used as an input for motif enrichment
analysis using HOMER (52). A set of known matrices was
created by combining JASPAR (50) with more recent SE-
LEX datasets (51). Motif enrichment was calculated sepa-
rately for each factor in each set using a randomized set of
sequences with similar base composition as a background.
Motifs were filtered for factors expressed in the studied cell
types (log2(RPKM) > –2 in at least one cell type). Enrich-
ments for the most significantly motifs (enrichment over
background >3-fold; P-value < 0.01) in the cell type spe-
cific categories were displayed.
For motif analysis PRA based classification: Motif en-
richment analysis was adapted to account for the small size
of the sequences set. The same set of motifs was screened
over each subset of sequences and a set of control sequences.
Differences inmotif occurrence frequency between the fore-
ground and background set was calculated. Enrichment in
the motif frequency was plotted for the most significantly
enriched motifs.
PRA analysis
Assignment of the barcode with the CRE. Sequences from
Read1 starting with ‘TCCACTGGGAGAAGAGGAAG
TCAAA’were aligned fromposition 55 on to theMusMus-
culus genome (BSgenome.Mmusculus.UCSC.mm9) using
Bowtie.
Sequences fromRead2 between ‘CGTTTAAACTGTCG
ACCGAGCT’ and ‘TTCGGCGCATG’ were extracted as
barcodes and the reverse complement was generated. Bar-
codes and aligned reads were matched using their read IDs.
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Barcodes were associated with a CRE if >90% of the reads
linked to the barcode corresponded to this CRE.
Calculation of CRE transcriptional activity. Analysis was
performed on biological triplicates. Barcode sequences were
extracted from 50 bp reads by taking only reads start-
ing with the expected backbone sequence: ‘TCCTGCTG
GAGTTCGTGACCTGCATGCGCCGAA’. From these
reads the sequence at position 34–48 was extracted. The
frequency of each barcode sequence was calculated to get
counts for each sample. Counts of barcodes were normal-
ized to library size. Enrichment of barcodes in the RNA
sample was calculated over their representation in the AAV
input. Barcodes not sufficiently covered in the AAV se-
quencing were discarded (2–16 reads, depending on the se-
quencing depth). The median activity of all barcodes per
CRE was calculated. Only CREs that were covered in at
least two out of three biological replicates with at least three
barcodes were used for downstream analysis.
RESULTS
Transcriptome and epigenome of four cell types of the retina
The cis-regulatory landscape associated with the cellular di-
versity of the retina has only been partially characterized
through chromatin measures at the level of the entire tissue
(24) and for two types of photoreceptors (26,53). Perform-
ing similar experiments is considerablymore challenging for
most cell-types of the retina since these can be significantly
less abundant (2). For instance, while rods make up 65% of
the mouse retina, horizontal cells only represent 0.5% of the
retina (2) which corresponds to <10 000 cells per retina.
Unlike chromatin associated marks, robust DNAmethy-
lation measures can readily be achieved from a low number
of cells (<5000 cells) and furthermore do not require the
preservation of cellular or nuclear integrity during the iso-
lation of cells from complex tissues. Therefore, we took ad-
vantage of the fact that in most cell types low levels of DNA
methylation indicate accessibility of putative CRE regions
(17–20,49) to expand our understanding of the complex-
ity of the cis-regulatory landscape of the retina. We mea-
sured gene expression and DNA methylation genome-wide
for four cell-types; cones and rods representing two types
of photoreceptors; starburst amacrine cells and horizontal
cells representing two types of interneurons.
Wemade use of our previously generated library of trans-
genic mice that express florescent proteins in specific cell
types (3,4) (Supplementary Table S1). Labeled cells were
FACS-sorted followed by whole genome bisulfite sequenc-
ing (WGBS) and matching sequencing of RNA (RNA-seq)
(Figure 1A). The purity of cell isolates was confirmed by
their expression of established marker genes (Figure 1B)
and the robustness of the procedure is reflected in the
high reproducibility of genome-wide expression patterns
(R>0.96 - Supplementary Figure S1A). Due to the pro-
fusion of rods in the photoreceptor layer of the mouse
retina (2,54), we observed a systematic contamination of
our cone sorted isolates with ∼10% rods (as observed pre-
viously (4,26)). This leads to a systematic underestimation
of the rod-specific signal, which is particularly marked at
the level of gene expression (Figure 1B). It is however much
less pronounced in the methylation profiles since unlike
RNA molecules, DNA molecules are directly proportional
to the number of contaminating cells (Supplementary Fig-
ure S2B).
Despite this technical limitation, we could unambigu-
ously identify a unique transcriptional signature defining
each of the tested cell types (Figure 1B). When clustering
cells by proximity of their transcriptomes, we observed a
grouping by cellular subtypes, with the highest similarity
observed between HCs and SACs (Figure 1C, Supplemen-
tary Figure S1A and B). In an attempt to list potential reg-
ulators of this diversity, we extracted the transcription fac-
tors showing the most transcriptional divergence between
cell types (Figure 1D). We observed many TFs having dif-
ferential expression between photoreceptors and interneu-
rons, including many of the previously described regula-
tors of these linages (Figure 1D; 4,55,56). For instance ex-
pression of Otx2, Nrl or Rax as well as several members
of the nuclear receptor family appear as a clear signature
of photoreceptors. Similarly, interneurons are characterized
by high expression of neuronal fate markers such as Pax6.
Additionally, each cell type shows unique TF expression
signatures. For example rods show elevated levels of Essrb,
Nr2e3, Olig3 while cones show preferential expression of
RxR gamma, NfKB, Elk3. Similarly, HCs uniquely express
several members of the Onecut TF family while SACs dis-
play high levels of Pou6f2, Tbx2 or Ap-2 (tfap2b) (Figure
1D). In summary, we define here a catalog of differentially
expressed TFs in the four studied cell types that may play a
role in regulating their unique transcriptional signature.
Defining the cis-regulatory landscapes of four cell types of the
retina
We then used our genome-wide maps of DNA methylation
to define a catalog of CREs putatively active in the four
studied cell types. For each cell type including rare pop-
ulation of interneurons, we could determine the methyla-
tion level for ∼70% of the 20.3 million autosomal CpGs
(≥64% in all samples – coverage ≥ 8×). We note that our
data from rods and cones agree very well with recently pub-
lished methylation datasets that were generated using a dif-
ferent isolation strategy (26) (Figure 2- Supplementary Fig-
ure S2A). To identify regulatory regions across the tested
retinal cell types, we applied our established segmentation
approach (18,49). We identified between 80–100 thousand
LMRs in each cell type as putative CREs of the retinal sys-
tem.
Since methylation differences at CREs is an indirect in-
dication of regulatory activity, we compared the methyla-
tion status of these regions between cell types (Figure 2A,
B, Supplementary Figure S2C-H). We observe only sub-
tle differences in the DNA methylation levels at these re-
gions between cones and rods (Figure 2A, Supplementary
Figure S2C). However, HCs and to an even higher extend
SACs show substantial differences in their methylation lev-
els at LMRs (Figure 2A, B, Supplementary Figure S2D–G)
in agreement with the functional divergence between pho-
toreceptors and interneurons. Interestingly, contrasting our
data with previously published methylation datasets from
purified neurons (20) reveals a closer proximity of SACs but
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Figure 1. Transcriptome profiling of four cell types isolated from mouse retinas. (A) Scheme used to generate transcriptome and methylation datasets at
the resolution of single cell types. Cell populations of rods, cones, horizontal cells and starburst amacrine cells are isolated by cell sorting from mouse
transgenic lines carrying fluorescent markers that label these particular cell types of the retina. From cell isolates, whole genome methylation maps and
expression datasets are generated. (B) Known cell specific expression markers reproducibly discriminate between cell isolates illustrating the reproducibility
of the FACS procedure. Expression levels for markers of the studied retinal cell types. RPKM values for genic RNA-seq signal for samples issued from
independent cell sorts. Side bar depicts the cell type associated with the marker (Siegert et al, 2009) (rods: dark green; cones: light green; HCs: orange;
SACs: purple). Levels Rhodopsin in non-rod samples shows a particularly high degree of systematic contamination of cone samples with rods, as previously
observed (Siegert et al, 2012; Mo et al, 2016). (C) The tested cell types show divergence in their expression profiles. Correlation heatmap comparing
transcriptomes of the four studied cell types. Pearson correlation for genic RNA-seq signal merged across three biological replicates for each cell type.
(D) Transcription factors showing differential expression between the tested cell types. Heatmap depicting the expression level of the most differentially
expressed transcription factors between the tested cell types (top 10% variance). Shown are the RPKM values for genic RNA-seq merged across three
biological replicates for each cell type. The heatmap was organized by hierarchical clustering.
not HCs with these neuronal types (Figure 2; Supplemen-
tary Figure S2A).
Reduced DNA methylation levels at regulatory regions
is generally correlated with nucleosome depletion and in-
creased chromatin accessibility. We therefore wondered if
existing accessibility data derived from entire retinas (24,26)
could support and strengthen our identification of cell type
specificCREs.Wefirst asked how theDNAmethylation lev-
els derived at the single cell-type level, would compare to ex-
isting ATAC-seq data derived from entire retinas or isolated
photoreceptors (26). While we observed the expected anti-
correlation between DNAmethylation and accessibility for
photoreceptors (Supplementary Figure S2I), we found no
clear correlation for HCs or SACs. In line with the cellu-
lar composition of mouse retinas, this result suggests that
accessibility data derived from entire retinas do not quanti-
tatively reflect the chromatin status of rare cell-types such as
interneurons. We nevertheless asked if interneuron specific
LMRs would have low but detectable ATAC-seq signal in
the whole retina datasets (Supplementary Figure S2J). This
revealed that in contrast to photoreceptors, a large majority
of interneuron LMRs (>95%) are not scored accessible in
the dataset from whole retina (Supplementary Figure S2J).
This suggests that whole retina is only poorly informative
when studying CREs from rare cell types. Additionally, as
previously reported (26), we noted that in rods, a signifi-
cant fraction of LMRs are not accessible in a rod specific
dataset (Supplementary Figure S2I, J). In order to simplify
the identification of active regulatory regions, we excluded
these regions for the downstream analyses.
Methylation information for individual cell types enabled
us to classify these candidate regions based on their differ-
ential methylation (Figure 2B). For interneuron sub-types,
this identifies several thousand cell type-specific regions
(HC: 3520; SAC: 13520) (Figure 2B, exemplified in Figure
2D). Similarly, we identify several thousand regions spe-
cific for photoreceptors (n = 4640; Figure 2B, exemplified
in Figure 2E). In addition, we observe significantly fewer
elements specific for either rods (n = 1090) or cones (n =
487). This suggests that a large majority of regulatory re-
gions are shared between these two developmentally closely
related photoreceptors.
Identification of sequence determinants of cell-type speci-
ficity
Having defined sets of putative CREs in four cell types of
the retina using cell type specific features of the methylome,
we next asked if their sequences can educate on transcrip-
tion factors involved in their regulation (18,19,49). Toward
this goal, we performed motif enrichment analysis (Fig-
ure 2C) but restricted to sequence motifs linked to TFs ex-
pressed in at least one of the four retinal cell types that we
studied in order to enhance the quality of our predictions.
This analysis revealed that each set of specific CREs is
characterized by the enrichment of distinct sequence motifs
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Figure 2. DNAmethylation-based identification of putative CRE of the retinal system. (A) Correlation heatmap comparing methylation within lowmethy-
lated regions detected in the retinal cell types. Pearson correlation for methylation of single CpGs located within the merged list of LMRs across cell types.
Heatmap was subjected to hierarchical clustering. (B) Heatmap displaying average methylation of all putative CREs identified across the four studied reti-
nal cell types. LMRs were grouped based on their binarized average methylation pattern (methylation < 60%). Sidebar indicates cell type specific clusters.
Clusters were colored according to the specificity of the putative CRE (rods: dark green; cones: light green; HCs: orange; SACs: purple). (C) TF motifs
enriched within subsets of putative CREs defined by their low methylated in individual cell types. Enrichment for known motifs was calculated for each
set of cell-type specific LMRs and compared to a set of control sequences. Enrichments are displayed only for motifs significantly enriched in at least one
cell-type specific subset, and for predicted transcription factors expressed in at least one of the cell types. Side-bar depicts the TF family associated with
the enriched motif. (D, E) DNA methylation pattern of the four analyzed cell types of the retina at exemplified genomic regions. (D) Shown is the average
WGBS signal around the Snx5 gene containing several SAC-specific low methylated regions (purple box) and the Faim gene containing a photoreceptor
specific low methylated region (purple box). Black boxes denote regions displaying low methylation in at least one of the analyzed cell types, indicative of
putative retinal CREs.
(Figure 2C). Photoreceptor CREs share enrichment for the
motif of Otx2, which could also be bound by CRX. Both
factors are critical for the development of the photorecep-
tor lineage (57–59). Interestingly, we find that distinct mo-
tifs for nuclear receptors (NRs) discriminate CREs in cones
versus rods. These include canonical tandem repeat motifs
implyingNRdimerization, but also several monomeric mo-
tifs hinting at a role for orphan NR in this cellular special-
ization (Figure 2C). Our data further suggest a putative role
for Sox- and Nfia-family factors in HCs identity, expanding
on their previously described functions in multiple cellular
differentiation processes within the central nervous system
(60,61). Interestingly, TFAP-motifs discriminate SACs from
other cell types. These motifs are recognized by AP-2 which
has been recently linked to the amacrine cell fate (62).
Importantly, several of the motifs identified within these
cell type specific CREs are potentially bound by TFs that
are differentially expressed in our expression dataset (Fig-
ure 1D). In photoreceptors, these include Otx2 and sev-
eral nuclear receptors (Figures 1D and 2C). In the case of
SACs enrichment of motifs recognized AP-2 family of fac-
tors (Tfap2a–d), is in agreement with the high expression of
Tfap2-a in these cell types. Altogether this dataset provides
a comprehensive catalog of CREs putatively active in four
cell types of the retina and identify sequence determinants
potentially involved in their specificity.
Parallel reporter assay (PRA) in isolated cell types
Having identified a large set of putative CREs active in sev-
eral cell types of the retinal system, we aimed to systemat-
ically test their ability to drive transcription autonomously
in a reporter assay. We adapted the PRA-based strategy
(23,34) to enable measurement of enhancer activity for
thousands of constructs in distinct cell populations of the
mouse retina in vivo using barcoded transcripts (Figure 3A).
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Figure 3. Parallelized reporter assay in specific retinal cell types. (A) Schematic representation of the procedure used to perform parallel reporter assays at
the resolution of single cell types. Putative CREs are selected based on the detection of cell type-specific lowmethylation. Subsets of CREs are batch-cloned
in front of a minimal promoter driving transcription of a GFP cassette followed by a unique barcode. These libraries are packaged into adeno-associated
viruses and injected as pools in retinas of transgenic mice labeled for the cell types of interest. Three weeks following injection, cell populations are FACS
sorted and RNA is extracted. CRE activity is determined as function of the barcode counts in the RNA normalized to the barcode counts in the AAV
gDNA. (B) Histogram representing the distribution of activities observed for putative rod CREs (lowly methylated - green) and control regions (highly
methylated - grey). Fragment activity was determined as ratio of barcode abundance in RNA sample versus abundance in the AAV pool used for infection.
Displayed are average activity values derived from at least 3 biological replicates. CREs that were tested with an individual GFP reporter system are marked
in the plot at their respective activity group. (C–E) Comparison of activity levels measured by PRAwith trans-membraneGFP reporter signal for individual
CREs. Immunohistochemical staining of whole mount and vibratome sections from wild type mouse retinas injected with individual constructs showing
no (C), intermediate (D) or high (E) activity in the PRA assay. Green: GFP, white: Hoechst staining of DNA.
Studying individual cell types within a complex tissue poses
several technical hurdles. Its success relies on the ability to
measure complex libraries of fragments in the target cell
type. This creates the necessity to reproducibly deliver di-
verse DNA libraries and to recover them from cell types un-
der study. This is particularly challenging for cells that are
rare within a tissue, which is the case for most cell types of
the retina and true for most regions of the brain (2,54,63).
To test the general feasibility of our approach (Figure
3A), we first benchmarked our assay using a library that tar-
gets rod photoreceptors as the most abundant retinal cell
type (2,54) using photoreceptor-specific methylation as a
guide. We designed a pilot library of 384 fragments con-
sisting of regions showing low methylation in rods (Figure
2B) plus 13 negative controls chosen to be highly methy-
lated in rods and devoid of DHS signal in the whole retina
(24). Most of the selected sequences arise from CREs that
locate distal from promoters (Supplementary Figure S3B)
and tend to be short (<600 bp, Supplementary Figure S3C).
These sequences were cloned in front of aminimal promoter
and a GFP coding sequence plus a 15 basepair random-
ized barcode at the 3′-end (Supplementary Figure S3A).We
aimed for at least 10 barcodes per sequence to exclude bar-
code specific biases, and enhance technical reproducibility
(29,30; Supplementary Figure S3D). We sequenced these
plasmids to assign each CRE with its corresponding BCs
and excluded barcodes that would associate with more than
one CRE. These constructs were then packaged in high titer
AAV (serotype 8) and subsequently used for sub-retinal in-
jection into eyes of rod-labeled transgenic mice (Supple-
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mentary Table S1). AAV allows for efficient infection of all
target cell types used here due to its broad tropism (64).
Moreover it is able to transduce non-dividing cells, displays
low toxicity and supports strong and persistent transgene
expression (65,66). Three weeks following injection, rods
were isolated by FACS and RNA was extracted from ∼100
000 sorted rods or unsorted total retinas as a control. Bar-
code containing mRNAs were amplified and sequenced.
The efficacy of infection was determined by measuring bar-
code complexity in each sample and by comparing it to the
input viral AAV pool. This revealed an average recovery
of 66%, illustrating that a large proportion of the library
is present in the isolated cell population (Supplementary
Figure S3E). For each of the 258 recovered sequences, we
determined their relative activity as a measure of barcode
abundance in the RNA relative to its DNA copy number
in the viral pool (Figure 3A). This activity measure showed
high reproducibility between samples from independently
injected mice (Supplementary Figure S3F andG). Amajor-
ity of the tested putative rod CREs show only basal activ-
ity that is comparable to our negative controls (Figure 3B)
while ∼25% of the inserted sequences show transcriptional
activity above background. The finding that only a minor-
ity of putative CREs are autonomous in driving detectable
transcription in this ectopic context is expected and in line
with previous reports (21,25,28–31). Importantly however,
active sequences display expression over a wide dynamic
range suggesting that our assay provides a sensitive and
quantitative readout (Figure 3B). Moreover, we observed
high correlation between activity levels observed in rods
with that of total retinas (R = 0.96 - Supplementary Figure
S3H), in agreement with the fact that rods make up ∼65%
of this tissue (2,54).
Out of this library, we independently tested seven con-
structs in vivo, which cover a range of activities measured by
PRA (Figure 3C–E). The fragments were cloned individu-
ally into a reporter system driving expression of GFP fused
to the trans-membrane protein Channelrhodopsin (ChR2).
Individual AAV preparations were injected into eyes of wild
type mice. ChR2-GFP expression pattern in the retina was
analyzed after antibody staining by confocal microscopy
three weeks following injection. While unlikely to reflect
quantitative expression differences, this validation system
should enable to discriminate highly active from inactive
constructs, and to identify the involved cell-types though
spatial distribution of the fluorescence. We indeed observed
a good agreement between PRA-measured activity and the
ChR2-GFP signal observed in the retinal sections (Figure
3C–E). Only the fragments with high PRA signal displayed
detectable GFP levels which are restricted to the photore-
ceptor layer. We conclude that PRA accurately reflects the
autonomous transcriptional activity of DNA fragments in
vivo when performed at the level of single cell types.
Autonomous CRE activities in four retinal cell types
Next we aimed to characterize the autonomous activity of
putative CREs identified in the four cell types of interest:
rods, cones, HCs or SACs (Figure 3A). We designed two
additional libraries that cover a spectrum of putative CREs
based on their local hypo-methylation (Figure 2B). These
libraries contained shared elements but their composition
was biased either toward CRE active in photoreceptors (li-
brary #2) (Supplementary Figure S4A) or interneurons (li-
brary #3) (Supplementary Figure S4B) as measured by dif-
ferential DNA methylation. After generating viral pools,
we infected retinas of adult transgenic mice (P50–150) that
carry specific markers for a particular cell type (3,4; Sup-
plementary Table S1). For each experiment, we sorted cells
from three independently injected mice. We systematically
performed activity measures in the labeled target cell type
and contrasted it with its activity in the remaining unlabeled
cell types of the retina.
We first aimed to characterize the in vivo activity of pu-
tative photoreceptor CREs (Figure 2B) in cones and rods
separately. We infected retinas with AAVs carrying library
#2 that contains elements showing preferential putative ac-
tivity in photoreceptors based on their differential methy-
lation. As observed for our pilot experiment in rods (Fig-
ure 3B), we observed that only a fraction of the tested
CREs drive detectable activity in rods (Figure 4A) or cones
(Figure 4B). Additionally, we found that the tested set of
CREs display very similar activity in rods and cones (Fig-
ure 4C), with only subtle differences between the two cell
types. Thus, we were unable to separate cones from rods
with the tested set of CREs. This is unlikely to be the sole
consequence of contamination by rods as this should not
affect the detection of cone specific elements. More likely, it
could reflect the high similarity in the regulatory networks
active in these two cell types (Figure 2A, B). Alternatively,
we cannot exclude that the episomal reporter system used
here does not accurately recapitulate differences at the chro-
mosomal level between these cell types (67).
The remaining unlabeled cells behaved similarly to rods
and cones. This is mostly due to the fact that these cells con-
tain cones or rods depending on the sorted cell type (Figure
4A, B). Additionally, we cannot exclude that some of the
labeled cells are sorted into the unlabeled fraction if their
signal was low since we aimed for higher stringency in the
labeled cells rather than the unlabeled fraction.
Interneurons such as SACs and HCs on the other hand
differ largely from photo-receptors in their repertoire of
CREs (Figure 2A, B), which would suggest high differen-
tial CRE activity. We then constructed a third library com-
bining 5 fragments identified to have a high autonomous
activity in photoreceptors (Figure 4A–C) with a set of
365 CREs showing low methylation in interneurons (HCs
and/or SACs). We measured the activity of these fragments
in SACs or HCs as well as in the respective remaining un-
labeled cells of the retina. Contrasting CRE activity in in-
terneurons with the remaining unlabeled total retina (com-
posed of ∼65% rod photoreceptors) revealed differences
over three orders of magnitude (Figure 4D, E). In contrast
the two types of interneurons show very similar activity pro-
files for the tested set of fragments (Figure 4F). These ob-
servations are in line with the divergence between the tested
cell types (Figures 1C and 2A) and identify a set of CRE
with differential autonomous activity between photorecep-
tor and interneurons.
Since only a fraction of our tested sequences were ac-
tive in our assay, we wondered if any genetic or chromatin
features enrich at sequences that show autonomous activ-
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Figure 4. Characterization of the autonomous activity of CREs in distinct cell types of the retina. (A, B)Most tested sequences show similar activity in rods
and cones. Scatter plot contrasting activity of CREs as measured by PRA in (A) rods or (B) cones against the remaining pool of unlabeled cells from the
retina. For each experiment fluorescently labeled cells and remaining unlabeled cells were sorted from retinas infected by the AAV PRA library. Displayed
is the normalized activity for each fragment averaged over biological replicates. (C) Scatter plot contrasting activity of CREs as measured by PRA in
rods versus cones. (D, E) Most of the tested sequences show similar activity in HCs and SACs that largely differs from activity observed in whole retina.
Similar scatterplot as in (A-B), contrasting PRA activity in (D) HCs or (E) SACs against the remaining pool of unlabeled cells from the retina. (F) Scatter
plot contrasting activity of CREs as measured by PRA in HCs versus SACs. (G-H) Microscopical validation of the specificity of individual photoreceptor
specific CREs in the tissue context. Shown is Chr2-GFP fluorescence for individual reporter constructs with indicated CRE. Immunohistochemical staining
of vibratome sections from transgenic mouse (cone-labeled, mCAR) retinas injected with two CREs detected by PRA to be active in photoreceptor but
not in interneurons. White, Hoechst; green, GFP; purple, cone marker mCAR. Scale bar, 10 m. Side bar depicts the expected localization of the different
studied cell types based on the considered retina layers. (I and J) Similar validation as in (G-H) for interneuron specific CREs. Shown is Chr2-GFP
fluorescence for individual reporter constructs with indicated CRE. Immunohistochemical staining of retina mounts from transgenic mouse (SAC-labeled,
ChAT) retinas injected with two CREs detected by PRA to be active in interneurons but not in photoreceptors. White, Hoechst; green, GFP; purple, cone
marker ChAT. Scale bar, 10 m. Side bar depicts the expected localization of the different studied cell types based on the considered retina layers.
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ity. Indeed active sequences show a slightly higher enrich-
ment for TF motifs compared to the inactive ones (Supple-
mentary Figure S4C). Enriched motifs include CRX/Otx2
or NR type motifs for photoreceptors and AP2 motifs for
interneurons, suggesting that these factors may be impor-
tant for the activity in the respective cell types. It is impor-
tant to note however that these are also enriched (though
to a lesser degree) in inactive fragments compared to back-
ground sequences (Supplementary Figure S4C), indicating
that presence of these motifs alone is not sufficient to ex-
plain activity. We then asked if methylation or accessibil-
ity of their originating sequences would also help to predict
their activity (SupplementaryFigure S4D,E).None of these
chromatin features could clearly discriminate active from
inactive fragments.However, we noted that fragments active
in photoreceptors tend to show lower methylation levels in
cones when compared to inactive ones (Supplementary Fig-
ure S4D). Additionally, fragments active in photoreceptors
tend to originate from regions showing higher accessibility
in whole-retina (Supplementary Figure S4E). Together, this
suggests that selecting fragments containing a high number
of TF motif occurrences and high levels of chromatin al-
terations (lower methylation levels and high accessibility)
could potentially improve identification of sequences with
autonomous activity.
Having determined the relative activity of individual ele-
ments at the level of mRNA, we next wanted to ask if their
activity is sufficient to autonomously drive the expression
levels of the large reporter gene mentioned above (Chr2-
GFP) in a specific fashion and at levels that can be de-
tected by in situ microscopy. For this we selected 20 CRE
sequences and cloned them into a ChR2-GFP reporter for
individual testing in the entire retina. Compared to conven-
tional GFP, the utilized fusion protein locates to the cel-
lular membrane, which facilitates the identification of reti-
nal cell types in vivo. We observed that only the fragments
showing the highest relative activity in PRA led to robustly
detectable GFP signal in retinal sections for photorecep-
tors (Supplementary Figure S4F) and interneurons (Sup-
plementary Figure S4G). From this small subset, we iden-
tified fragments driving specific activity in photoreceptors
(Figure 4G, H) or in inter-neurons (Figure 4I, J), mirroring
the strong differences observed between these cell-types in
PRA (Figure 4D, E). In contrast to this clear separation of
retinal sub-types (photoreceptors versus inter-neurons), the
expression pattern of the tested fragments was rarely limited
to a single cell-type. Additionally while several CREs dis-
play clear activity in HC and amacrine cells (i.e. Figure 4I,
J, Supplementary Table S2), we did not detect Chr2-GFP
in starbust amacrine cells, the ChAT positive amacrine cell
subtype that we used in the sort. These results likely illus-
trate the inherent limits of the current screen in which we fo-
cused on only four out of the >50 cell types composing the
retina. In summary, we show proof of principle that PRA
can be used to systematically characterize the autonomous
activity pattern of CREs inmultiple cell-types and therefore
identify short DNA fragments able to confer robust tran-
scriptional activity in different cellular subsets of the retina.
A summary of all PRA results is provided as Supplementary
files.
Functional dissection of the architecture of two photoreceptor
CREs
Analysis of the occurrence of sequence motifs within CREs
active in retinal cell types revealed putative TF motifs in-
volved in their regulation (Figure 2C). We aimed to test if
and how some of thesemotifs contribute toCREactivity ec-
topically. Such information would be relevant to better un-
derstand the regulatory landscape that controls cell identity,
but could also provide opportunities to effectivelymodulate
the activity of identified elements.
To do so, we selected two elements that we identified as
being active in photoreceptors (Figure 4C and Supplemen-
tary Table 2) and that contained TFmotifs specific for these
cell types (Figure 5A, B). For these, we generated a library of
sequence mutants to systematically test the effect of delet-
ing each motif instance on CRE activity (Figure 5C, D).
Each motif occurrence detected within the sequence was it-
eratively replaced with a random sequence (Figure 5C, D),
generating a collection of individual mutants for each frag-
ment.
Performing PRA with this mutant library identifies di-
verse effects depending on the mutation. This included re-
duced activity upon motif randomization as might be ex-
pected from removing a binding site for an activating fac-
tor. However, we also detect in several cases increased lev-
els of CRE activity upon ablation of TF motifs suggesting
removal of a binding site for a repressive factor. Together
this suggests that negative and positive regulatory inputs
co-exist to modulate precise activity level of these particular
CREs.
More specifically we detect reduced CRE activity upon
deletion of CRX/Otx2, Sp1 or motifs typically bound by
factors containing a homeodomain (Figure 5C, D). This is
in agreement with the notion that these motifs act as ac-
tivators. In contrast, mutating the conserved monomeric
NRmotif enhanced CRE activity (Figure 5C), arguing that
NR mediated repression negatively modulates the activity
of this element (Faim-Intra). This evidence for repression
seems particularly interesting given that this element al-
ready displayed the highest activity in our screen (Figure
4C). Similarly, deletion of the NRL motif enhances CRE
activity suggesting that NRL can act as a repressor in this
context. This potentially reveals a novel mechanism of ac-
tion for NRL that was hitherto only known for its activa-
tion function at the rhodopsin promoter (56,68). In sum-
mary, we show how PRA assays can be used to identify and
functionally annotate determinant TF motifs within CREs.
Moreover, we demonstrate how discrete sequence changes
can be used to rationally enhance or reduce transgene ex-
pression levels in vivo.
DISCUSSION
Using transcriptome and epigenome profiling, this study
identifies a large collection of putative cis-regulatory ele-
ments active in four distinct cell types of the retina. Addi-
tionally, we provide proof of concept for the usage of par-
allel reporter assays to measure the autonomous transcrip-
tional activity within the retinal tissue at the level of indi-
vidual cell types. We successfully apply this framework to
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Figure 5. Dissection of the architecture of two photoreceptor CREs. (A, B) DNA methylation pattern of the four analyzed cell types of the retina around
the two CREs selected for functional dissections (purple box); (A) Faim-Intra and (B) Intragenic 3 enhancers. Black boxes denote regions displaying low
methylation in at least one of the analyzed cell types, representing putative retinal CREs. The TF architecture of the CREs is detailed, showing the TF
binding sites identified (colored according to the TF family as in Figure 2C) and the PhyloP conservation track for the region. (C, D) Effects on activity
of systematic deletion of TF motifs for two CREs. Each motif identified in the CRE sequence was iteratively replaced by a randomized sequence (shown
in upper panel). Activity of the generated library of mutants was compared to the wild type sequence. Boxplots represents the distribution of individual
measurements from different biological replicates. Statistical significance of changes in activity were tested using a bidirectional t-test (*P < 0.05; **P <
0.01).
define the activity pattern of hundreds of short DNA se-
quences in several cell types of the retina. This effort let to
the identification of a small set of short sequences show-
ing preferential activity in different cellular subsets of the
retina. We also demonstrate how this technology can be
used to dissect the architecture of regulatory regions in vivo.
PRA has been previously applied in vivo but without dis-
criminating between specific cell types that make up a tissue
(23,38,40). Here we use FACS-sorting on a library of mouse
lines, where various cell types are fluorescently labeled. This
enables reproducible isolation of pure cell populations (3,4),
but is inherently constrained by the number of cells avail-
able, which is particularly limiting for rare cell types. In or-
der to circumvent these bottlenecks and to derive accurate
PRAmeasures for low cell numbers, we combined high effi-
ciency AAV-based delivery of our libraries with multiplexed
measures for each fragment. When contrasting whole tis-
sue with cell-type specific data we observed that whole tis-
sue data only reflects sequence activity in photoreceptors,
which is the dominant cell type in mouse retina. Conse-
quently whole tissue analysis failed to capture activities in
rare cell types thus demonstrating that cell type isolation
and activity assignment is critical.
It has recently been established that DNA hypo-
methylation at distal regulatory regions coincides with their
accessibility and putative activity in many cell types and tis-
sues (18,49). Here we used this epigenetic feature as a guide
to nominate CREs active in a cell-type specific manner. In
agreement with previous reports (21,25,28–31), most of the
hypo-methylated CREs tested failed to autonomously drive
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transcription in our reporter assay. Using chromatin acces-
sibility data available for some cell types (26), we found that
most of these inactive sequences are indeed accessible, rul-
ing out that alterations of DNA methylation dynamics (as
observed in rods (26)) could explain this high rate of nega-
tives. Alternatively, we think that this result can likely be ex-
plained by the inherent inability of some CREs to function
autonomously (21,25,28–31), their incompatibility with the
TATA containing minimal promoter used in this assay (69)
and/or the truncation of the regulatory element in our sys-
tematic library design (21,25,28–31). In any case, this con-
firms the requirement of a high throughput screening strat-
egy to identify CREs that function autonomously.
Mining of the resulting datasets identified TF binding
motifs that associate with cell type specific activity within
the retina. Mutational analysis indeed reveals functional
relevance for these motifs within a given CRE. One strik-
ing observation was the enrichment for NR motifs within
sequences active in photoreceptors. This included differen-
tial enrichment of monomeric NRmotifs between rods and
cones, suggesting a role for orphan NRs in distinguishing
between these closely related cell types. Importantly dele-
tion of this motif leads to increased activity in an example
CRE, which is in agreement with the repressive function as-
signed to some orphan NR (70). While the motif does not
reveal the responsible TF, we note that only a few candidate
orphan NRs are differentially expressed between rods and
cones, whichwe hypothesize to be likely candidates (Supple-
mentary Figure S4C). One of these is Nr1h3 (LXR) a well-
known regulator of lipid metabolism in liver. This factor is
highly expressed in cones and was recently linked to the de-
velopment of the zebrafish visual system (71). Another rele-
vant finding relates to the recognitionmotif forNRL, which
is a known decisive factor during photo-receptor differenti-
ation (56,72). Mutations of this motif resulted in enhanced
CRE activity, indicating an unexpected repressive role for
NRL at least within the tested element. This contrasts with
its function at the rhodopsin promoter (56,68,72), suggest-
ing that NRL function could be context specific, in line with
recent reports of regulation of its activity through complex
interactions (73).
For several inherited retinal diseases, gene-replacement
or targeted expression of optogenetic sensors is considered a
credible strategy to reverse phenotypes and at least partially
restore vision (5–7). Such approach critically relies on short
sequences that can drive expression of a transgene from an
AAV in a defined cell type in vivo. Our parallel measure-
ments defined the expression pattern within four defined
cell types for a catalogue of short sequences in the mouse
retina. Testing the ability of a subset of these CREs to drive
levels of transgene relevant for cellular manipulation high-
lights the importance of selecting CREs displaying specific
but also strong activity patterns. In the current screen, we
identified a small set of sequences with preferential expres-
sion in different cellular subtypes of the retina, but not iden-
tifying unique cell types. Yet only sequences displaying the
highest activity level in our parallel assay led to expression
levels of a fusion reporter protein considered to be sufficient
for cellular manipulation. Thus targeting of disease rele-
vant cell-types of the retina, will ultimately require a bet-
ter understanding of the sequence features that define cell
type specific expression and thus further screening efforts
and sequence engineering to more cell types. The current
study demonstrates that PRA applied at the cell type spe-
cific level provides throughput and sensitivity to contribute
to this goal.
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Supplementary gure 1: 
(A) Reproducibility of cell isolation as measured by RNA-seq. Correlation heatmap comparing 
RNA-seq signal for biological replicates. Pearson correlation for genic RNA-seq signal for samples 
issued from independent cell sorts for each cell type studied. 
 (B) Comparison of the generated expression proles with photo-receptors sorted by INTACT 
nuclei-purication procedure. Correlation heatmap comparing RNA-seq signal obtained in this 
study using whole cell purication (bold labels) with previously generated nuclear RNA-seq 
datasets for the same cell types (Mo et al, 2016) (normal labels).  
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Supplementary gure 2: 
(A) Comparison of the generated WGBS data with datasets previously generated by 
INTACT-nuclei purication procedure. Correlation heatmap comparing single CpG methyla-
tion levels at LMRs (bold labels) with previously generated datasets for retinal and neuronal 
cell types (Mo et al, 2015, 2016) (normal labels).  
(B) Rod specic hypo-methylation is observed at the Rhodopsin gene locus. Shown is the 
average smoothed methylation for the indicted cell types over a 70 kb chromosomal region 
around the rod specic Rhodopsin gene. Read counts for accessibility measure of total retinas 
(ATAC-seq) is shown as smoothed signal. Black boxes denote regions having low methylation 
in at least one of the analyzed cell types, representing putative retinal CREs. (C-H) Variation of 
DNA methylation levels at LMRs across the four retina cell types. Pairwise smoothed scatter 
plots representing average methylation levels for LMRs in the corresponding cell types. (I) 
Quantitative comparison of methylation levels at LMRs with chromatin accessibility as meas-
ured by ATAC-seq. Correlation heatmap comparing average methylation levels at LMRs (bold 
labels) with previously generated ATAC-seq datasets in whole-retina and isolated photore-
ceptors (Mo et al, 2016) (normal labels). (J) Overlap between cell type-specic LMRs identied 
in isolated cell types with accessibility in whole-retina and photoreceptors. Heatmap depict-
ing the percentage overlap between LMRs detected in isolated cell types (x axis) and 
ATAC-seq signal in whole retina or isolated photoreceptors (log2(RPKM)>0.5) (y axis) (Mo et al, 
2016).  
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Supplementary gure 3: 
(A) Experimental procedure used to construct the PRA libraries.
Methylation maps informed on putative CREs, fragments were PCR amplied in 384-well format 
and pooled. Pooled fragments were cloned into a vector containing the expression cassette 
consisting of a multiple cloning site, a random 15bp barcode sequence and a polyA signaling 
sequence (pA). In order to average out the contribution of barcode specic biases to the signal 
we aimed for at least ten dierent barcodes per unique fragment. To link CREs to barcodes the 
CRE-barcode sequences were amplied using Primer #2 and one of the Indexing primers (Prim-
ers #3-11) containing the Illumina ow cell annealing sequences. PCR products were puried 
and sequenced. Next the vector was cut between the enhancer and BC and a sequence contain-
ing a 31bp minimal promoter, CpG free eGFP and the annealing sequence for Primer #1 was 
cloned in. Subsequently the construct was cut out of the cloning vector into the AAV vector for 
virus packaging. (Also see methods)
(B) Most tested putative CREs are located kilobases away from genes. Histogram displaying 
distance distribution of assayed CREs to nearest transcriptional start site.  (C) The tested CREs 
are restricted in size, not exceeding 600bp. Histogram displaying size distribution of assayed 
CREs. 
(D) Histogram displaying distribution of number of barcodes per CRE. The red line indicates 
cuto for minimal number of Barcodes per CRE in the reporter assay (3 BCs), the blue line repre-
sents median BCs per CRE (13 BCs).
(E) Fraction of recovered barcodes scales the number of sampled cells and cell number tested. 
Boxplot displaying percentage of unique barcodes recovered in the dierent cell types relative 
to their representation in the AAV input for all cell types tested. Each box shows % recovered 
barcodes of all replicates for per cell type. 
(F) PRA signal reproducibility at the level of barcodes in sorted rod photoreceptors.  Reproduci-
bility of barcode level activity is illustrated here by comparing two independent biological 
replicates. 
(G) Using multiple barcodes to derive CRE activity levels enhance PRA accuracy. PRA signal 
reproducibility at the level of fragment in sorted rod photoreceptors. Activities of multiple 
barcodes (median ~13) is used to derive mean activity for each tested fragment to reducing the 
technical noise of the assay. 
(H) The tested set of CRE shows very similar activity between rods and whole retina. Scatterplot 
comparing activity of CREs at the fragment level in whole Retina and rods.
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Supplementary gure 4:
(A-B) Scatterplot depicting the average methylation levels of the regions used to design the 
constructs in (A) library #2 and (B) library #3. Methylation is compared among photoreceptors or 
interneurons. 
(C) Active fragments have slightly more TF binding sites than inactive ones. TF motifs enriched 
within fragments showing activity in photoreceptors or interneurons. Activity of a fragment was 
dened by PRA. Shown are motif occurrence frequencies in % for the indicated set of fragments 
after subtracting motif frequency in a background set of sequences. (D) Methylation levels of 
endogenous regions from which fragments originate are displayed as a function of their activity 
in the PRA. (E) Active fragments tend to have higher chromatin accessibility than inactive ones. 
Same as D but showing chromatin accessibility of endogenous regions relative to their activity in 
the PRA. ATAC-seq data from whole retina were used (Mo et al, 2016). p-values were derived 
using a bi-directional t-test. (F-G) Single fragment validation results are in good agreement with 
PRA activity measures. Boxplot depicting comparing the PRA measured activity for fragments 
showing or not detectable Chrd2-GFP in (F) photoreceptors (G) interneurons. The fragments 
where Chr2-GFP is detected by immunostaining have signicantly higher PRA activity in the 
respective cell type. P-value was calculated using an unidirectional t-test.
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Supplementary gure 5: 
(A) Repertoire of nuclear receptors expressed in the studied cell types. Heatmap representing 
RPKM for nuclear receptors expressed in at least one of the studied cell type.  Heatmap was 
organized by hierarchical clustering.
	
cell	type	 mouse	strain	
rods	 b2-Cre	x	B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J	#	007913	
cones	 d4-Cre	x	B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J	#	007911	
horizontal	cells	 B6Cf1-Tg(Gja10-Cre,	#14)BR	x	B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J	#	007917	
starburst	amacrine	cells	 129S6-Chat_tm1(cre)Lowl/J	x	B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J	#	007921	
	
Supplementary	Table	1:		
Table	of	mouse	strains	used	to	FACS	sort	specific	cell	types	from	the	whole	retina	(Siegert	et	al,	2009).	
	
GFP signal detected in
Supplementary Table 2:
Table of individually tested enhancers and their activity pattern in the whole retina and log2 
activity in csPRA. Second last column shows in which cell types GFP signal was detected under 
the microscope when single CREs were tested. 'negative' means no GFP signal could be found. 
The last column shows in which cell type CREs are expected to be active in csPRA. 'negative' 
means that activity is below threshold in csPRA.
Sequences	  of	  mutated	  CREs:	  
	  
>107_WT	  
GAGGCTTTCACTGACCTTTCCATGTACGAGACTAGCCCCGCCCAGAGTGCTGTCTGGGATTAACTGTTACAGTCT
TAATTGTATTAGTATTTAGGTGACTTTGGGATTATTAGACTATTCCTGTGCATAGCTGCCTCTTGAGGGGAGAGC
CGGGAGAGAGAAGCAGCTGCATGTGCTGTGAGTAGGACATCTGGGGGCATCACTTTACCATCTCATAGTTCTA
GGGCCCTTGAAAACCTGGTATTGTCATGCTGGAAGGGT	  
>107_all_MEIS1_mut	  
GAGGCTTTCACTGACCTTTCCATGTACGAGACTAGCCCCGCCCAGAGTGCTGTCTGGGATTAACTGTTACAGTCT
TAATTGTATTAGTATTTAGGTGACTTTGGGATTATTAGACTATTCCTGTGCATAGCTGCCTCTTGAGGGGAGAGC
CGGGAGAGAGAAGCAGCTGCATGTGCTGTGAGTAGGACATCTGGGGGCATCACTTTACCATCTCATAGTTCTA
GGGCCCTTGAAAACCTGGTTTCTAGTTGCTGGAAGGGT	  
>107_all_SP1_mut	  
GAGGCTTTCACTGACCTTTCCATGTACGAGACTAAGGTAGTACAGAGTGCTGTCTGGGATTAACTGTTACAGTC
TTAATTGTATTAGTATTTAGGTGACTTTGGGATTATTAGACTATTCCTGTGCATAGCTGCCTCTTGAGGGGAGAG
CCGGGAGAGAGAAGCAGCTGCATGTGCTGTGAGTAGGACATCTGGGGGCATCACTTTACCATCTCATAGTTCT
AGGGCCCTTGAAAACCTGGTATTGTCATGCTGGAAGGGT	  
>107_all_ID4_mut	  
GAGGCTTTCACTGACCTTTCCATGTACGAGACTAGCCCCGCCCAGAGTGCTGTCTGGGATTAACTGTTCAGTCTT
AATTGTATTAGTATTTAGGTGACTTTGGGATTATTAGACTATTCCTGTGCATAGCTGCCTCTTGAGGGGAGAGCC
GGGAGAGAGACGCGATAGCATGTGCTGTGAGTAGGACATCTGGGGGCATCACTTTACCATCTCATAGTTCTAG
GGCCCTTGAAAACCTGGTATTGTCATGCTGGAAGGGT	  
>107_all_Nr1h3_mut	  
GAGGCTTTCATTACAATTTCCATGTACGAGACTAGCCCCGCCCAGAGTGCTGTCTGGGATTAACTGTTACAGTCT
TAATTGTATTAGTATTTAGGTGACTTTGGGATTATTAGACTATTCCTGTGCATAGCTGCCTCTTGAGGGGAGAGC
CGGGAGAGAGAAGCAGCTGCATGTGCTGTGAGTAGGACATCTGGGGGCATCACTTTACCATCTCATAGTTCTA
GGGCCCTTGAAAACCTGGTATTGTCATGCTGGAAGGGT	  
>483_WT	  
CGGGGCAGGAGTGAGTCATTCACACAGAGGCGGGTCAGAGAGTAGTGGTCACTCTTCAGCTTACAGCTCTCTC
TAGTCCTCTATCCAGACTCTAGTTTCATGAACTTTGTAGTTAGACATTTTTCCTAGTGAATATTTATTACCCCCCAC
TGTAATCCTTCATTTAACATAATATAAAATTTGTGGAAAGGGAGAGTAATTAGTAATAAATCATCATCTCATCCA
TTAGCAGTAAATAATGCCACTTTATCAAAGTCACAGCCATCGAACAGGCGGCTAGAGGTGGTTATGTATGCCAC
CCGACTGGAAGCAGGCCAAAAGCAAACCGCAGCCCCCGTTTATTATCCTAATTATGCCCTAATACGATGCCATC
TTTTTCTCCTATAAACTTGATGACAATAAAAGGGTAACAATGAAAATTGGCAGGGTAAGTGAGCAAGGAAGAT
AGGCTGGGAAACCACCTAGCCCCACCGGCTACCA	  
GCCTGAGTCCTGAGGCTGAAAGGGCTGAAAACCCCATGGGAATGAAATGGAGCAGGGGACTCAAGTGGTTGG	  
>483_all_MEIS1_mut	  
CGGGGCAGGAGTGAGTCATTCACACAGAGGCGGGTCAGAGAGTAGTGGTCACTCTTCAGCTTACAGCTCTCTC
TAGTCCTCTATCCAGACTCTAGTTTCATGAACTTTGTAGTTAGACATTTTTCCTAGTGAATATTTATTACCCCCCAC
TGTTCTAGTTCATTTAACATAATATAAAATTTGTGGAAAGGGAGAGTAATTAGTAATAAATCATCATCTCATCCA
TTAGCAGTAAATAATGCCACTTTATCAAAGTCACAGCCATCGAACAGGCGGCTAGAGGTGGTTATGTATGCCAC
CCGACTGGAAGCAGGCCAAAAGCAAACCGCAGCCCCCGTTTATTATCCTAATTATGCCCTAATACGATGCCATC
TTTTTCTCCTATAAACTTGATGACAATAAAAGGGTAACAATGAAAATTGGCAGGGTAAGTGAGCAAGGAAGAT
AGGCTGGGAAACCACCTAGCCCCACCGGCTACCA	  
GCCTGAGTCCTGAGGCTGAAAGGGCTGAAAACCCCATGGGAATGAAATGGAGCAGGGGACTCAAGTGGTTGG	  
>483_all_CRX_mut	  
CGGGGCAGGAGTGAGTCATTCACACAGAGGCGGGTCAGAGAGTAGTGGTCACTCTTCAGCTTACAGCTCTCTC
TAGTCCTCTATCCAGACTCTAGTTTCATGAACTTTGTAGTTAGACATTTTTCCTAGTGAATATTTATTACCCCCCAC
TGTAATCCTTCATTTAACATAATATAAAATTTGTGGAAAGGGAGAGTAATTAGTAATAAATCATCATCTCATCCA
TTAGCAGTAAATAATGCCACTTTATCAAAGTCACAGCCATCGAACAGGCGGCTAGAGGTGGTTATGTATGCCAC
CCGACTGGAAGCAGGCCAAAAGCAAACCGCAGCCCCCGTTTATTATCCTAATTATGCCCTAATACGATGCCATC
TTTTTCTCCTATAAACTTGCAGGTGTTAAAAGGGTAACAATGAAAATTGGCAGGGTAAGTGAGCAAGGAAGAT
AGGCTGGGAAACCACCTAGCCCCACCGGCTACCA	  
GCCTGAGTCCTGAGGCTGAAAGGGCTGAAAACCCCATGGGAATGAAATGGAGCAGGGGACTCAAGTGGTTGG	  
>483_all_NRL_mut	  
CGGGGCAGGAGTGAGTCATTCACACAGAGGCGGGTCAGAGAGTAGTGGTCACTCTTCAGCTTACAGCTCTCTC
TAGTCCTCTATCCAGACTCTAGTTTCATGAACTTTGTAGTTAGACATTTTTCCTAGTGAATATTTATTACCCCCCAC
TGTAAGCGAACGTAGAACATAATATAAAATTTGTGGAAAGGGAGAGTAATTAGTAATAAATCATCATCTCATCC
ATTAGCAGTAAATAATGCCACTTTATCAAAGTCACAGCCATCGAACAGGCGGCTAGAGGTGGTTATGTATGCCA
CCCGACTGGAAGCAGGCCAAAAGCAAACCGCAGCCCCCGTTTATTATCCTAATTATGCCCTAATACGATGCCAT
CTTTTTCTCCTATAAACTTGATGACAATAAAAGGGTAACAATGAAAATTGGCAGGGTAAGTGAGCAAGGAAGA
TAGGCTGGGAAACCACCTAGCCCCACCGGCTACCA	  
GCCTGAGTCCTGAGGCTGAAAGGGCTGAAAACCCCATGGGAATGAAATGGAGCAGGGGACTCAAGTGGTTGG	  
>483_all_En2_mut	  
CGGGGCAGGAGTGAGTCATTCACACAGAGGCGGGTCAGAGAGTAGTGGTCACTCTTCAGCTTACAGCTCTCTC
TAGTCCTCTATCCAGACTCTAGTTTCATGAACTTTGTAGTTAGACATTTTTCCTAGTGAATATTTATTACCCCCCAC
TGTAATCCTTCATTTAACATAATATAAAATTTGTGGAAAGGGAGAGCGGAGTAAACTAAATCATCATCTCATCCA
TTAGCAGTAAATAATGCCACTTTATCAAAGTCACAGCCATCGAACAGGCGGCTAGAGGTGGTTATGTATGCCAC
CCGACTGGAAGCAGGCCAAAAGCAAACCGCAGCCCCCGTTTATTATCCCGGAGTAAACCTAATACGATGCCATC
TTTTTCTCCTATAAACTTGATGACAATAAAAGGGTAACAATGAAAATTGGCAGGGTAAGTGAGCAAGGAAGAT
AGGCTGGGAAACCACCTAGCCCCACCGGCTACCA	  
GCCTGAGTCCTGAGGCTGAAAGGGCTGAAAACCCCATGGGAATGAAATGGAGCAGGGGACTCAAGTGGTTGG	  
	  
	  
	  
	  
Primers	  used	  for	  csPRA	  library	  preparation:	  
	  
Name	   Sequence	  
Primer	  #1	   AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT	  
Primer	  #2	   AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTCCACTGGGAGAAGAGGAAGTCAAA	  
	  
Indexing	  Primers:	  
Name	   Sequence	   Index	  
Primer	  #3	   CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   1	  
Primer	  #4	   CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   2	  
Primer	  #5	   CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   6	  
Primer	  #6	   CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   12	  
Primer	  #7	   CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   4	  
Primer	  #8	   CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   7	  
Primer	  #9	   CAAGCAGAAGACGGCATACGAGATGACTGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   5	  
Primer	  #10	   CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   8	  
Primer	  #11	   CAAGCAGAAGACGGCATACGAGATGTGATCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT	   9	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4 General	discussion	and	Conclusions	Within	 this	 thesis	 design	 principles	 of	 promoter	 and	 enhancer	 activity	 in	mammalian	genomes	were	investigated	using	the	mouse	as	a	model	system.	This	has	been	achieved	 through	 the	development	of	an	advanced	reporter	assay	 for	transcriptional	 activity.	 This	 allowed	 to	 test	 the	 activity	 of	 regulatory	 regions	integrated	 into	genomic	DNA	or	within	 specific,	 low	abundant	 cell	 types	 in	 the	retina.	In	the	first	study,	we	show	that	CpG	density	contributes	to	CGI	promoter	activity	in	 combination	 with	 the	 binding	 of	 specific	 TFs.	 This	 finding	 is	 likely	 to	 be	generalizable	to	other	vertebrates	and	their	CGI	promoters.	The	second	project	provided	proof	of	concept	for	how	active	regulatory	regions	can	be	identified	and	tested	for	their	transcriptional	activity	in	high-throughput	in	individual	cell	types	of	the	retina.	This	strategy	has	the	potential	to	be	used	for	other	cell	types	and	tissues	in	a	variety	of	organisms.		
4.1 Design	principles	of	CpG	island	promoter	activity	CGIs	 were	 identified	 nearly	 three	 decades	 ago	 based	 on	 their	 lack	 of	 DNA	methylation	(Bird	et	al,	1985).	Since	then,	their	high	CpG	density	has	been	linked	to	active	chromatin	and	transcriptional	activity	by	correlative	means	(Weber	et	
al,	 2007;	 Guenther	 et	 al,	 2007;	 Thomson	 et	 al,	 2010;	 Deaton	 &	 Bird,	 2011;	Fenouil	et	al,	2012).	Recently,	attempts	were	taken	to	functionally	assay	the	role	of	 CpGs	 in	 CGIs	 (Lienert	 et	al,	 2011;	 Krebs	 et	al,	 2014;	 Wachter	 et	al,	 2014).	However,	 to	 what	 extend	 and	 how	 high	 CpG	 density	 contributes	 to	transcriptional	activity	of	CGI	promoters	remained	unclear.	Our	initial	computational	analysis	showed	that	CpG	density	and	motif	occurrence	perform	 well	 in	 predicting	 binding	 of	 specific	 TFs.	 However,	 the	 non-uniform	distribution	 of	 CpGs	 within	 mammalian	 genomes	 and	 the	 lack	 of	 CpG	 dense	regions	 that	 are	 not	 under	 functional	 selection	makes	 it	 inherently	 difficult	 to	assign	a	functional	role	to	CpGs.	To	circumvent	this	problem,	we	assayed	a	large	number	 of	 promoter	 mutants	 for	 their	 transcriptional	 activity.	 These	 assays	show	 that	 CpG	 density	 does	 indeed	 functionally	 contribute	 to	 transcriptional	
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activity	of	CGI	promoters	in	combination	with	the	presence	of	more	complex	TF	motifs.	Our	 data	 indicate	 that	 the	 CpG	 density	 required	 for	 transcriptional	 activity	 is	around	0.6	(OE)	or	higher	which	we	observed	in	most	promoter	mutants	across	all	 experiments.	 This	 value	 is	 surprisingly	 similar	 to	 the	 currently	 used	 CGI	definition.	The	same	 threshold	can	also	be	deduced	 from	ChIP-seq	data	of	 four	TFs	that	were	mapped	genome-wide	within	this	study.	More	motifs	are	occupied	when	the	CpG	density	is	>0.6	while	much	fewer	are	bound	at	lower	densities.	We	speculate	 that	 these	 differences	 are	 linked	 to	 accessibility	 of	 the	 regions.	 In	agreement	with	this,	accessibility	increases	with	CpG	density.	This	is	consistent	with	 published	data	 showing	 that	 CpG	 and	GC	 rich	 artificial	 sequences	 display	marks	of	accessible	chromatin	(Wachter	et	al,	2014;	Lienert	et	al,	2011;	Krebs	et	
al,	2014).		The	 putative	 link	 between	 CpG	 density	 and	 accessibility	 raises	 the	 question	 if	accessibility	 decreases	 upon	 CpG	 depletion	 in	mutant	 constructs	with	 reduced	CpG	density.	To	answer	this	question,	changes	in	accessibility	could	be	tested	on	the	mutant	CpG	density	constructs	using	NOMe-seq	(Kelly	et	al,	2012;	Nabilsi	et	
al,	2014;	Krebs	et	al,	2017).	Additionally,	histone	modifications	could	play	a	role	in	 changes	 in	 activity	 observed	 upon	 mutation	 of	 CpGs.	 For	 example,	 it	 was	shown	that	CGI	promoters	are	depleted	in	H3K36me2,	catalyzed	by	the	ZF-CxxC	domain	 containing	 histone	 demethylase	 KDM2A	 (Blackledge	 et	al,	 2010).	 One	potential	 scenario	 could	 be	 that	 unmethylated	 CpGs	mediate	 demethylation	 of	H3K36me2	 at	 the	promoter,	 thus	 preventing	H3K36me2	 from	 interfering	with	transcriptional	initiation.	This	model	could	be	further	tested	by	performing	ChIP	on	individual	CpG	mutant	constructs.	In	 non-transformed	 cells,	 DNA	 methylation	 does	 not	 occur	 at	 CpG	 rich	 DNA	sequences	but	only	at	those	with	lower	CpG	density	(Lienert	et	al,	2011;	Krebs	et	
al,	 2014).	 Thus,	 we	 wondered	 how	 DNA	 methylation	 would	 affect	 the	transcriptional	activity	of	CpG	density	mutant	promoters.	Our	results	argue	that	removal	of	DNA	methyltransferases	 leads	 to	 increased	activity	of	mutants	with	low	CpG	densities.	One	might	speculate	that	high	CpG	density	is	required	at	CGIs	to	prevent	DNA	methylation	which	would	allow	binding	of	methylation	sensitive	TFs.	 A	 protective	 function	 of	 high	 CpG	 density	 against	 DNA	methylation	 could	
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also	explain	why	high	CpG	density	together	with	motif	occurrence	is	such	a	good	predictor	of	TF	binding.	Taken	 together	 our	 results	 suggest	 that	 high	CpG	density	 at	 CGIs	 is	 not	 only	 a	relict	of	evolution	due	to	its	unmethylated	state	in	the	germline.	Rather,	CpGs	are	required	for	high	transcriptional	activity	of	CGI	promoters.			
4.2 	Cis-regulatory	landscape	of	four	cell	types	of	the	retina	The	identification	of	cis-regulatory	elements	is	essential	 in	order	to	understand	the	 transcriptional	 regulatory	 principles	 that	 control	 cell-type	 specification.	Using	transcriptome	and	epigenome	profiling,	we	identified	a	large	collection	of	putative	 cis-regulatory	 elements	 active	 in	 four	 distinct	 cell	 types	 of	 the	 retina.	Additionally,	 we	 provide	 proof	 of	 concept	 for	 the	 usage	 of	 parallel	 reporter	assays	to	measure	the	autonomous	transcriptional	activity	of	regulatory	regions	in	 individual	 retinal	 cell	 types.	 We	 successfully	 applied	 this	 assay	 to	 quantify	activity	 of	 hundreds	of	 short	DNA	 sequences	 in	 four	 individual	 cell	 types.	This	effort	allowed	us	to	identify	a	small	set	of	short	sequences	that	are	preferentially	active	 in	different	 cellular	 subsets	of	 the	 retina.	Additionally,	we	demonstrated	how	 this	 technology	 can	 be	 employed	 for	 dissection	 of	 the	 architecture	 of	regulatory	regions	in	vivo.		Parallel	 reporter	 assays	 have	 been	 previously	 applied	 in	 vivo	 but	 without	discriminating	between	specific	cell	types	that	make	up	a	tissue	(Gisselbrech	et	
al,	2014;	Shen	et	al,	2015;	Patwardhan	et	al,	2012).	We	used	FACS-sorting	on	a	library	 of	 mouse	 lines	 with	 various	 fluorescently	 labeled	 retinal	 cell	 types	enabling	 reproducible	 isolation	 of	 pure	 cell	 populations	 (Siegert	 et	 al,	 2009,	2012).	However,	this	approach	is	inherently	constrained	by	the	number	of	cells	available,	 which	 is	 limiting	 in	 the	 case	 of	 rare	 cell	 types.	 To	 circumvent	 these	bottlenecks	and	to	derive	accurate	parallel	reporter	assay	measures	for	low	cell	numbers,	we	combined	high	efficiency	Adeno-associated	virus-based	delivery	of	our	libraries	with	multiple	measures	for	each	fragment.	Contrasting	whole	tissue	with	 cell-type	 specific	 data	 demonstrated	 that	 whole	 tissue	 data	 only	 reflects	sequence	 activity	 in	 photoreceptors,	which	 is	 the	 dominant	 cell	 type	 in	mouse	retina.	Consequently,	analysis	on	whole	tissue	failed	to	capture	activities	in	rare	
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cell	 types,	 demonstrating	 that	 cell	 type	 isolation	 and	 activity	 assignment	 is	critical.	Besides	the	potential	to	advance	our	understanding	of	regulatory	principles,	the	introduced	 experimental	 strategy	 is	 capable	 to	 identify	 candidate	 regulatory	elements	 controlling	 transgene	 activity	 for	 gene	 therapy.	 For	 several	 inherited	retinal	 diseases,	 gene-replacement	 or	 targeted	 expression	 of	 transgenes	 is	considered	 a	 credible	 strategy	 to	 at	 least	 partially	 restore	 vision	 (Boye	 et	 al,	2013;	Nash	et	al,	2015;	Sahel	&	Roska,	2013).	 Ideally	such	regulatory	elements	are	 short	 and	 specifically	 active	 in	 the	 target	 cell	 type.	 We	 determined	 the	expression	pattern	of	putative	regulatory	regions	within	 four	cell	 types	 leading	to	a	catalogue	of	short	sequences	that	drive	expression	in	the	mouse	retina.	This	screen	 allowed	 us	 to	 identify	 a	 small	 set	 of	 sequences	 that	 are	 preferentially	expressed	in	different	cellular	subtypes	of	the	retina,	but	not	uniquely	in	one	cell	type.	 Targeting	 of	 disease	 relevant	 cell-types	 of	 the	 retina	 specifically,	 will	require	 a	 better	 understanding	 of	 the	 sequence	 features	 defining	 cell	 type	specific	expression.	Therefore,	further	screening	in	more	cell	types	is	required.	Additionally,	we	demonstrated	that	mutation	of	TF	motifs	can	be	utilised	to	tune	transcriptional	 activity	 of	 identified	 cis-regulatory	 elements.	 Such	 mutations	could	 be	 utilised	 to	 obtain	 accurate	 expression	 levels	 of	 the	 transgene	 for	restoration	of	cellular	function.			Taken	 together,	 the	 work	 presented	 here	 advances	 our	 knowledge	 about	location	 and	 regulation	 of	 regulatory	 regions	 that	 function	 in	 specialised	 cell	types	and	also	provides	insight	into	the	regulation	of	CGI	promoters	that	tend	to	be	ubiquitously	expressed.			 	
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